<!DOCTYPE HTML PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html lang="en" xmlns="http://www.w3.org/1999/xhtml" xml:lang="en">

<!DOCTYPE HTML PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">

<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">


<meta name="wpd_version" content="0.2">
<meta name="wpd_baseurl" content="http://www.annualreviews.org.proxy.library.emory.edu/doi/full/10.1146/annurev.med.46.1.133?select23=Choose">
<meta name="wpd_url" content="http://www.annualreviews.org.proxy.library.emory.edu/doi/full/10.1146/annurev.med.46.1.133?select23=Choose">
<meta name="wpd_date" content="2010-10-28T03:37Z">






    
    
            

















            
                
            
              








    









        
        
    



        
        
    
<title>MOLECULAR APPROACHES TO AMYOTROPHIC LATERAL SCLEROSIS - Annual Review of Medicine, 46(1):133 </title>














            

<meta name="robots" content="noarchive,nofollow">




<link rel="schema.DC" href="http://purl.org.proxy.library.emory.edu/DC/elements/1.0/"><meta name="dc.Title" content="MOLECULAR APPROACHES TO AMYOTROPHIC LATERAL SCLEROSIS"><meta name="dc.Creator" content=" R. Glenn Smith, M.D., Ph.D.  and "><meta name="dc.Creator" content=" Stanley H. Appel, M.D."><meta name="dc.Subject" content="autoimmune motoneuron injury; calcium channel; excitotoxicity; oxidative injury; superoxide dismutase deficiency"><meta name="dc.Description" content="▪ Abstract New discoveries are expanding our knowledge of mechanisms involved in amyotrophic lateral sclerosis (ALS) pathogenesis. Some recent advances in our understanding of motoneuron death in familial ALS (fALS) and sporadic ALS (sALS) are reviewed, with emphasis on molecular similarities that may further unite these phenotypically linked diseases."><meta name="dc.Publisher" content=" Annual Reviews  4139 El Camino Way, P.O. Box 10139, Palo Alto, CA 94303-0139, USA  "><meta name="dc.Date" scheme="WTN8601" content="2003-11-28"><meta name="dc.Type" content="review-article"><meta name="dc.Format" content="text/HTML"><meta name="dc.Identifier" scheme="doi" content="10.1146/annurev.med.46.1.133"><meta name="dc.Source" content="http://dx.doi.org.proxy.library.emory.edu/10.1146/annurev.med.46.1.133"><meta name="dc.Language" content="en"><meta name="dc.Coverage" content=" 4139 El Camino Way, P.O. Box 10139, Palo Alto, CA 94303-0139, USA "><meta name="dc.Rights" content="Copyright © 1995 by Annual Reviews Inc. All rights reserved"><meta name="keywords" content="autoimmune motoneuron injury, calcium channel, excitotoxicity, oxidative injury, superoxide dismutase deficiency">





<meta name="MSSmartTagsPreventParsing" content="true">
<link rel="SHORTCUT ICON" href="about:blank?favicon.ico">

    




    



    
        
    

          















<script type="text/javascript" src="script.js"></script>
<script type="text/javascript" src="script_002.js"></script>
<script type="text/javascript" src="yui-min.js"></script>
<script type="text/javascript" src="script_003.js"></script>
<script type="text/javascript" src="article.js"></script>

<meta name="apple-mobile-web-app-capable" content="yes">
<meta name="apple-mobile-web-app-status-bar-style" content="black-translucent">
















 




<script type="text/javascript">

        /*
         * won't use browser specific css anymore, add browser class in body
         * e.g to add IE specific styling add in beggining of css rule .ie*Body ... {}
         */
        function addUAClass() {
            // when IE6, add ie6Body class in body, when IE7 add class ie7Body
            // in body and when IE >= 8 add class ieBody in body
            if (/MSIE (\d+\.\d+);/.test(navigator.userAgent)) {
                var ieversion = new Number(RegExp.$1);
                if (ieversion >= 8) {
                    document.body.className = document.body.className + ' ieBody';
                } else if (ieversion == 7) {
                    document.body.className = document.body.className + ' ie7Body';
                } else if (ieversion == 6) {
                    document.body.className = document.body.className + ' ie6Body';
                }
            }
            // when FF add ffBody className in body
            if (/Firefox[\/\s](\d+\.\d+)/.test(navigator.userAgent)){ //test for Firefox/x.x or Firefox x.x (ignoring remaining digits);
                document.body.className = document.body.className + ' ffBody';
            }

            // when Chrome add chromeBody className in body
            if (/Chrome[\/\s](\d+\.\d+)/.test(navigator.userAgent)){ //test for Chrome
                document.body.className = document.body.className + ' chromeBody';
            }
        }
    </script>
<link rel="stylesheet" type="text/css" href="annurev.med.46.1.css" media="all">
</head>
<body onload="addUAClass();" class="yui3-skin-sam ">



<div id="headerContent" class=" ">



<div class="headerTop">
     
    <span class="logo">
        <a href="http://www.annualreviews.org.proxy.library.emory.edu/"><img src="logo.png" alt="Annual Reviews"></a>
    </span>
    <div class="identities-bar">
        








    <div id="identity-bar">
        <span id="individual-menu">
            

            
                    
                    <a href="https://www-annualreviews-org.proxy.library.emory.edu/action/showLogin?uri=%2Fdoi%2Ffull%2F10.1146%2Fannurev.med.46.1.133%3Fselect23%3DChoose">

                        Log in
                    </a>
                    <span class="divider">

                        &nbsp; | &nbsp;
                    </span>
                    <a href="https://www-annualreviews-org.proxy.library.emory.edu/action/registration">

                        Register
                    </a>
                
            
                <span class="divider">

                    &nbsp; | &nbsp;
                </span>
                <a href="https://www-annualreviews-org.proxy.library.emory.edu/action/mobileDevicePairingLogin">&nbsp;Mobile&nbsp;</a>
            
            
                <span class="divider">

                    &nbsp; | &nbsp;
                </span>
                <a href="http://www.annualreviews.org.proxy.library.emory.edu/page/activationForm.jsp">

                    Activate
                </a>
            
            
                <span class="divider">

                    &nbsp; | &nbsp;
                </span>
                <a href="http://www.annualreviews.org.proxy.library.emory.edu/help?context=main" onclick="newWindow(this.href);return false;">

                    Help
                </a>
            
            
                <span class="divider">

                    &nbsp; | &nbsp;
                </span>
                
                
                <a href="http://www.annualreviews.org.proxy.library.emory.edu/action/showCart?backUri=%2Fdoi%2Ffull%2F10.1146%2Fannurev.med.46.1.133%3Fselect23%3DChoose" class="smallBlackTxt">
                    <span class="shoppingCart">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span>
                    Item:0
                </a>
            
                    </span>
    </div>

        












    <div id="quickSearch">
        
            
        
        
        <form action="http://www.annualreviews.org.proxy.library.emory.edu/action/doSearch" name="quickSearchLineForm" class="quickSearch" method="get"><div class="searchBox">
                <span class="searchText">
                
                <input name="pageSize" value="20" type="hidden">
                <input onkeypress="if(event.keyCode==13) {submitQuickSearch(this.form);return false;}" name="searchText" value="" size="40" type="text">
                </span>
                <span class="searchBtnImg">
                    <input onclick="submitQuickSearch(this.form);return false;" class="formbutton" value="">
                </span>
            </div>
            
                <div id="radioBtnsLine">
                <span id="radioBtnsGroup" class="yui3-buttongroup">
                    
                        <input id="radio1" name="type" value="journals" checked="checked" type="radio">
                        <span class="labelForSearch">Journals</span>
                    
                        <input id="radio2" name="type" value="geninfo" type="radio">
                        <span class="labelForSearch">General Info</span>
                    
                </span>
                <span class="advSearchLink">
                    <a href="http://www.annualreviews.org.proxy.library.emory.edu/action/doSearch">

                        advanced search
                    </a>
                </span>
            </div></form>
    </div>
   
    </div>
</div>
<div class="headerBottom">
    













<div class="instBanner">
    
            
            
                <div class="instText">
                    <span class="instText1">Access provided by:</span><br>
                    <span class="instText2">EMORY UNIVERSITY</span>
                </div>
            
        

</div>


    









    

    <div id="navigationWrapper">
        <div id="hiddenSubMenu">
            














<div class="multiColumnListWrapper">
    
        <ul class="mainNavJournalList ">
            
                <li class="journal"><a href="http://www.annualreviews.org.proxy.library.emory.edu/journal/anchem">Analytical Chemistry</a></li>
            
                <li class="journal"><a href="http://www.annualreviews.org.proxy.library.emory.edu/journal/anthro">Anthropology</a></li>
            
                <li class="journal"><a href="http://www.annualreviews.org.proxy.library.emory.edu/journal/astro">Astronomy and Astrophysics</a></li>
            
                <li class="journal"><a href="http://www.annualreviews.org.proxy.library.emory.edu/journal/biochem">Biochemistry</a></li>
            
                <li class="journal"><a href="http://www.annualreviews.org.proxy.library.emory.edu/journal/bioeng">Biomedical Engineering</a></li>
            
                <li class="journal"><a href="http://www.annualreviews.org.proxy.library.emory.edu/journal/biophys">Biophysics</a></li>
            
                <li class="journal"><a href="http://www.annualreviews.org.proxy.library.emory.edu/journal/cellbio">Cell and Developmental Biology</a></li>
            
                <li class="journal"><a href="http://www.annualreviews.org.proxy.library.emory.edu/journal/chembioeng">Chemical and Biomolecular Engineering</a></li>
            
                <li class="journal"><a href="http://www.annualreviews.org.proxy.library.emory.edu/journal/clinpsy">Clinical Psychology</a></li>
            
                <li class="journal"><a href="http://www.annualreviews.org.proxy.library.emory.edu/journal/arcompsci">Computer Science</a></li>
            
                <li class="journal"><a href="http://www.annualreviews.org.proxy.library.emory.edu/journal/conmatphys">Condensed Matter Physics</a></li>
            
        </ul>
    
        <ul class="mainNavJournalList ">
            
                <li class="journal"><a href="http://www.annualreviews.org.proxy.library.emory.edu/journal/earth">Earth and Planetary Sciences</a></li>
            
                <li class="journal"><a href="http://www.annualreviews.org.proxy.library.emory.edu/journal/ecolsys">Ecology, Evolution, and Systematics</a></li>
            
                <li class="journal"><a href="http://www.annualreviews.org.proxy.library.emory.edu/journal/economics">Economics</a></li>
            
                <li class="journal"><a href="http://www.annualreviews.org.proxy.library.emory.edu/journal/ento">Entomology</a></li>
            
                <li class="journal"><a href="http://www.annualreviews.org.proxy.library.emory.edu/journal/energy">Environment and Resources</a></li>
            
                <li class="journal"><a href="http://www.annualreviews.org.proxy.library.emory.edu/journal/financial">Financial Economics</a></li>
            
                <li class="journal"><a href="http://www.annualreviews.org.proxy.library.emory.edu/journal/fluid">Fluid Mechanics</a></li>
            
                <li class="journal"><a href="http://www.annualreviews.org.proxy.library.emory.edu/journal/food">Food Science and Technology</a></li>
            
                <li class="journal"><a href="http://www.annualreviews.org.proxy.library.emory.edu/journal/genet">Genetics</a></li>
            
                <li class="journal"><a href="http://www.annualreviews.org.proxy.library.emory.edu/journal/genom">Genomics and Human Genetics</a></li>
            
                <li class="journal"><a href="http://www.annualreviews.org.proxy.library.emory.edu/journal/immunol">Immunology</a></li>
            
        </ul>
    
        <ul class="mainNavJournalList ">
            
                <li class="journal"><a href="http://www.annualreviews.org.proxy.library.emory.edu/journal/lawsocsci">Law and Social Science</a></li>
            
                <li class="journal"><a href="http://www.annualreviews.org.proxy.library.emory.edu/journal/marine">Marine Science</a></li>
            
                <li class="journal"><a href="http://www.annualreviews.org.proxy.library.emory.edu/journal/matsci">Materials Research</a></li>
            
                <li class="journal"><a href="http://www.annualreviews.org.proxy.library.emory.edu/journal/med">Medicine</a></li>
            
                <li class="journal"><a href="http://www.annualreviews.org.proxy.library.emory.edu/journal/micro">Microbiology</a></li>
            
                <li class="journal"><a href="http://www.annualreviews.org.proxy.library.emory.edu/journal/neuro">Neuroscience</a></li>
            
                <li class="journal"><a href="http://www.annualreviews.org.proxy.library.emory.edu/journal/nucl">Nuclear and Particle Science</a></li>
            
                <li class="journal"><a href="http://www.annualreviews.org.proxy.library.emory.edu/journal/nutr">Nutrition</a></li>
            
                <li class="journal"><a href="http://www.annualreviews.org.proxy.library.emory.edu/journal/pathmechdis">Pathology: Mechanisms of Disease</a></li>
            
                <li class="journal"><a href="http://www.annualreviews.org.proxy.library.emory.edu/journal/pharmtox">Pharmacology and Toxicology</a></li>
            
                <li class="journal"><a href="http://www.annualreviews.org.proxy.library.emory.edu/journal/physchem">Physical Chemistry</a></li>
            
        </ul>
    
        <ul class="mainNavJournalList lastList">
            
                <li class="journal"><a href="http://www.annualreviews.org.proxy.library.emory.edu/journal/physiol">Physiology</a></li>
            
                <li class="journal"><a href="http://www.annualreviews.org.proxy.library.emory.edu/journal/phyto">Phytopathology</a></li>
            
                <li class="journal"><a href="http://www.annualreviews.org.proxy.library.emory.edu/journal/arplant">Plant Biology</a></li>
            
                <li class="journal"><a href="http://www.annualreviews.org.proxy.library.emory.edu/journal/polisci">Political Science</a></li>
            
                <li class="journal"><a href="http://www.annualreviews.org.proxy.library.emory.edu/journal/psych">Psychology</a></li>
            
                <li class="journal"><a href="http://www.annualreviews.org.proxy.library.emory.edu/journal/publhealth">Public Health</a></li>
            
                <li class="journal"><a href="http://www.annualreviews.org.proxy.library.emory.edu/journal/resource">Resource Economics</a></li>
            
                <li class="journal"><a href="http://www.annualreviews.org.proxy.library.emory.edu/journal/soc">Sociology</a></li>
            
        </ul>
    
    <div class="contentRight">
        <ul class="mainNavJournalList"> <li class="journal"><a href="http://www.annualreviews.org.proxy.library.emory.edu/page/journal/pubdates">Publication Dates</a></li><li class="journal"><a href="http://www.annualreviews.org.proxy.library.emory.edu/page/help/coursereader">Adding to Your Course Reader</a></li><li class="journal">  <a href="http://www.annualreviews.org.proxy.library.emory.edu/page/about/copyright-and-permissions">Copyright & Permissions</a></li><li class="journal"><a href="http://www.annualreviews.org.proxy.library.emory.edu/db/suppl">Supplemental Materials</a></li><li class="journal"><a href="http://www.annualreviews.org.proxy.library.emory.edu/page/about/metadata">Access Metadata</a>  </li><li class="journal"><a href="http://www.annualreviews.org.proxy.library.emory.edu/page/about/isi-rankings">JCR Rankings</a></li><li class="journal"><a href="http://www.annualreviews.org.proxy.library.emory.edu/page/audio">Annual Reviews Audio & Video Series</a></li></ul>
    </div>
    <div style="clear: both;"></div>
</div>



        </div>
        <div class="navTabs">
            

<div id="topNavigation" class="yui3-menu yui3-menu-horizontal"><div class="yui3-menu-content"><ul><li class="yui3-menuitem"><a href="http://www.annualreviews.org.proxy.library.emory.edu/action/showPublications" class="yui3-menuitem-content"><span class="rnd_corners tp"><span class="rnd1"></span><span class="rnd2"></span><span class="rnd3"></span></span><span class="innerMenuitemContentSpan">Journals</span></a></li>
<li class="yui3-menuitem"><a class="yui3-menu-label" href="http://www.annualreviews.org.proxy.library.emory.edu/page/subscriptions/general-information"><span class="rnd_corners tp"><span class="rnd1"></span><span class="rnd2"></span><span class="rnd3"></span></span><span class="innerMenuLabel">Subscriptions </span></a><div id="subscriptions-sub-menu" class="yui3-menu yui3-menu-hidden"><div class="yui3-menu-content"><ul><li class="yui3-menuitem"><a href="http://www.annualreviews.org.proxy.library.emory.edu/page/subscriptions/general-information" class="yui3-menuitem-content"><span class="innerMenuitemContentSpan">General Ordering Info</span></a></li>
<li class="yui3-menuitem"><a href="http://www.annualreviews.org.proxy.library.emory.edu/page/subscriptions/online-activation-instructions" class="yui3-menuitem-content"><span class="innerMenuitemContentSpan">Online Activation Instructions</span></a></li>
<li class="yui3-menuitem"><a href="http://www.annualreviews.org.proxy.library.emory.edu/action/ecommerce" class="yui3-menuitem-content"><span class="innerMenuitemContentSpan">Personal Pricing</span></a></li>
<li class="yui3-menuitem"><a href="http://www.annualreviews.org.proxy.library.emory.edu/action/ecommerce?subscriberType=institution" class="yui3-menuitem-content"><span class="innerMenuitemContentSpan">Institutional Pricing</span></a></li>
<li class="yui3-menuitem"><a href="http://www.annualreviews.org.proxy.library.emory.edu/page/about/society-partnerships" class="yui3-menuitem-content"><span class="innerMenuitemContentSpan">Society Partnerships</span></a></li>
</ul></div></div></li>
<li class="yui3-menuitem"><a class="yui3-menu-label" href="http://www.annualreviews.org.proxy.library.emory.edu/page/authors/general-information"><span class="rnd_corners tp"><span class="rnd1"></span><span class="rnd2"></span><span class="rnd3"></span></span><span class="innerMenuLabel">Authors </span></a><div id="authors-sub-menu" class="yui3-menu yui3-menu-hidden"><div class="yui3-menu-content"><ul><li class="yui3-menuitem"><a href="http://www.annualreviews.org.proxy.library.emory.edu/page/authors/general-information" class="yui3-menuitem-content"><span class="innerMenuitemContentSpan">General Information</span></a></li>
<li class="yui3-menuitem"><a href="http://www.annualreviews.org.proxy.library.emory.edu/page/authors/author-instructions" class="yui3-menuitem-content"><span class="innerMenuitemContentSpan">Author Instructions</span></a></li>
</ul></div></div></li>
<li class="yui3-menuitem"><a class="yui3-menu-label" href="http://www.annualreviews.org.proxy.library.emory.edu/page/librarians/librarian-resource-page"><span class="rnd_corners tp"><span class="rnd1"></span><span class="rnd2"></span><span class="rnd3"></span></span><span class="innerMenuLabel">Librarians & Agents </span></a><div id="librarians-sub-menu" class="yui3-menu yui3-menu-hidden"><div class="yui3-menu-content"><ul><li class="yui3-menuitem"><a href="http://www.annualreviews.org.proxy.library.emory.edu/page/librarians/librarian-resource-page" class="yui3-menuitem-content"><span class="innerMenuitemContentSpan">Librarian Resource Center</span></a></li>
<li class="yui3-menuitem"><a href="http://www.annualreviews.org.proxy.library.emory.edu/action/institutionAdminSubscriptionManager" class="yui3-menuitem-content"><span class="innerMenuitemContentSpan">Librarian Administration Tool</span></a></li>
<li class="yui3-menuitem"><a href="http://www.annualreviews.org.proxy.library.emory.edu/page/librarians/sitelicense" class="yui3-menuitem-content"><span class="innerMenuitemContentSpan">Site License Information</span></a></li>
<li class="yui3-menuitem"><a href="http://www.annualreviews.org.proxy.library.emory.edu/page/librarians/terms-and-conditions" class="yui3-menuitem-content"><span class="innerMenuitemContentSpan">Vendor Terms & Conditions</span></a></li>
</ul></div></div></li>
<li class="yui3-menuitem"><a class="yui3-menu-label" href="http://www.annualreviews.org.proxy.library.emory.edu/page/about/overview"><span class="rnd_corners tp"><span class="rnd1"></span><span class="rnd2"></span><span class="rnd3"></span></span><span class="innerMenuLabel">About</span></a><div id="about-sub-menu" class="yui3-menu yui3-menu-hidden"><div class="yui3-menu-content"><ul><li class="yui3-menuitem"><a href="http://www.annualreviews.org.proxy.library.emory.edu/page/about/overview" class="yui3-menuitem-content"><span class="innerMenuitemContentSpan">Overview</span></a></li>
<li class="yui3-menuitem"><a href="http://www.annualreviews.org.proxy.library.emory.edu/page/about/our-mission-and-our-founder" class="yui3-menuitem-content"><span class="innerMenuitemContentSpan">Our Mission & Our Founder </span></a></li>
<li class="yui3-menuitem"><a href="http://www.annualreviews.org.proxy.library.emory.edu/page/about/philanthropy" class="yui3-menuitem-content"><span class="innerMenuitemContentSpan">Philanthropy</span></a></li>
<li class="yui3-menuitem"><a href="http://www.annualreviews.org.proxy.library.emory.edu/page/about/our-team" class="yui3-menuitem-content"><span class="innerMenuitemContentSpan">Our Team</span></a></li>
<li class="yui3-menuitem"><a href="http://www.annualreviews.org.proxy.library.emory.edu/page/about/careers-at-annual-reviews" class="yui3-menuitem-content"><span class="innerMenuitemContentSpan">Careers at Annual Reviews</span></a></li>
<li class="yui3-menuitem"><a href="http://www.annualreviews.org.proxy.library.emory.edu/page/about/isi-rankings" class="yui3-menuitem-content"><span class="innerMenuitemContentSpan">JCR Rankings</span></a></li>
<li class="yui3-menuitem"><a href="http://www.annualreviews.org.proxy.library.emory.edu/page/about/copyright-and-permissions" class="yui3-menuitem-content"><span class="innerMenuitemContentSpan">Copyright & Permissions</span></a></li>
<li class="yui3-menuitem"><a href="http://www.annualreviews.org.proxy.library.emory.edu/page/about/society-partnerships" class="yui3-menuitem-content"><span class="innerMenuitemContentSpan">Society Partnerships</span></a></li>
<li class="yui3-menuitem"><a href="http://www.annualreviews.org.proxy.library.emory.edu/page/about/metadata" class="yui3-menuitem-content"><span class="innerMenuitemContentSpan">Access Metadata</span></a></li>
<li class="yui3-menuitem"><a href="http://www.annualreviews.org.proxy.library.emory.edu/page/about/news-and-events" class="yui3-menuitem-content"><span class="innerMenuitemContentSpan">News & Events</span></a></li>
<li class="yui3-menuitem"><a href="http://www.annualreviews.org.proxy.library.emory.edu/page/about/news-and-events/awards" class="yui3-menuitem-content"><span class="innerMenuitemContentSpan">Author Awards</span></a></li>
<li class="yui3-menuitem"><a href="http://www.annualreviews.org.proxy.library.emory.edu/page/about/faq" class="yui3-menuitem-content"><span class="innerMenuitemContentSpan">FAQ</span></a></li>
<li class="yui3-menuitem"><a href="http://www.annualreviews.org.proxy.library.emory.edu/db/directory" class="yui3-menuitem-content"><span class="innerMenuitemContentSpan">Annual Reviews Directory</span></a></li>
<li class="yui3-menuitem"><a href="http://www.annualreviews.org.proxy.library.emory.edu/page/about/contact-us" class="yui3-menuitem-content"><span class="innerMenuitemContentSpan">Contact Us</span></a></li>
<li class="yui3-menuitem"><a href="http://www.annualreviews.org.proxy.library.emory.edu/page/about/rssfeeds" class="yui3-menuitem-content"><span class="innerMenuitemContentSpan">RSS Feeds</span></a></li>
<li class="yui3-menuitem"><a href="http://www.annualreviews.org.proxy.library.emory.edu/page/about/privacy" class="yui3-menuitem-content"><span class="innerMenuitemContentSpan">Privacy Policy</span></a></li>
</ul></div></div></li>
</ul></div></div>

        </div>
    </div>

    
    <script type="text/javascript">

        //  Call the "use" method, passing in "node-menunav".  This will load the
        //  script and CSS for the MenuNav Node Plugin and all of the required
        //  dependencies.
        //  also load module "custommenunavskin" to customize skin of top navigation

        var dict = {
            modules: {
                "custommenunavskin": {
                    type: "css",
                    fullpath: "/templates/jsp/_style4/_ar/css/custommenunav.css",
                   supersedes: ['skin-sam-node-menunav']
               }
           }
        };

        // use these values of dict to change way we retrieve content over https
        // the base is used to load loader-min.js (over https we'll serve it locally)
        if (document.location.protocol == "https:") {
            dict['comboBase'] = '/action/yui/combo?';
            dict['combine'] = true;
            dict['timeout'] = 10000;
            dict['base'] = '/templates/jsp/js/';
        }

        YUI(dict).use("node-menunav", "custommenunavskin", function(Y) {
            Y.on("domready", function () {
                var menu = Y.one('#topNavigation');
                menu.plug(Y.Plugin.NodeMenuNav, { submenuShowDelay: 0, submenuHideDelay: 0 });

                // move hidden submenu of all journals in correct place
                var hiddenSubMenu = Y.one("div#hiddenSubMenu > div:first-child");
                var journalsSubMenu = Y.one("div#topNavigation ul li.yui3-menuitem");
                if(journalsSubMenu != null) {
                    journalsSubMenu.append(hiddenSubMenu);
                }


                // add custom handler on mouse move, since yui widget will try by default to align
                // left hand side of submenu with parent menu's item left hand side, for this submenu we wnat it
                // to display centered under its parent
                var journalsTopMenuItemLabel = Y.one("div#topNavigation ul li.yui3-menuitem a");
                journalsTopMenuItemLabel.on('mousemove', setMultiColStyle);

                function setMultiColStyle() {
                    var multiColumnsList = Y.one("div#topNavigation .multiColumnListWrapper");
                    multiColumnsList.setStyle('left', '-32em')
                    multiColumnsList.setStyle('position', 'absolute');
                    multiColumnsList.setStyle('top', '4px');
                    multiColumnsList.setStyle('width', '85em');
                }

            });

        });
    </script>
   
</div>
</div>

        



<div id="bodyWrapper">
    <div id="doc4">
        <div class="outerBorder">
            <div class="innerBorder">
                <div id="bd">
                      <div class="shared_bodyWrapper">
                        <div id="yui3-main">
                            








<script type="text/javascript">

<!-- // hide it from old browsers

var anyDbId = -1;
var sideParts = {
  citation: "<a href=\"javascript:newWindow('{$linkoutUrl}')\">{$display}<\/a>| ",
  citingIsi: "<tr><td class=\"black9pt\" width=\"15\" valign=\"top\">&nbsp;&bull;&nbsp;<\/td><td class=\"black9pt\" valign=\"top\">Search for citing articles in:<br/>&nbsp;<a href=\"javascript:newWindow('/servlet/linkout?suffix=s0&dbid=128&doi={$doi}&url={$urlEnc}')\">ISI Web of Science<\/a> ({$citNum} or more)<\/a><\/td><\/tr>",
  citingCrossref: "<tr><td class=\"black9pt\" width=\"15\" valign=\"top\">&nbsp;&bull;&nbsp;<\/td><td class=\"black9pt\" valign=\"top\"><a href=\"{$url}\">Citing articles in CrossRef<\/a><\/td><\/tr>",
  quicksearch: "<option value=\"{$value}\">{$display}<\/option>",
  related: "<a href=\"javascript:newWindow('{$linkoutUrl}')\">{$display}<\/a>"
};

function genSide(part, dbid, linkoutUrl, display, doi, url, citNum, value) {
  if (dbid != anyDbId && (34359738367 & dbid) == 0) return;
	var content = sideParts[part];
	if (linkoutUrl) { content = content.replace(/{\$linkoutUrl}/g, linkoutUrl); }
	if (display) { content = content.replace(/{\$display}/g, display); }
	if (doi) { content = content.replace(/{\$doi}/g, doi); }
	if (url) {
	  content = content.replace(/{\$url}/g, url);
	  content = content.replace(/{\$urlEnc}/g, encodeURIComponent(encodeURIComponent(url)));
  }
	if (citNum) { content = content.replace(/{\$citNum}/g, citNum); }
	if (value) { content = content.replace(/{\$value}/g, value); }
	document.write(content);
}

function hasSfxLinks() {
	return true;
}


function genSfxLinks(id, url, doi) {
	if (! doi) { doi = ""; }
	genSfxLink0(id, url, doi);

}
function popSfxLink(prefix, id, url, doi) {
	if (doi) {
		url += "&id=doi:"+doi;
	} else {
		doi = "10.1146%2Fannurev.med.46.1.133";
	}
	var redirect = prefix + encodeURIComponent("?sid=ar&genre=article"+url);
	var href = "/servlet/linkout?suffix="+id+"&dbid=16384&doi="+doi+"&url=" + encodeURIComponent(redirect);
	return newWindow(href);
}

var prefix0 = "http%3A%2F%2Fsfx.galib.uga.edu%2Fsfx_emu1";
function genSfxLink0(id, url, doi) {
    var href = "javascript:popSfxLink(prefix0,'"+id+"','"+url+"','"+doi+"')";
    var name =  "null";
    if( name == null || name == "") name = "OpenURL EMORY UNIVERSITY";
    document.write('<a href="'+href+'" title="'+name+'">');
	document.write('<img src="/userimages/188118/sfxbutton" alt="'+name+'" border="0" valign="bottom" height="20" width="85" />');
	document.write('<\/a>');
}

var sfxRefDisplay = {
	64:"ADS",
	32:"CAS",
	8192:"CIS",
	256:"CSA",
	16:"CrossRef",
	128:"<i>Web of Science<\/i> &#174;",
	4096:"JSTOR",
	8:"Medline"
};
function genRefLink(dbid, id, key, textOfLink) {
	if (34359738367 & dbid != 0) {
	    if (typeof textOfLink === "undefined") textOfLink = "["+sfxRefDisplay[dbid]+"]"; // ToDo: move '[' and ']' to sfxRefDisplay
	    else textOfLink = unescape(textOfLink);
		document.write("<a class='ref' href=\"javascript:popRefLink("+dbid+",'"+id+"','"+key+"')\">"+textOfLink+"<\/a>");
	}
}
function popRefLink(dbid, id, key) {
	var redirect = "/servlet/linkout?suffix=" + id + "&dbid=" + dbid + "&doi=10.1146%2Fannurev.med.46.1.133&key=" + key;
	return newWindow(redirect);
}
function popRefFull(rid, citart, ptype, area) {
	return popRefImplFull(rid, citart, ptype, area, 525, 750);
}
function popRefImplFull(rid, citart, ptype, area, width, height) {
	var doi = "10.1146%2Fannurev.med.46.1.133";
	if (! ptype) { ptype = ""; }
	var pt = rid.charAt(0) + "annurevmed461133" + ptype;
	return popupFull(rid, doi, pt, area, width, height);
}
function popRef(rid, citart, ptype, area) {
	return popRefImpl(rid, citart, ptype, area, 525, 750);
}
function popRef2(rid, citart, ptype, area) {
	return popRefImpl(rid, citart, ptype, area, 400, 100);
}
function popRefImpl(rid, citart, ptype, area, width, height) {
	var doi = "10.1146%2Fannurev.med.46.1.133";
	if (! citart) { citart = "citart1"; }
	if (! ptype) { ptype = ""; }
	var pt = rid.charAt(0) + "annurevmed461133" + ptype;
	return popupRef(citart, rid, doi, pt, area, width, height);
}



function genCitingIsi() { genSide('citingIsi',128,'','','10.1146%2Fannurev.med.46.1.133','http://gateway.isiknowledge.com.proxy.library.emory.edu/gateway/Gateway.cgi?&GWVersion=2&DestApp=WOS_CPL&DestLinkType=CitingArticles&SrcAuth=AnnualReviews&SrcApp=AnnualReviews&KeyAID=10.1146%2Fannurev.med.46.1.133',28);
}

function genCitingCrossref() {if (!window.doNotShowCitedByLink) genSide('citingCrossref',anyDbId,'','','10.1146%2Fannurev.med.46.1.133','/doi/citedby/10.1146/annurev.med.46.1.133','');
}

var citLinkDisplay = {

	0:"SYSTEM",
	4:"SYSTEM",
	20:"SYSTEM",
	64:"ADS",
	32:"CAS",
	8192:"CIS",
	256:"CSA",
	16:"CrossRef",
	128:"ISI",
	4096:"JSTOR",
	8:"MEDLINE"
};
var feeBasedMask = 4480;

function genCitLink(dbid, suffix, key) {
  if (dbid != anyDbId && (feeBasedMask & dbid) != 0 && (34359738367 & dbid) == 0) return;

	var param = "/servlet/linkout?suffix=" + suffix + "&dbid=" + dbid + "&doi=10.1146%2Fannurev.med.46.1.133&key=" + key;
	var display = citLinkDisplay[dbid];
	var img = "/templates/jsp/_style4/_ar/images/" + display + "_btn.gif";



	document.write("<a class='ref' href='javascript:newWindow(\"" + param + "\")'>");
	document.write("<img src='"+img+"' width='85' height='20' align='BOTTOM' alt='"+display+" Abstract' border='0'/>");
	document.write("<\/a>");
}
// stop hiding -->
</script>












<div class="bodyTopToolBar">
    
            
            
            
                
                
            
            
            
                
            
            
            
                    
                
            
        
    <span class="breadcrumbs">


    
        
            
            
                    <a href="http://www.annualreviews.org.proxy.library.emory.edu/">Home</a>
                
        
            / 
            
                    <a href="http://www.annualreviews.org.proxy.library.emory.edu/action/showPublications">Journals</a>
                
        
            / 
            
                    <a href="http://www.annualreviews.org.proxy.library.emory.edu/journal/med">Medicine</a>
                
        
            / 
            
                    <a href="http://www.annualreviews.org.proxy.library.emory.edu/toc/med/46/1">Volume 46, 1995</a>
                
        
            / 
            Smith, M.D., Ph.D, pp. 133-145
        
    
     
 </span>

    
        











            
                
            
              








    









        
        
    
<span class="quickLinks page_quickLinks">
    
            
            
                <a href="http://www.annualreviews.org.proxy.library.emory.edu/personalize/addFavoriteArticle?doi=10.1146%2Fannurev.med.46.1.133" title="Add to Favorites">
                    <img src="thumbs-up.png" alt="Add to Favorites" height="19" width="19">&nbsp;Add to Favorites
                </a>
                <a href="http://www.annualreviews.org.proxy.library.emory.edu/action/showMailPage?href=%2Fdoi%2Ffull%2F10.1146%2Fannurev.med.46.1.133%3Fselect23%3DChoose&title=MOLECULAR+APPROACHES+TO+AMYOTROPHIC+LATERAL+SCLEROSIS&doi=10.1146%2Fannurev.med.46.1.133" onclick="newWindow(this.href); return false;">
                    
                    
                    <img src="envelope.png" border="0">
                    Email Page To a Friend
                </a>
            
        
    <!-- AddThis Button BEGIN -->
    <a class="addthis_button_compact" href="http://www.addthis.com/bookmark.php?v=250&username=xa-4b6b2e341379daeb">
        <img src="lg-share-en.gif" alt="Bookmark and Share" style="border: 0pt none;" height="16" width="125">
    </a>
    <script type="text/javascript" src="addthis_widget.js"></script>
    
    <script type="text/javascript">

        var addthis_config = {
            services_compact:'twitter,facebook,digg,connotea,delicious,bebo,bitly,care2,citulike,diigo,friendfeed,friendster,googlebuzz,hackernews,linkedin,misterwong,mixx,orkut,reddit,stumbleupon,technorati,tumblr,buzz',
            ui_click: true
        }
    </script>
    <!-- AddThis Button END -->
</span>

    
</div>





        
        
        

<div class="bodyTopHeader">
    
            
            
            

            <span class="bodyTopHeaderTitle"><h3>Medicine</h3></span>
            <div class="bodyTopHeaderVolumeInfo">
                
                        <a href="http://www.annualreviews.org.proxy.library.emory.edu/toc/med/46/1">

                            Volume 46, 1995
                        </a>
                    
            </div>
        
</div>

        
        <div class="yui3-g articleFullText">
            <div class="yui3-u first">
                


<span class="fullTextLabel">FULL-TEXT HTML</span>
<div class="prevNextLinks">
    
            <a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/full/10.1146/annurev.med.46.1.123">
                <img src="left-arrow-small-circle.png">&nbsp;Prev.
            </a>
        
    <span class="divider"> | </span>
    
            <a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/full/10.1146/annurev.med.46.1.147">

                Next&nbsp;<img src="right-arrow-small-circle.png">
            </a>
        
</div>
<br>
<br>
<hr>
<br>
 
                













    



<!-- abstract content --><!-- abstractTopStart --><div class="arttitle">MOLECULAR APPROACHES TO AMYOTROPHIC LATERAL SCLEROSIS</div><p class="fulltext"></p><div class="journalTitle">Annual Review of Medicine</div><div class="issueInfo">

                Vol. 46: 133-145
			    (Volume publication date February 1995)
		    </div><div class="artAuthors"><div class="contrib">R. Glenn Smith, M.D., Ph.D. and Stanley H. Appel, M.D.</div><div class="fulltext">Department of Neurology, Baylor College of Medicine, Houston, Texas 77030 </div><br></div><div class="article_link"><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/pdf/10.1146/annurev.med.46.1.133"><img src="pdf.png" alt="PDF" border="0">PDF
                                (93 KB)
                            </a> | <a href="https://www.copyright.com/ccc/openurl.do?sid=armed0066-4219&servicename=all&WT.mc_ID=armed0066-4219&issn=0066-4219"> Permissions </a><!-- rightsLinkReplace --></div><div class="articleLinks2">

            Citation:
            <script type="text/javascript">

             genSideCitation('8','/servlet/linkout?suffix=s0&dbid=8&doi=10.1146%2Fannurev.med.46.1.133&url=http%253A%252F%252Fwww.ncbi.nlm.nih.gov%252Fentrez%252Fquery.fcgi%253Fcmd%253Dretrieve%2526db%253Dpubmed%2526dopt%253DAbstract%2526list_uids%253D7598450','PubMed');
        </script><a href="http://www.annualreviews.org.proxy.library.emory.edu/action/showCitFormats?doi=10.1146%2Fannurev.med.46.1.133"> Download</a>| <a href="http://www.annualreviews.org.proxy.library.emory.edu/action/addCitationAlert?doi=10.1146%2Fannurev.med.46.1.133">Email notification</a>| <a href="http://www.annualreviews.org.proxy.library.emory.edu/action/showFeed?ui=0&mi=3g98xl&ai=sm&jc=med&type=etoc&feed=rss"><img src="rss14x14pad.gif" align="absbottom" border="0"></a></div><div class="articleLinks2"><i>Web of Science</i> &reg;:
                <script type="text/javascript">

             genSideRelated('128','/servlet/linkout?suffix=s0&dbid=128&doi=10.1146%2Fannurev.med.46.1.133&url=http%253A%252F%252Flinks.isiglobalnet2.com%252Fgateway%252FGateway.cgi%253F%2526GWVersion%253D2%2526SrcAuth%253DAnnualReviews%2526SrcApp%253DAnnualReviews%2526DestLinkType%253DRelatedRecords%2526KeyAID%253D10.1146%252Fannurev.med.46.1.133%2526DestApp%253DWOS_CPL','Related Records &#174;');
        </script>| <script type="text/javascript">

             genSideRelated('128','/servlet/linkout?suffix=s0&dbid=128&doi=10.1146%2Fannurev.med.46.1.133&url=http%253A%252F%252Flinks.isiglobalnet2.com%252Fgateway%252FGateway.cgi%253F%2526GWVersion%253D2%2526SrcAuth%253DAnnualReviews%2526SrcApp%253DAnnualReviews%2526DestLinkType%253DCitingArticles%2526KeyAID%253D10.1146%252Fannurev.med.46.1.133%2526DestApp%253DWOS_CPL','Times Cited: 28');
        </script></div><!-- abstractTopEnd --><!-- abstractStart --><a name="abstract"><!--title--></a><div class="outerBoxWrapper"><div class="boxContentWrapper"><div class="yui3-module simpleBox"><span class="rnd_corners tp"><span class="rnd1"></span><span class="rnd2"></span><span class="rnd3"></span></span><div class="yui3-hd"><span class="headerTitle">ABSTRACT</span><span class="headerSelect collapsedSections"></span><div style="clear: both;"></div></div><div class="chooseSections hiddenSection"><div class="section" secid="#">Top of page</div><div class="section" secid="#h2">INTRODUCTION</div><div class="section" secid="#h3">FREE RADICALS AND FAMILIAL ALS</div><div class="section" secid="#h4">GLUTAMATE, EXCITOTOXICITY, AND SPORADIC ALS</div><div class="section" secid="#h5">AUTOIMMUNITY AND SPORADIC ALS</div><div class="section" secid="#h6">ALS PATHOPHYSIOLOGY: A COMPILATION OF THE DATA</div><div class="section" secid="#h7">FUTURE DIRECTIONS</div><div class="section" secid="#h8">Literature Cited</div></div><div class="yui3-bd"><div class="abstractSection">  <p class="first last"><span class="title" id="d40680e165">▪ <b>Abstract</b><img src="2002.gif" alt="" class="entityA" align="bottom"></span> New discoveries are expanding our knowledge of mechanisms involved in amyotrophic lateral sclerosis (ALS) pathogenesis. Some recent advances in our understanding of motoneuron death in familial ALS (fALS) and sporadic ALS (sALS) are reviewed, with emphasis on molecular similarities that may further unite these phenotypically linked diseases.</p> </div><div id="Abbreviations" style="display: none;"><h1>Acronyms</h1><div class="abbreviations"> </div></div><div id="TermDefinitions" style="display: none;"><h1>Terms</h1><div class="abbreviations"> </div></div></div></div></div></div><!-- abstractEnd --><!-- /abstract content --><!-- fulltext content --><div id="ss1" class="NLM_sec NLM_sec_level_1"><a name="h2"><!--title--></a><div class="outerBoxWrapper"><div class="boxContentWrapper"><div class="yui3-module simpleBox"><span class="rnd_corners tp"><span class="rnd1"></span><span class="rnd2"></span><span class="rnd3"></span></span><div class="yui3-hd"><span class="headerTitle">INTRODUCTION</span><span class="headerSelect collapsedSections"></span><div style="clear: both;"></div></div><div class="chooseSections hiddenSection"><div class="section" secid="#">Top of page</div><div class="section current" secid="">INTRODUCTION</div><div class="section" secid="#h3">FREE RADICALS AND FAMILIAL ALS</div><div class="section" secid="#h4">GLUTAMATE, EXCITOTOXICITY, AND SPORADIC ALS</div><div class="section" secid="#h5">AUTOIMMUNITY AND SPORADIC ALS</div><div class="section" secid="#h6">ALS PATHOPHYSIOLOGY: A COMPILATION OF THE DATA</div><div class="section" secid="#h7">FUTURE DIRECTIONS</div><div class="section" secid="#h8">Literature Cited</div></div><div class="yui3-bd"><p class="last">Amyotrophic lateral sclerosis (ALS) is a progressive, devastating syndrome that affects both upper and lower motoneurons and results in limb and facial motor weakness, atrophy, spasticity, and death (<span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b1" id="XR1" refid="b1">1</a></span>, <span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b2" id="XR2" refid="b2">2</a></span>, <span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b3" id="XR3" refid="b3">3</a></span>). The age-adjusted worldwide incidence of ALS is 0.5&ndash;3 per 100,000 person years (without obvious race-related differences). Older males and postmenopausal females are most typically affected (<span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b3" id="XR4" refid="b3">3</a></span>, <span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b5" id="XR5" refid="b5">5</a></span>). Familial ALS (fALS) accounts for less than 10% of diagnosed cases (<span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b3" id="XR6" refid="b3">3</a></span>, <span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b6" id="XR7" refid="b6">6</a></span>, <span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b7" id="XR8" refid="b7">7</a></span>, <span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b8" id="XR9" refid="b8">8</a></span>), with sporadic ALS (sALS) comprising the remainder of diagnoses. Although the pathogenesis of ALS remains unknown, notable progress has been made in identifying molecular processes potentially involved in ALS-mediated motoneuron injury. This chapter reviews some of these recent advances in our understanding of the molecular bases of sALS and fALS.</p></div></div></div></div></div><div id="ss2" class="NLM_sec NLM_sec_level_1"><a name="h3"><!--title--></a><div class="outerBoxWrapper"><div class="boxContentWrapper"><div class="yui3-module simpleBox"><span class="rnd_corners tp"><span class="rnd1"></span><span class="rnd2"></span><span class="rnd3"></span></span><div class="yui3-hd"><span class="headerTitle">FREE RADICALS AND FAMILIAL ALS</span><span class="headerSelect collapsedSections"></span><div style="clear: both;"></div></div><div class="chooseSections hiddenSection"><div class="section" secid="#">Top of page</div><div class="section" secid="#h2">INTRODUCTION</div><div class="section current" secid="">FREE RADICALS AND FAMILIAL ALS</div><div class="section" secid="#h4">GLUTAMATE, EXCITOTOXICITY, AND SPORADIC ALS</div><div class="section" secid="#h5">AUTOIMMUNITY AND SPORADIC ALS</div><div class="section" secid="#h6">ALS PATHOPHYSIOLOGY: A COMPILATION OF THE DATA</div><div class="section" secid="#h7">FUTURE DIRECTIONS</div><div class="section" secid="#h8">Literature Cited</div></div><div class="yui3-bd"><p>A significant discovery in ALS research was the identification of a genetic defect associated with 10&ndash;15% of fALS kindreds (<span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b7" id="XR10" refid="b7">7</a></span>). The involved gene, <i>SOD1</i>, encodes a cytosolic form of superoxide dismutase (SOD), and identified mutations in exons 1, 2, 4, and 5 of the <i>SOD1</i> gene all appear to reduce Cu<sup>2+</sup>/Zn<sup>2+</sup> SOD stability and SOD-catalyzed free-radical metabolism (<span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b8" id="XR11" refid="b8">8</a></span>, <span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b9" id="XR12" refid="b9">9</a></span>).</p><p>Differences in the location of these missense mutations apparently affect both clinical fALS severity and measured SOD activity levels. For example, a very slowly progressive form of fALS in two Japanese kindreds is associated with a His<sup>46</sup> &rarr; Arg point mutation on the SOD molecule. This mutation may alter Cu<sup>2+</sup> binding to the enzyme's catalytic site and reduces erythrocyte lysate SOD activity by approximately 20% (<span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b10" id="XR13" refid="b10">10</a></span>). In Caucasian fALS kindreds with rapid rates of clinical disease progression, many <i>SOD1</i> mutations instead code for the dimer contact region and appear to destabilize SOD dimer formation. Two such point mutations (Ala<sup>4</sup> &rarr; Val and Gly<sup>41</sup> &rarr; Ser) produce an enzyme with less than 50% of normal Cu<sup>2+</sup>/Zn<sup>2+</sup> SOD activity (<span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b11" id="XR14" refid="b11">11</a></span>), and death of affected patients occurs after less than one year of symptom onset (<span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b11" id="XR15" refid="b11">11</a></span>, <span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b12" id="XR16" refid="b12">12</a></span>).</p><p>To understand ALS pathogenesis, one must understand how altering SOD activity can induce cell injury. SOD protects against direct superoxide anion (O<sub>2</sub><sup>&bull;&minus;</sup>)-induced cell damage by reducing [O<sub>2</sub><sup>&bull;&minus;</sup>]<i>i</i>; hence, reduced Cu<sup>2+</sup>/Zn<sup>2+</sup> SOD activity in patients with fALS equates to increased steady-state levels of [O<sub>2</sub><sup>&bull;&minus;</sup>]<i>i</i> (<span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b13" id="XR17" refid="b13">13</a></span>). However, O<sub>2</sub><sup>&bull;&minus;</sup> is also readily converted to other, more toxic radicals. For example, O<sub>2</sub><sup>&bull;&minus;</sup> can be converted to the highly destructive hydroxyl radical (OH&bull;) in the presence of elemental iron. Moreover, it interacts with nitric oxide to form peroxynitrite (ONOO<sup>&minus;</sup>) (<span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b14" id="XR18" refid="b14">14</a></span>), which can disrupt lipid bilayers and oxidize protein methionine residues and thiols (<span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b15" id="XR19" refid="b15">15</a></span>). Peroxynitrites also react with SOD to form nitronium-like molecules, which modify tyrosine residues (<span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b16" id="XR20" refid="b16">16</a></span>). Peroxynitrites are also protonated to form nitrosyl radicals, which decompose to OH&bull; (<span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b17" id="XR21" refid="b17">17</a></span>).</p><p>To attempt to recreate SOD-associated fALS in vitro, some researchers have directly blocked cellular SOD activity in culture systems. Inhibition of Cu<sup>2+</sup>/Zn<sup>2+</sup> SOD in cultured rat spinal cord slices with <i>SOD1</i> antisense oligodeoxynucleotides leads to apoptotic degeneration of most spinal neurons (including motoneurons) within several weeks (<span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b18" id="XR22" refid="b18">18</a></span>). However, SOD may be essential to aerobic life (<span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b19" id="XR23" refid="b19">19</a></span>), and significant enzyme inhibition may likewise be injurious to all cells.</p><p>A more specific approach has been to test the phenotypic and biochemical consequences of <i>SOD1</i> gene insertion into transgenic mice. Overexpression of normal <i>SOD1</i> resulted in increased lipid peroxidation (<span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b20" id="XR24" refid="b20">20</a></span>) and distal tongue and hindlimb motor deficits (<span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b21" id="XR25" refid="b21">21</a></span>) in such mice, but these changes may have been caused by overproduction of H<sub>2</sub>O<sub>2</sub> by SOD, with a subsequent paradoxical increase in [OH&bull;] synthesis. Expression in transgenic mice of human fALS <i>SOD1</i> (containing Gly<sup>93</sup> &rarr; Ala or Ala<sup>4</sup> &rarr; Val missense mutations) produced more obvious paralytic disease in these animals, who developed asymmetric weakness by three to four months of age and died within six months (<span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b22" id="XR26" refid="b22">22</a></span>). Pathologically, selective lower motoneuron loss and sprouting of remaining neurons were observed in these animals, without upper motoneuron deficits. However, without endogenous mouse <i>SOD1</i> gene knockout prior to transfection with mutant human <i>SOD1</i>, SOD activity levels measured in transfected mice were again 50&ndash;400% higher than those observed in nontransfected control mice. Thus, gain-of-function <i>SOD1</i> mutations indicate that increased SOD activity in the presence of mutant enzyme is associated with rapidly progressive lower motoneuron disease, but they do not yet show whether reduced SOD activity by mutant <i>SOD1</i> causes a similar process or, consequently, how this mouse transgenic model relates to human fALS SOD defects.</p><p class="last">Because the clinical syndromes of fALS and sALS are quite similar, it has been suggested that the mechanisms of cell injury are similar as well. However, although reduced Cu<sup>2+</sup>/Zn<sup>2+</sup> SOD activity was observed in fALS patients with mutant <i>SOD1</i>, no SOD activity changes occurred in other ALS patients (<span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b23" id="XR27" refid="b23">23</a></span>, <span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b24" id="XR28" refid="b24">24</a></span>, <span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b25" id="XR29" refid="b25">25</a></span>, <span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b26" id="XR30" refid="b26">26</a></span>). Subtle forms of oxidative damage have nevertheless been observed in postmortem tissues from sALS patients (<span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b24" id="XR31" refid="b24">24</a></span>, <span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b25" id="XR32" refid="b25">25</a></span>, <span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b27" id="XR33" refid="b27">27</a></span>, <span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b28" id="XR34" refid="b28">28</a></span>). This finding implies that radical-mediated cellular injury may also occur in sALS pathogenesis and contribute to a final common pathway of motoneuron loss.</p></div></div></div></div></div><div id="ss3" class="NLM_sec NLM_sec_level_1"><a name="h4"><!--title--></a><div class="outerBoxWrapper"><div class="boxContentWrapper"><div class="yui3-module simpleBox"><span class="rnd_corners tp"><span class="rnd1"></span><span class="rnd2"></span><span class="rnd3"></span></span><div class="yui3-hd"><span class="headerTitle">GLUTAMATE, EXCITOTOXICITY, AND SPORADIC ALS</span><span class="headerSelect collapsedSections"></span><div style="clear: both;"></div></div><div class="chooseSections hiddenSection"><div class="section" secid="#">Top of page</div><div class="section" secid="#h2">INTRODUCTION</div><div class="section" secid="#h3">FREE RADICALS AND FAMILIAL ALS</div><div class="section current" secid="">GLUTAMATE, EXCITOTOXICITY, AND SPORADIC ALS</div><div class="section" secid="#h5">AUTOIMMUNITY AND SPORADIC ALS</div><div class="section" secid="#h6">ALS PATHOPHYSIOLOGY: A COMPILATION OF THE DATA</div><div class="section" secid="#h7">FUTURE DIRECTIONS</div><div class="section" secid="#h8">Literature Cited</div></div><div class="yui3-bd"><p>The theory that sALS is caused by glutamate-induced excitotoxic injury was derived from two sets of observations. First, epidemiologic studies of Western Pacific ALS (ALS-Parkinsonism-dementia complex) implicated a toxin possibly derived from cycad seed flour (<span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b29" id="XR35" refid="b29">29</a></span>). One of these toxins, &beta;-<i>N</i>-methylamino-<span class="smallcaps">l</span>-alanine (BMAA), has a structure similar to that of glutamate (<span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b30" id="XR36" refid="b30">30</a></span>) and has neurotoxic effects similar to those of &beta;-oxalylamino-<span class="smallcaps">l</span>-alanine (BOAA, the cause of lathyrism) when added to CNS explant cultures (<span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b31" id="XR37" refid="b31">31</a></span>, <span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b32" id="XR38" refid="b32">32</a></span>). However, reports that <span class="smallcaps">l</span>-BMAA induced an ALS-like illness in monkeys (<span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b33" id="XR39" refid="b33">33</a></span>) remain unconfirmed (<span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b34" id="XR40" refid="b34">34</a></span>), and <span class="smallcaps">l</span>-BMAA levels present in washed cycad flour ingested by Chamorro Indians appear to be much lower (<span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b35" id="XR41" refid="b35">35</a></span>) than those needed to produce other toxic effects in animal models (<span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b36" id="XR42" refid="b36">36</a></span>) or in vitro. Furthermore, the incubation period of Western Pacific ALS is not consistent with the known effects of <span class="smallcaps">l</span>-BMAA (<span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b37" id="XR43" refid="b37">37</a></span>).</p><p>Second, tissue glutamate levels (<span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b38" id="XR44" refid="b38">38</a></span>, <span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b39" id="XR45" refid="b39">39</a></span>) and glutamate transport activity (<span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b40" id="XR46" refid="b40">40</a></span>) are reduced in spinal cords in patients with sALS. Because glutamate and glutamate receptor agonists induce neuronal death in vitro and in vivo (<span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b37" id="XR47" refid="b37">37</a></span>, <span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b41" id="XR48" refid="b41">41</a></span>), these data have suggested to some researchers that motoneuron death in sALS results from prolonged exposure to elevated glutamate concentrations. Others have countered that these data simply reflect glutamatergic cell loss mediated by other mechanisms (<span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b42" id="XR49" refid="b42">42</a></span>), without invoking excitotoxic injury as the primary mechanism responsible for sALS. Certainly, the rapid time course for excitotoxic cell injury is not compatible with slow motoneuron loss in ALS, unless another process chronically triggers glutamate release.</p><p class="last">However, although clinical data implicating glutamate in sALS pathogenesis are limited, alterations in glutamate levels result in motoneuron loss in vitro. For example, chronic inhibition of glutamate uptake in organotypic rat spinal cord cultures produced both an increase in extracellular glutamate concentrations and motoneuron degeneration, which was mediated by activation of &alpha;-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA)-sensitive glutamate receptors (<span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b43" id="XR50" refid="b43">43</a></span>). Moreover, glutamate may induce cell death in part by increasing O<sub>2</sub><sup>&bull;&minus;</sup> concentrations. Following stimulation of <i>N</i>-methyl-<span class="smallcaps">D</span>-aspartate (NMDA)-sensitive glutamate receptors in cerebellar granule cells, O<sub>2</sub><sup>&bull;&minus;</sup>-activated death was dependent on calcium (Ca<sup>2+</sup>) and release of arachidonate and was reduced by trapping O<sub>2</sub><sup>&bull;&minus;</sup> (<span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b44" id="XR51" refid="b44">44</a></span>). Additionally, apoptotic death of cultured rat spinal neurons induced by SOD inhibition could be greatly potentiated by concomitant block of glutamate transport and reduced by addition of AMPA receptor antagonists (<span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b18" id="XR52" refid="b18">18</a></span>). Therefore, glutamate can certainly induce motoneuron death in a process initiated by receptor-operated calcium channel (ROCC) activation.</p></div></div></div></div></div><div id="ss4" class="NLM_sec NLM_sec_level_1"><a name="h5"><!--title--></a><div class="outerBoxWrapper"><div class="boxContentWrapper"><div class="yui3-module simpleBox"><span class="rnd_corners tp"><span class="rnd1"></span><span class="rnd2"></span><span class="rnd3"></span></span><div class="yui3-hd"><span class="headerTitle">AUTOIMMUNITY AND SPORADIC ALS</span><span class="headerSelect collapsedSections"></span><div style="clear: both;"></div></div><div class="chooseSections hiddenSection"><div class="section" secid="#">Top of page</div><div class="section" secid="#h2">INTRODUCTION</div><div class="section" secid="#h3">FREE RADICALS AND FAMILIAL ALS</div><div class="section" secid="#h4">GLUTAMATE, EXCITOTOXICITY, AND SPORADIC ALS</div><div class="section current" secid="">AUTOIMMUNITY AND SPORADIC ALS</div><div class="section" secid="#h6">ALS PATHOPHYSIOLOGY: A COMPILATION OF THE DATA</div><div class="section" secid="#h7">FUTURE DIRECTIONS</div><div class="section" secid="#h8">Literature Cited</div></div><div class="yui3-bd"><p>Until recently, evidence for an autoimmune etiology of sALS was largely clinical. sALS patients have an increased incidence of autoimmune disease (<span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b2" id="XR53" refid="b2">2</a></span>), paraproteinemias (<span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b45" id="XR54" refid="b45">45</a></span>, <span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b46" id="XR55" refid="b46">46</a></span>, <span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b47" id="XR56" refid="b47">47</a></span>), and serum monoclonal immunoglobulins (<span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b48" id="XR57" refid="b48">48</a></span>), although the lack of motoneuron-specific antibodies in patients with monoclonal gammopathy suggests that such changes are a general manifestation of altered immune function. Likewise, increased cellular immunity to poliovirus (<span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b49" id="XR58" refid="b49">49</a></span>, <span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b50" id="XR59" refid="b50">50</a></span>), myelin basic protein (<span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b50" id="XR60" refid="b50">50</a></span>), and other CNS protein species (<span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b50" id="XR61" refid="b50">50</a></span>, <span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b51" id="XR62" refid="b51">51</a></span>) may be a secondary phenomenon (<span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b52" id="XR63" refid="b52">52</a></span>). However, the presence of circulating immune complexes and immune complex deposition in kidneys (<span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b49" id="XR64" refid="b49">49</a></span>, <span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b53" id="XR65" refid="b53">53</a></span>, <span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b54" id="XR66" refid="b54">54</a></span>, <span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b55" id="XR67" refid="b55">55</a></span>) of sALS patients; the postmortem identification of extracellular immunoglobulin and complement deposition at the neuromuscular junction, motor cortex, and spinal cord (<span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b56" id="XR68" refid="b56">56</a></span>); and IgG internalization within motoneurons (<span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b57" id="XR69" refid="b57">57</a></span>) of sALS patients all suggest alterations observed in autoimmune disease.</p><p>Two distinct guinea pig models and a rabbit model for immune motoneuron disease have been reported. These models indicate the potentiality for selective immune-mediated motoneuron loss in humans (see <a href="javascript:void(0);" class="scrollFig f1" id="XR70" figid="f1">Figure 1</a>). Lower motoneuron disease in guinea pigs was induced by inoculation of purified bovine spinal cord motor neurons (<span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b58" id="XR71" refid="b58">58</a></span>), while both upper and lower motoneuron degeneration was caused by inoculation of bovine spinal cord ventral horn homogenates (<span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b59" id="XR72" refid="b59">59</a></span>). In contrast, rabbit motoneuron loss was induced by injection of motoneuron hybrid cell homogenates (<span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b60" id="XR73" refid="b60">60</a></span>). High serum antibody titers to motoneurons, IgG precipitates at neuromuscular junctions and in motoneurons (<span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b57" id="XR74" refid="b57">57</a></span>), and inflammatory cells within the spinal cord (<span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b61" id="XR75" refid="b61">61</a></span>) were all documented in guinea pig models. Pathological studies showed motoneuron loss in immunized animals, while electrophysiologic tests documented increased resting acetylcholine (ACh) release from remaining motor nerve terminals.</p><a name="f1"><!--FIG--></a><div class="figureThumbnail"><table summary=""><tbody><tr><td class="image"><a href="javascript:void(0);" class="scrollFig" figid="f1" id="                            figd40680e719"><img src="me46_0133_1.gif" align="bottom" border="1"></a></td></tr><tr><td class="caption"> <p class="first last"><span class="captionLabel"><a href="javascript:void(0);" class="scrollFig" figid="f1" id="                    figd40680e695"><b>Figure<img src="2009.gif" alt="" class="entityA" align="bottom">1</b><img src="2002.gif" alt="" class="entityA" align="bottom"></a></span> <span class="captionText">Proposed mechanisms for motoneuron loss in ALS. (a) Mutant SOD-associated familial ALS. Increaased intracellular O<sub>2</sub><sup>&bull;&minus;</sup> results from decreased cytosolic SOD activity, and secondarily induces calcium release from internal stores and cell death. (b) Excitotoxic injury and sporadic ALS. Ostensibly the result of reduced glutamate uptake (GluT), increased levels of extracellular glutamate (Glu) would activate receptor-operated Ca<sup>2+</sup> channels (ROCCs), increase Ca<sup>2+</sup> entry, and secondarily induce oxidative injury and cell death. (c) Autoimmunity in sporadic ALS. Most sALS patients have antibodies directed against voltage-gated Ca<sup>2+</sup> channels (VGCCs), which augment Ca<sup>2+</sup> entry into motoneurons and may secondarily activate oxidative injury and cell death. Anti-VGCC antibodies also may increase presynaptic glutamate release onto motoneurons to produce secondary excitotoxic injury.</span></p> </td></tr></tbody></table></div><p>IgG from sALS patients and guinea pig models also passively transferred physiologic changes to mouse neuromuscular junctions (<span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b62" id="XR76" refid="b62">62</a></span>). Increased ACh release was observed from motor nerve terminals of mice injected with guinea pig model IgG or human sALS IgG, but not with control IgG. In such mice, passively transferred IgG histochemically localized to motoneurons and neuromuscular junctions (<span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b62" id="XR77" refid="b62">62</a></span>), whereas chronic ALS IgG injections induced axonal degeneration (<span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b63" id="XR78" refid="b63">63</a></span>).</p><p>Because ACh release at neuromuscular junctions is dependent upon voltage-gated calcium channel (VGCC) activation and increased intracellular Ca<sup>2+</sup> concentrations (<span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b64" id="XR79" refid="b64">64</a></span>, <span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b65" id="XR80" refid="b65">65</a></span>), enhanced ACh release might ensue from immune-mediated increases in VGCC currents and presynaptic intracellular Ca<sup>2+</sup> levels. Early electrophysiologic studies tested this hypothesis on L-type VGCCs but demonstrated reduced L-type Ca<sup>2+</sup> currents and charge movement following sALS IgG or F<sub>ab</sub> fragment addition to L-type VGCCs in myotubes (<span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b66" id="XR81" refid="b66">66</a></span>, <span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b67" id="XR82" refid="b67">67</a></span>, <span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b68" id="XR83" refid="b68">68</a></span>, <span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b69" id="XR84" refid="b69">69</a></span>) and VGCCs inserted in lipid bilayers (<span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b70" id="XR85" refid="b70">70</a></span>). Recently, however, sALS IgG was shown to increase P-type Ca<sup>2+</sup> currents in cerebellar Purkinje cells (<span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b71" id="XR86" refid="b71">71</a></span>) and adrenal cells (<span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b72" id="XR87" refid="b72">72</a></span>) and to increase N-type Ca<sup>2+</sup> currents expressed in oocytes (<span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b73" id="XR88" refid="b73">73</a></span>). Since P- and N-type VGCCs couple mammalian neuromuscular junction Ca<sup>2+</sup> entry to ACh release, these data may explain increased miniature end plate potential (MEPP) rates observed after sALS IgG transfer.</p><p>L-type VGCC antibodies were also biochemically identified by enzyme-linked immunoadsorbent assay in sera from 75% of sALS patients. Antibody titers appeared to correlate with ALS progression rate (<span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b74" id="XR89" refid="b74">74</a></span>). In Western immunoblot, sALS IgG reacted only with the ionophore-containing &alpha;<sub>1</sub>-subunit of the VGCC (<span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b76" id="XR90" refid="b76">76</a></span>). Although patients with Lambert-Eaton myasthenic syndrome (another VGCC-directed autoimmune disease) also possessed anti-VGCC antibodies, their antibodies reacted with both VGCC &alpha;<sub>1</sub>- and &beta;-subunits in immunoblot. IgG from patients with fALS and other neurologic diseases did not contain immunoreactive antibodies.</p><p>To determine whether sALS IgG could augment VGCC-mediated Ca<sup>2+</sup> currents and affect survival in motoneurons, a motoneuron-neuroblastoma hybrid cell line (VSC 4.1) was produced using techniques that had formerly yielded a substantia nigra cell line (<span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b76" id="XR91" refid="b76">76</a></span>) and other motoneuron lines (<span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b60" id="XR92" refid="b60">60</a></span>, <span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b77" id="XR93" refid="b77">77</a></span>). In physiological experiments using whole cell patch-clamp of cyclic adenosine monophosphate (cAMP)-differentiated VSC 4.1 cells, sALS IgG significantly increased high-threshold VGCC currents (<span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b78" id="XR94" refid="b78">78</a></span>). Furthermore, using confocal scanning microscopy and the Ca<sup>2+</sup>-sensitive dye Fluo-3, sALS IgG-mediated Ca<sup>2+</sup> entry into VSC 4.1 cells was found to follow two patterns (<span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b79" id="XR95" refid="b79">79</a></span>). A fast transient increase was observed within 15&ndash;120 s of IgG addition, and a second, slower progressive increase was found within 4 h of the initial transient in one third of cells.</p><p class="last">When sALS IgG was added to cAMP-treated VSC 4.1 cells, significant cell loss was observed after two to three days (<span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b80" id="XR96" refid="b80">80</a></span>). This sALS IgG-mediated cytotoxicity can be prevented by 1000-fold reduction of extracellular [Ca<sup>2+</sup>] with ethylene glycol-bis(&beta;-amino ethyl ether)N,N,N,N&prime;-tetraacetic acid (EGTA), by preincubating immunoglobulins with purified intact L-type VGCC or with VGCC &alpha;<sub>1</sub>-subunit (but not with other VGCC subunits), or by preincubating cells with inhibitors of N- and P-type VGCCs (but not with inhibitors of dihydropyridine-sensitive L-type VGCCs). Observed cell death was apoptotic, and DNA fragmentation and laddering were observed within 12 h of sALS IgG addition. Cell blebbing and fragmentation began shortly thereafter (<span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b81" id="XR97" refid="b81">81</a></span>). sALS IgG-induced apoptosis can be prevented by previous incubation with the endonuclease inhibitor aurintricarboxylate or with the protein synthesis inhibitor cycloheximide, but not by inhibitors of glutamate receptors.</p></div></div></div></div></div><div id="ss5" class="NLM_sec NLM_sec_level_1"><a name="h6"><!--title--></a><div class="outerBoxWrapper"><div class="boxContentWrapper"><div class="yui3-module simpleBox"><span class="rnd_corners tp"><span class="rnd1"></span><span class="rnd2"></span><span class="rnd3"></span></span><div class="yui3-hd"><span class="headerTitle">ALS PATHOPHYSIOLOGY: A COMPILATION OF THE DATA</span><span class="headerSelect collapsedSections"></span><div style="clear: both;"></div></div><div class="chooseSections hiddenSection"><div class="section" secid="#">Top of page</div><div class="section" secid="#h2">INTRODUCTION</div><div class="section" secid="#h3">FREE RADICALS AND FAMILIAL ALS</div><div class="section" secid="#h4">GLUTAMATE, EXCITOTOXICITY, AND SPORADIC ALS</div><div class="section" secid="#h5">AUTOIMMUNITY AND SPORADIC ALS</div><div class="section current" secid="">ALS PATHOPHYSIOLOGY: A COMPILATION OF THE DATA</div><div class="section" secid="#h7">FUTURE DIRECTIONS</div><div class="section" secid="#h8">Literature Cited</div></div><div class="yui3-bd"><p>Although questions remain as to how such data relate to ALS, these apparently different directions in ALS research converge in several significant areas, thus providing important clues to the mechanisms involved in motoneuron injury and death. First, early changes in Ca<sup>2+</sup> homeostasis are hypothesized to occur in sALS pathogenesis. VGCC activation by sALS IgG reduces motoneuron hybrid survival in vitro, while ROCC activation by glutamate reduces motoneuron survival in vitro. However, although glutamate-mediated cytotoxicity might result from reduced glutamate transport, Ca<sup>2+</sup> entry into presynaptic terminals of glutamatergic neurons contacting motoneurons (<span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b82" id="XR98" refid="b82">82</a></span>, <span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b83" id="XR99" refid="b83">83</a></span>) might also be induced by sALS IgG. This entry of Ca<sup>2+</sup> in turn would increase glutamate release, activate motoneuron ROCCs, and add to motoneuron damage caused by VGCC-mediated Ca<sup>2+</sup> entry. Although glutamate receptor antagonists did not block sALS IgG-mediated cytotoxicity in VSC 4.1 cells, VGCC activation has been implicated in the regulation of excitotoxic ligand-gated ion channel function (<span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b84" id="XR100" refid="b84">84</a></span>), in intracellular Ca<sup>2+</sup> homeostasis, and in neuronal survival (<span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b85" id="XR101" refid="b85">85</a></span>, <span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b86" id="XR102" refid="b86">86</a></span>, <span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b87" id="XR103" refid="b87">87</a></span>, <span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b88" id="XR104" refid="b88">88</a></span>). Thus, sALS IgG may trigger motoneuron death both by VGCC activation and by enhancing glutamate release and activating motoneuron excitotoxic ROCCs. This cytotoxicity may be triggered by transient rather than sustained Ca<sup>2+</sup> entry (<span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b79" id="XR105" refid="b79">79</a></span>, <span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b89" id="XR106" refid="b89">89</a></span>), suggesting that Ca<sup>2+</sup> acts as a signal initiating a cell death cascade.</p><p>Second, at least in vitro, activation of VGCCs by sALS IgG or of ROCCs by glutamate induces a cascade of cellular mechanisms leading to endonuclease activation and apoptotic motoneuron death. Since prolonged Ca<sup>2+</sup> entry occurs prior to DNA fragmentation in both processes, Ca<sup>2+</sup> entry may be an important initiating factor for apoptosis. However, much remains to be determined about the specific steps involved in this process.</p><p class="last">Third, this final common pathway may involve free radical-mediated cell injury. Both SOD-associated fALS and in vitro glutamate-induced motoneuron death document increased intracellular levels of O<sub>2</sub><sup>&bull;&minus;</sup> resulting from reduced SOD activity. Although not yet tested with sALS IgG in motoneuron hybrids, VGCC activation and increased intracellular Ca<sup>2+</sup> have been shown to increase mitochondrial activity (<span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b90" id="XR107" refid="b90">90</a></span>) and oxidative injury (<span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b91" id="XR108" refid="b91">91</a></span>, <span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b92" id="XR109" refid="b92">92</a></span>), and Ca<sup>2+</sup> chelators can prevent H<sub>2</sub>O<sub>2</sub><sup>&minus;</sup>-induced DNA breakdown and cytotoxicity (<span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b93" id="XR110" refid="b93">93</a></span>). Because oxidative stress may also increase release of Ca<sup>2+</sup> from intracellular stores, activate endonucleases, and induce DNA fragmentation (<span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b94" id="XR111" refid="b94">94</a></span>), the role of free radicals in apoptosis may likewise be substantial. However, endonuclease activation is not a final step in this process because stimulation of poly[adenosine diphosphate (ADP)-ribose] synthetase after radical- or endonuclease-induced DNA strand breakage can cause nuclear protein polyribosylation and cell death by depletion of &beta;-nicotinamide adenine dinucleotide and adenosine triphosphate (ATP) (<span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b95" id="XR112" refid="b95">95</a></span>).</p></div></div></div></div></div><div id="ss6" class="NLM_sec NLM_sec_level_1"><a name="h7"><!--title--></a><div class="outerBoxWrapper"><div class="boxContentWrapper"><div class="yui3-module simpleBox"><span class="rnd_corners tp"><span class="rnd1"></span><span class="rnd2"></span><span class="rnd3"></span></span><div class="yui3-hd"><span class="headerTitle">FUTURE DIRECTIONS</span><span class="headerSelect collapsedSections"></span><div style="clear: both;"></div></div><div class="chooseSections hiddenSection"><div class="section" secid="#">Top of page</div><div class="section" secid="#h2">INTRODUCTION</div><div class="section" secid="#h3">FREE RADICALS AND FAMILIAL ALS</div><div class="section" secid="#h4">GLUTAMATE, EXCITOTOXICITY, AND SPORADIC ALS</div><div class="section" secid="#h5">AUTOIMMUNITY AND SPORADIC ALS</div><div class="section" secid="#h6">ALS PATHOPHYSIOLOGY: A COMPILATION OF THE DATA</div><div class="section current" secid="">FUTURE DIRECTIONS</div><div class="section" secid="#h8">Literature Cited</div></div><div class="yui3-bd"><p>Even with our current understanding of ALS pathogenesis, a number of questions must still be addressed. First, we need to understand how selective cell vulnerability arises in this and other forms of neurodegeneration. In ALS, such selectivity may in part rely on functional differences in protective mechanisms present in different cell types. For example, the calcium-binding proteins calbindin-D<sub>28K</sub> and parvalbumin are absent in motoneurons lost early in ALS (i.e. cortical and spinal motoneurons and lower cranial nerve motoneurons) but are present at high immunoreactive levels in motoneurons damaged late or infrequently in the disease (i.e. Onuf's nucleus motoneurons and oculomotor, trochlear, and abducens nerve neurons) (<span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b96" id="XR113" refid="b96">96</a></span>, <span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b97" id="XR114" refid="b97">97</a></span>). In addition, undifferentiated VSC 4.1 cells are far more resistant to cytotoxic effects of sALS IgG than are cAMP-differentiated cells. This finding is consistent with the presence of much higher immunoreactive calbindin and parvalbumin levels in undifferentiated VSC 4.1 cells (<span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b97" id="XR115" refid="b97">97</a></span>). Thus, cell-specific differences in regulatory protein activity may help explain selective motoneuron vulnerability in ALS.</p><p>Second, we need to understand how neurodegeneration progresses over the years. While transgenic mouse models may eventually help us explain the impact of SOD mutations in fALS, no good models yet exist with which to examine the potential slow effects of autoimmunity or excitotoxicity on motoneuron death in sALS.</p><p>Finally, we as physicians must learn to more effectively treat patients with ALS. We are only now beginning to understand ALS pathogenesis, and therapies based on such knowledge are therefore limited. As for most endocrine diseases, treatment of ALS with conventional immunosuppressants has not stopped disease progression, perhaps because it is too little, too late. Indeed, type I diabetes mellitus, which is also resistant to standard immunosuppressant therapy, may result from pancreatic islet cell destruction initiated by antibody-mediated increased Ca<sup>2+</sup> entry through L-type VGCCs (<span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b98" id="XR116" refid="b98">98</a></span>). Thus, treatments that affect the consequences of initial cell injury may be necessary to protect motoneurons in patients with ALS. Unfortunately, therapies designed to reduce excitotoxic cell injury are often associated with significant side effects, although medicines such as riluzole (<span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b99" id="XR117" refid="b99">99</a></span>) are currently being tested. Although available antioxidants (1-deprenyl, &alpha;-tocopherol, vitamins A and C, etc) have not prevented ALS disease progression, new therapies that protect against oxygen radical formation are presently under development. Antiapoptotic agent use is also in its infancy, but its treatment potential for this disease will hopefully soon be assessed. In addition, because they protect motoneurons, various growth factors [insulin-like growth factor I (IGF-I) and brain-derived neurotrophic factor (BDNF)] are currently under investigation to determine their effectiveness in treating ALS. Still, until definitive remedies and gene therapies are available, helping ALS patients remains a considerable challenge for clinicians (<span class="scrollRefElements"><a href="javascript:void(0);" class="scrollRef b100" id="XR118" refid="b100">100</a></span>).</p><p class="last">In summary, exciting discoveries are revolutionizing our understanding of the mechanisms involved in ALS pathogenesis and motoneuron death. These ideas are being applied to other neurodegenerative diseases as well and will eventually permit the development of effective therapy.</p></div></div></div></div></div><div class="back">  </div><!-- /fulltext content -->
            </div>
            <div class="yui3-u fullTextSidebar">
                <div class="fullTextSidebarInner" style="top: 290px;">
                    



<div id="figuresTab"><div class="topImgNav"><a class="left_scroll" href="javascript:void(0)"></a><div class="topSlide"><div class="innerSlider"><div id="view-port"><ul class="carousel"><li class="f1"><span class="image" href="javascript:void(0)"><img src="me46_0133_1.gif" medium="/na101/home/literatum/publisher/ar/journals/content/med/1995/med.1995.46.issue-1/annurev.med.46.1.133/production/images/medium/me46_0133_1.gif" medimgid="f1" pptlink="/na101/home/literatum/publisher/ar/journals/content/med/1995/med.1995.46.issue-1/annurev.med.46.1.133/production/images/medium/"><span class="caption" style="display: none;"> Figure<img src="2009.gif" alt="" class="entityA" align="bottom">1<img src="2002.gif" alt="" class="entityA" align="bottom">Proposed mechanisms for motoneuron loss in ALS. (a) Mutant SOD-associated familial ALS. Increaased intracellular O2&bull;&minus; results from decreased cytosolic SOD activity, and secondarily induces calcium release from internal stores and cell death. (b) Excitotoxic injury and sporadic ALS. Ostensibly the result of reduced glutamate uptake (GluT), increased levels of extracellular glutamate (Glu) would activate receptor-operated Ca2+ channels (ROCCs), increase Ca2+ entry, and secondarily induce oxidative injury and cell death. (c) Autoimmunity in sporadic ALS. Most sALS patients have antibodies directed against voltage-gated Ca2+ channels (VGCCs), which augment Ca2+ entry into motoneurons and may secondarily activate oxidative injury and cell death. Anti-VGCC antibodies also may increase presynaptic glutamate release onto motoneurons to produce secondary excitotoxic injury. </span><span class="imgReferences" style="display: none;"><ul class="references" figid="f1"><li class="refElement"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...These models indicate the potentiality for selective immune-mediated motoneuron loss in humans (see Figure 1)....</span></li></ul></span></span></li></ul></div></div></div><a class="right_scroll" href="javascript:void(0)"></a></div><div class="mainImageContent"><div id="main_preview"><img src="me46_0133_1_002.gif"></div><div class="imageTabs"><div class="imageTabs-hd"><ul class="medImgtabs"><li class="figCaption imageTabs-hd-active"><a href="javascript:void(0)">FIGURE CAPTION</a></li><li class="figReferences"><a href="javascript:void(0)">FIGURE LOCATIONS</a></li></ul><div class="imageLinks"><span class="enlargeLink"><a onclick="javascript:popRef('f1')" href="javascript:void(0);"><input src="enlarge.png" alt="Enlarge" border="0" type="image"></a></span></div><div class="clearfix"></div></div><div class="imageTabs-bd"><div class="figCaptionContent"> Figure<img src="2009.gif" alt="" class="entityA" align="bottom">1<img src="2002.gif" alt="" class="entityA" align="bottom">Proposed mechanisms for motoneuron loss in ALS. (a) Mutant SOD-associated familial ALS. Increaased intracellular O2&bull;&minus; results from decreased cytosolic SOD activity, and secondarily induces calcium release from internal stores and cell death. (b) Excitotoxic injury and sporadic ALS. Ostensibly the result of reduced glutamate uptake (GluT), increased levels of extracellular glutamate (Glu) would activate receptor-operated Ca2+ channels (ROCCs), increase Ca2+ entry, and secondarily induce oxidative injury and cell death. (c) Autoimmunity in sporadic ALS. Most sALS patients have antibodies directed against voltage-gated Ca2+ channels (VGCCs), which augment Ca2+ entry into motoneurons and may secondarily activate oxidative injury and cell death. Anti-VGCC antibodies also may increase presynaptic glutamate release onto motoneurons to produce secondary excitotoxic injury. </div><div class="figRefContent imageTabs-bd-hidden"><ul class="references" figid="f1"><li class="refElement"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...These models indicate the potentiality for selective immune-mediated motoneuron loss in humans (see Figure 1)....
                                            </span></li></ul></div></div></div></div></div><div id="referencesTab"><ul><li class="fulltext b1" refid="b1" id="b1ref"><span class="toggleImg whiteToggleImg"></span><span class="position">1.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Rowland LP. 1985. Motor neuron diseases and amyotrophic lateral sclerosis. <i>Trends Neurosci.</i> 7:110&ndash;12 <script type="text/javascript">

				genRefLink(16, 'b1', '10.1016%2FS0166-2236%2884%2980236-2');
			</script> <script type="text/javascript">

				genRefLink(128, 'b1', 'A1984SQ89000005');
			</script> <script type="text/javascript">

            genSfxLinks('b1', '%26aulast%3DRowland%26aufirst%3DLP%26date%3D1985%26atitle%3DMotor%2Bneuron%2Bdiseases%2Band%2Bamyotrophic%2Blateral%2Bsclerosis.%26stitle%3DTrends%2BNeurosci.%26volume%3D7%26spage%3D110%26id%3Ddoi%3A10.1016%252FS0166-2236%252884%252980236-2');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR1"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...devastating syndrome that affects both upper and lower motoneurons and results in limb and facial motor weakness, atrophy, spasticity, and death (1,...</span></li></ul><div class="otherReviews" style="display: none;"></div></li><li class="fulltext b2" refid="b2" id="b2ref"><span class="toggleImg whiteToggleImg"></span><span class="position">2.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Appel SH, Stockton-Appel V, Stewart SS, et al. 1986. Amyotrophic lateral sclerosis: associated clinical disorders and immunologic evaluations. <i>Arch. Neurol.</i> 43:234&ndash;38 <script type="text/javascript">

				genRefLink(8, 'b2', '3484947');
			</script> <script type="text/javascript">

				genRefLink(128, 'b2', 'A1986A234700005');
			</script> <script type="text/javascript">

            genSfxLinks('b2', '%26aulast%3DAppel%26aufirst%3DSH%26date%3D1986%26atitle%3DAmyotrophic%2Blateral%2Bsclerosis%253A%2Bassociated%2Bclinical%2Bdisorders%2Band%2Bimmunologic%2Bevaluations.%26stitle%3DArch.%2BNeurol.%26volume%3D43%26spage%3D234');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR2"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...devastating syndrome that affects both upper and lower motoneurons and results in limb and facial motor weakness, atrophy, spasticity, and death (1, 2,...</span></li><li ref-id="XR53"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...evidence for an autoimmune etiology of sALS was largely clinical. sALS patients have an increased incidence of autoimmune disease (2),...</span></li></ul><div class="otherReviews" style="display: none;"></div></li><li class="fulltext b3" refid="b3" id="b3ref"><span class="toggleImg whiteToggleImg"></span><span class="position">3.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Norris F, Shepherd R, Denys E, et al. 1993. Onset, natural history, and outcome in idiopathic adult motor neuron disease. <i>J. Neurol. Sci.</i> 118:48&ndash;55 <script type="text/javascript">

				genRefLink(16, 'b3', '10.1016%2F0022-510X%2893%2990245-T');
			</script> <script type="text/javascript">

				genRefLink(8, 'b3', '8229050');
			</script> <script type="text/javascript">

				genRefLink(128, 'b3', 'A1993LR29000009');
			</script> <script type="text/javascript">

            genSfxLinks('b3', '%26aulast%3DNorris%26aufirst%3DF%26date%3D1993%26atitle%3DOnset%252C%2Bnatural%2Bhistory%252C%2Band%2Boutcome%2Bin%2Bidiopathic%2Badult%2Bmotor%2Bneuron%2Bdisease.%26stitle%3DJ.%2BNeurol.%2BSci.%26volume%3D118%26spage%3D48%26id%3Ddoi%3A10.1016%252F0022-510X%252893%252990245-T');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR3"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...devastating syndrome that affects both upper and lower motoneurons and results in limb and facial motor weakness, atrophy, spasticity, and death (1, 2, 3)....</span></li><li ref-id="XR4"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...Older males and postmenopausal females are most typically affected (3, 5)....</span></li><li ref-id="XR6"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...Familial ALS (fALS) accounts for less than 10% of diagnosed cases (3,...</span></li></ul><div class="otherReviews" style="display: none;"></div></li><li class="fulltext b4" refid="b4" id="b4ref"><span class="toggleImg whiteToggleImg"></span><span class="position">4.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Annegers JF, Appel SH, Lee R-J, et al. 1991. Incidence and prevalence of amyotrophic lateral sclerosis in Harris County, Texas, 1985&ndash;1988. <i>Arch. Neurol.</i> 48:589&ndash;93 <script type="text/javascript">

				genRefLink(8, 'b4', '2039380');
			</script> <script type="text/javascript">

				genRefLink(128, 'b4', 'A1991FP88100008');
			</script> <script type="text/javascript">

            genSfxLinks('b4', '%26aulast%3DAnnegers%26aufirst%3DJF%26date%3D1991%26atitle%3DIncidence%2Band%2Bprevalence%2Bof%2Bamyotrophic%2Blateral%2Bsclerosis%2Bin%2BHarris%2BCounty%252C%2BTexas%252C%2B1985%25E2%2580%25931988.%26stitle%3DArch.%2BNeurol.%26volume%3D48%26spage%3D589');
        </script></div><ul class="refSnip" style="display: none;"></ul><div class="otherReviews" style="display: none;"></div></li><li class="fulltext b5" refid="b5" id="b5ref"><span class="toggleImg whiteToggleImg"></span><span class="position">5.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Ringel SP, Murphy JR, Alderson MK, et al. 1993. The natural history of amyotrophic lateral sclerosis. <i>Neurology</i> 43:1316&ndash;22 <script type="text/javascript">

				genRefLink(8, 'b5', '8327132');
			</script> <script type="text/javascript">

				genRefLink(128, 'b5', 'A1993LM10400010');
			</script> <script type="text/javascript">

            genSfxLinks('b5', '%26aulast%3DRingel%26aufirst%3DSP%26date%3D1993%26atitle%3DThe%2Bnatural%2Bhistory%2Bof%2Bamyotrophic%2Blateral%2Bsclerosis.%26stitle%3DNeurology%26volume%3D43%26spage%3D1316');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR5"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...Older males and postmenopausal females are most typically affected (3, 5)....</span></li></ul><div class="otherReviews" style="display: none;"></div></li><li class="fulltext b6" refid="b6" id="b6ref"><span class="toggleImg orangeToggleImg"></span><span class="position">6.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Mulder DW, Kurland LT, Offard KP, et al. 1986. Familial adult motor neuron disease: amyotrophic lateral sclerosis. <i>Neurology</i> 36:511&ndash;17 <script type="text/javascript">

				genRefLink(8, 'b6', '3960325');
			</script> <script type="text/javascript">

				genRefLink(128, 'b6', 'A1986A888500010');
			</script> <script type="text/javascript">

            genSfxLinks('b6', '%26aulast%3DMulder%26aufirst%3DDW%26date%3D1986%26atitle%3DFamilial%2Badult%2Bmotor%2Bneuron%2Bdisease%253A%2Bamyotrophic%2Blateral%2Bsclerosis.%26stitle%3DNeurology%26volume%3D36%26spage%3D511');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR7"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...Familial ALS (fALS) accounts for less than 10% of diagnosed cases (3, 6,...</span></li></ul><div class="otherReviews" style="display: none;"><p class="otherReviewsHeader">

                    Other reviews that cite this reference:
                </p><ul class="otherReviewsList"><li class="otherReviewEntry"><div class="otherReviewsTitle"><h2><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/abs/10.1146/annurev.neuro.27.070203.144244" target="_top">UNRAVELING THE MECHANISMS INVOLVED IN MOTOR NEURON DEGENERATION IN ALS</a></h2></div><div class="otherReviewsAuthor">Lucie I. Bruijn, Timothy M. Miller, Don W. Cleveland</div><div class="otherReviewsInfo">Annual Review of Neuroscience 
                    Vol. 27:
                    723
                        -
                        749</div><div class="otherReviewSnipp"><ul><li ref-id="XR1"><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/full/10.1146/annurev.neuro.27.070203.144244#XR1"> ...<ref-snippet xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-id="XR1">muscle atrophy, and paralysis (lower motor neurons) (Mulder et al. 1986).</ref-snippet>... </a></li></ul></div></li><li class="otherReviewEntry"></li></ul></div></li><li class="fulltext b7" refid="b7" id="b7ref"><span class="toggleImg orangeToggleImg"></span><span class="position">7.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Siddique T, Figlewicz D, Pericak-Vance MA, et al. 1991. Linkage of a gene causing familial amyotrophic lateral sclerosis to chromosome 21, and evidence of genetic locus heterogeneity. <i>New Engl. J. Med.</i> 324:1381&ndash;84 <script type="text/javascript">

				genRefLink(16, 'b7', '10.1056%2FNEJM199105163242001');
			</script> <script type="text/javascript">

				genRefLink(8, 'b7', '2020294');
			</script> <script type="text/javascript">

				genRefLink(128, 'b7', 'A1991FL12500001');
			</script> <script type="text/javascript">

            genSfxLinks('b7', '%26aulast%3DSiddique%26aufirst%3DT%26date%3D1991%26atitle%3DLinkage%2Bof%2Ba%2Bgene%2Bcausing%2Bfamilial%2Bamyotrophic%2Blateral%2Bsclerosis%2Bto%2Bchromosome%2B21%252C%2Band%2Bevidence%2Bof%2Bgenetic%2Blocus%2Bheterogeneity.%26stitle%3DNew%2BEngl.%2BJ.%2BMed.%26volume%3D324%26spage%3D1381%26id%3Ddoi%3A10.1056%252FNEJM199105163242001');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR8"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...Familial ALS (fALS) accounts for less than 10% of diagnosed cases (3, 6, 7,...</span></li><li ref-id="XR10"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...A significant discovery in ALS research was the identification of a genetic defect associated with 10&ndash;15% of fALS kindreds (7)....</span></li></ul><div class="otherReviews" style="display: none;"><p class="otherReviewsHeader">

                    Other reviews that cite this reference:
                </p><ul class="otherReviewsList"><li class="otherReviewEntry"><div class="otherReviewsTitle"><h2><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/abs/10.1146/annurev.neuro.23.1.343" target="_top">The Emergence of Modern Neuroscience: Some Implications for Neurology and Psychiatry</a></h2></div><div class="otherReviewsAuthor">W. Maxwell Cowan, Donald H. Harter, Eric R. Kandel</div><div class="otherReviewsInfo">Annual Review of Neuroscience 
                    Vol. 23:
                    343
                        -
                        391</div><div class="otherReviewSnipp"><ul><li ref-id="XR72"><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/full/10.1146/annurev.neuro.23.1.343#XR72"> ...<ref-snippet xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-id="XR72">an extensive team of collaborating scientists reported the finding of a locus on the long arm of chromosome 21 that showed strong linkage to a familial form of ALS in a group of 23 families (Siddique et al 1991).</ref-snippet>... </a></li></ul></div></li><li class="otherReviewEntry"></li></ul></div></li><li class="fulltext b8" refid="b8" id="b8ref"><span class="toggleImg orangeToggleImg"></span><span class="position">8.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Rosen DR, Siddique T, Patterson D, et al. 1993. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. <i>Nature</i> 362:59&ndash;62 <script type="text/javascript">

				genRefLink(16, 'b8', '10.1038%2F362059a0');
			</script> <script type="text/javascript">

				genRefLink(8, 'b8', '8446170');
			</script> <script type="text/javascript">

				genRefLink(128, 'b8', 'A1993KP97600059');
			</script> <script type="text/javascript">

            genSfxLinks('b8', '%26aulast%3DRosen%26aufirst%3DDR%26date%3D1993%26atitle%3DMutations%2Bin%2BCu%252FZn%2Bsuperoxide%2Bdismutase%2Bgene%2Bare%2Bassociated%2Bwith%2Bfamilial%2Bamyotrophic%2Blateral%2Bsclerosis.%26stitle%3DNature%26volume%3D362%26spage%3D59%26id%3Ddoi%3A10.1038%252F362059a0');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR9"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...Familial ALS (fALS) accounts for less than 10% of diagnosed cases (3, 6, 7, 8),...</span></li><li ref-id="XR11"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...and 5 of the SOD1 gene all appear to reduce Cu2+/Zn2+ SOD stability and SOD-catalyzed free-radical metabolism (8,...</span></li></ul><div class="otherReviews" style="display: none;"><p class="otherReviewsHeader">

                    Other reviews that cite this reference:
                </p><ul class="otherReviewsList"><li class="otherReviewEntry"><div class="otherReviewsTitle"><h2><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/abs/10.1146/annurev.neuro.27.070203.144244" target="_top">UNRAVELING THE MECHANISMS INVOLVED IN MOTOR NEURON DEGENERATION IN ALS</a></h2></div><div class="otherReviewsAuthor">Lucie I. Bruijn, Timothy M. Miller, Don W. Cleveland</div><div class="otherReviewsInfo">Annual Review of Neuroscience 
                    Vol. 27:
                    723
                        -
                        749</div><div class="otherReviewSnipp"><ul><li ref-id="XR168"><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/full/10.1146/annurev.neuro.27.070203.144244#XR168"> ...<ref-snippet xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-id="XR168">approximately 20% are caused by dominantly inherited mutations in the protein Cu/Zn superoxide dismutase (SOD1) (Rosen et al. 1993).</ref-snippet>... </a></li></ul></div></li><li class="otherReviewEntry"><div class="otherReviewsTitle"><h2><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/abs/10.1146/annurev.med.55.091902.103607" target="_top">Toward Alzheimer Therapies Based on Genetic Knowledge 					*</a></h2></div><div class="otherReviewsAuthor">John Hardy</div><div class="otherReviewsInfo">Annual Review of Medicine 
                    Vol. 55:
                    15
                        -
                        25</div><div class="otherReviewSnipp"><ul><li ref-id="XR19"><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/full/10.1146/annurev.med.55.091902.103607#XR19"> ...<ref-snippet xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-id="XR19">Superoxide dismutase mutations in amyotrophic lateral sclerosis (16) are less clearly linked to the pathological entity generally.</ref-snippet>... </a></li></ul></div></li><li class="otherReviewEntry"><div class="otherReviewsTitle"><h2><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/abs/10.1146/annurev.cellbio.19.111401.092306" target="_top">THE DYNAMIC AND MOTILE PROPERTIES OF INTERMEDIATE FILAMENTS</a></h2></div><div class="otherReviewsAuthor">Brian T. HelfandLynne Chang, Robert D. Goldman</div><div class="otherReviewsInfo">Annual Review of Cell and Developmental Biology 
                    Vol. 19:
                    445
                        -
                        467</div><div class="otherReviewSnipp"><ul><li ref-id="XR102"><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/full/10.1146/annurev.cellbio.19.111401.092306#XR102"> ...<ref-snippet xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-id="XR102">with a small proportion of these linked to mutations in Cu/Zn superoxide dismutase 1 (SOD1) (Cudkowicz et al. 1997, Rosen et al. 1993).</ref-snippet>... </a></li></ul></div></li><li class="otherReviewEntry"><div class="otherReviewsTitle"><h2><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/abs/10.1146/annurev.neuro.26.010302.081142" target="_top">PROTOFIBRILS, PORES, FIBRILS, AND NEURODEGENERATION: Separating the Responsible Protein Aggregates from The Innocent Bystanders*</a></h2></div><div class="otherReviewsAuthor">Byron Caughey, Peter T. Lansbury</div><div class="otherReviewsInfo">Annual Review of Neuroscience 
                    Vol. 26:
                    267
                        -
                        298</div><div class="otherReviewSnipp"><ul><li ref-id="XR206"><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/full/10.1146/annurev.neuro.26.010302.081142#XR206"> ...<ref-snippet xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-id="XR206">Approximately 20% of FALS cases are due to autosomal dominant inheritance of a missense mutation in the gene encoding SOD1 (Rosen et al. 1993).</ref-snippet>... </a></li></ul></div></li><li class="otherReviewEntry"><div class="otherReviewsTitle"><h2><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/abs/10.1146/annurev.pharmtox.37.1.239" target="_top">PHARMACOLOGY OF NEUROTROPHIC FACTORS</a></h2></div><div class="otherReviewsAuthor">Franz Hefti</div><div class="otherReviewsInfo">Annual Review of Pharmacology and Toxicology 
                    Vol. 37:
                    239
                        -
                        267</div><div class="otherReviewSnipp"><ul></ul></div></li><li class="otherReviewEntry"><div class="otherReviewsTitle"><h2><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/abs/10.1146/annurev.genet.30.1.197" target="_top">THE CYTOSKELETON AND DISEASE:Genetic Disorders of Intermediate Filaments</a></h2></div><div class="otherReviewsAuthor">Elaine Fuchs</div><div class="otherReviewsInfo">Annual Review of Genetics 
                    Vol. 30:
                    197
                        -
                        231</div><div class="otherReviewSnipp"><ul><li ref-id="XR114"><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/full/10.1146/annurev.genet.30.1.197#XR114"> ...<ref-snippet xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-id="XR114">and these have not been detected in the general population (47 but see 141).</ref-snippet>... </a></li></ul></div></li><li class="otherReviewEntry"></li></ul></div></li><li class="fulltext b9" refid="b9" id="b9ref"><span class="toggleImg whiteToggleImg"></span><span class="position">9.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Deng H-X, Hentati A, Tainer JA, et al. 1993. Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase. <i>Science</i> 261:1047&ndash;51 <script type="text/javascript">

				genRefLink(16, 'b9', '10.1126%2Fscience.8351519');
			</script> <script type="text/javascript">

				genRefLink(8, 'b9', '8351519');
			</script> <script type="text/javascript">

				genRefLink(128, 'b9', 'A1993LT74700035');
			</script> <script type="text/javascript">

            genSfxLinks('b9', '%26aulast%3DDeng%26aufirst%3DH-X%26date%3D1993%26atitle%3DAmyotrophic%2Blateral%2Bsclerosis%2Band%2Bstructural%2Bdefects%2Bin%2BCu%252CZn%2Bsuperoxide%2Bdismutase.%26stitle%3DScience%26volume%3D261%26spage%3D1047%26id%3Ddoi%3A10.1126%252Fscience.8351519');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR12"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...and 5 of the SOD1 gene all appear to reduce Cu2+/Zn2+ SOD stability and SOD-catalyzed free-radical metabolism (8, 9)....</span></li></ul><div class="otherReviews" style="display: none;"></div></li><li class="fulltext b10" refid="b10" id="b10ref"><span class="toggleImg whiteToggleImg"></span><span class="position">10.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Ogasawara M, Matsubara Y, Narisawa K, et al. 1993. Mild ALS in Japan associated with novel SOD mutation. <i>Nat. Genet.</i> 5:323&ndash;24 <script type="text/javascript">

				genRefLink(16, 'b10', '10.1038%2Fng1293-323');
			</script> <script type="text/javascript">

				genRefLink(8, 'b10', '8298637');
			</script> <script type="text/javascript">

				genRefLink(128, 'b10', 'A1993ML14500005');
			</script> <script type="text/javascript">

            genSfxLinks('b10', '%26aulast%3DOgasawara%26aufirst%3DM%26date%3D1993%26atitle%3DMild%2BALS%2Bin%2BJapan%2Bassociated%2Bwith%2Bnovel%2BSOD%2Bmutation.%26stitle%3DNat.%2BGenet.%26volume%3D5%26spage%3D323%26id%3Ddoi%3A10.1038%252Fng1293-323');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR13"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...This mutation may alter Cu2+ binding to the enzyme's catalytic site and reduces erythrocyte lysate SOD activity by approximately 20% (10)....</span></li></ul><div class="otherReviews" style="display: none;"></div></li><li class="fulltext b11" refid="b11" id="b11ref"><span class="toggleImg whiteToggleImg"></span><span class="position">11.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Siddique T, Juneja J, Caliendo J, et al. 1994. Spectrum of the phenotype in familial ALS with SOD1 mutations. <i>Neurology</i> 44 (Suppl. 2):A165(Abstr.)  <script type="text/javascript">

            genSfxLinks('b11', '%26aulast%3DSiddique%26aufirst%3DT%26date%3D1994%26atitle%3DSpectrum%2Bof%2Bthe%2Bphenotype%2Bin%2Bfamilial%2BALS%2Bwith%2BSOD1%2Bmutations.%26stitle%3DNeurology%26volume%3D44+%28Suppl.+2%29%26spage%3DA165');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR14"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...Two such point mutations (Ala4 &rarr; Val and Gly41 &rarr; Ser) produce an enzyme with less than 50% of normal Cu2+/Zn2+ SOD activity (11),...</span></li><li ref-id="XR15"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...and death of affected patients occurs after less than one year of symptom onset (11,...</span></li></ul><div class="otherReviews" style="display: none;"></div></li><li class="fulltext b12" refid="b12" id="b12ref"><span class="toggleImg whiteToggleImg"></span><span class="position">12.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Rainero I, Pinessi L, Tsuda T, et al. 1994. SOD1 missense mutation in an Italian family with ALS. <i>Neurology</i> 44:347&ndash;49 <script type="text/javascript">

				genRefLink(8, 'b12', '8309590');
			</script> <script type="text/javascript">

				genRefLink(128, 'b12', 'A1994MW89000034');
			</script> <script type="text/javascript">

            genSfxLinks('b12', '%26aulast%3DRainero%26aufirst%3DI%26date%3D1994%26atitle%3DSOD1%2Bmissense%2Bmutation%2Bin%2Ban%2BItalian%2Bfamily%2Bwith%2BALS.%26stitle%3DNeurology%26volume%3D44%26spage%3D347');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR16"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...and death of affected patients occurs after less than one year of symptom onset (11, 12)....</span></li></ul><div class="otherReviews" style="display: none;"></div></li><li class="fulltext b13" refid="b13" id="b13ref"><span class="toggleImg orangeToggleImg"></span><span class="position">13.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Olanow CW. 1993. A radical hypothesis for neurodegeneration. <i>Trends Neurosci.</i> 16:439&ndash;44 <script type="text/javascript">

				genRefLink(16, 'b13', '10.1016%2F0166-2236%2893%2990070-3');
			</script> <script type="text/javascript">

				genRefLink(8, 'b13', '7507613');
			</script> <script type="text/javascript">

				genRefLink(128, 'b13', 'A1993MF00800005');
			</script> <script type="text/javascript">

            genSfxLinks('b13', '%26aulast%3DOlanow%26aufirst%3DCW%26date%3D1993%26atitle%3DA%2Bradical%2Bhypothesis%2Bfor%2Bneurodegeneration.%26stitle%3DTrends%2BNeurosci.%26volume%3D16%26spage%3D439%26id%3Ddoi%3A10.1016%252F0166-2236%252893%252990070-3');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR17"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...reduced Cu2+/Zn2+ SOD activity in patients with fALS equates to increased steady-state levels of [O2&bull;&minus;]i (13)....</span></li></ul><div class="otherReviews" style="display: none;"><p class="otherReviewsHeader">

                    Other reviews that cite this reference:
                </p><ul class="otherReviewsList"><li class="otherReviewEntry"><div class="otherReviewsTitle"><h2><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/abs/10.1146/annurev.neuro.22.1.123" target="_top">ETIOLOGY AND PATHOGENESIS OF PARKINSON'S DISEASE</a></h2></div><div class="otherReviewsAuthor">C. W. Olanow, W. G. Tatton</div><div class="otherReviewsInfo">Annual Review of Neuroscience 
                    Vol. 22:
                    123
                        -
                        144</div><div class="otherReviewSnipp"><ul><li ref-id="XR27"><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/full/10.1146/annurev.neuro.22.1.123#XR27"> ...<ref-snippet xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-id="XR27">Oxidative stress has received the most attention in PD because of the potential of the oxidative metabolism of dopamine to yield hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) and other reactive oxygen species (ROS) (reviewed in Halliwell & Gutteridge 1985;, Olanow 1990, 1993) (Figure 1).</ref-snippet>... </a></li></ul></div></li><li class="otherReviewEntry"></li></ul></div></li><li class="fulltext b14" refid="b14" id="b14ref"><span class="toggleImg orangeToggleImg"></span><span class="position">14.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Huie RE, Padmaja S. 1993. The reaction of NO with superoxide. <i>Free Radic. Res. Commun.</i> 18:195&ndash;201 <script type="text/javascript">

				genRefLink(16, 'b14', '10.3109%2F10715769309145868');
			</script> <script type="text/javascript">

				genRefLink(8, 'b14', '8396550');
			</script> <script type="text/javascript">

            genSfxLinks('b14', '%26aulast%3DHuie%26aufirst%3DRE%26date%3D1993%26atitle%3DThe%2Breaction%2Bof%2BNO%2Bwith%2Bsuperoxide.%26stitle%3DFree%2BRadic.%2BRes.%2BCommun.%26volume%3D18%26spage%3D195%26id%3Ddoi%3A10.3109%252F10715769309145868');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR18"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...Moreover, it interacts with nitric oxide to form peroxynitrite (ONOO&minus;) (14),...</span></li></ul><div class="otherReviews" style="display: none;"><p class="otherReviewsHeader">

                    Other reviews that cite this reference:
                </p><ul class="otherReviewsList"><li class="otherReviewEntry"><div class="otherReviewsTitle"><h2><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/abs/10.1146/annurev.pharmtox.47.120505.105144" target="_top">Arsenic: Signal Transduction, Transcription Factor, and Biotransformation Involved in Cellular Response and Toxicity</a></h2></div><div class="otherReviewsAuthor">Yoshito Kumagai, Daigo Sumi</div><div class="otherReviewsInfo">Annual Review of Pharmacology and Toxicology 
                    Vol. 47:
                    243
                        -
                        262</div><div class="otherReviewSnipp"><ul><li ref-id="XR20"><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/full/10.1146/annurev.pharmtox.47.120505.105144#XR20"> ...<ref-snippet xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-id="XR20">Superoxide can react with NO rapidly with a rate constant of 4.3&ndash;19&times;10<sup>9</sup> M<sup>&minus;1</sup> S<sup>&minus;1</sup> (20</ref-snippet>... </a></li></ul></div></li><li class="otherReviewEntry"><div class="otherReviewsTitle"><h2><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/abs/10.1146/annurev.pharmtox.45.120403.095959" target="_top">NITROXYL (HNO): Chemistry, Biochemistry, and Pharmacology</a></h2></div><div class="otherReviewsAuthor">Jon M. Fukuto, Christopher H. Switzer, Katrina M. Miranda, David A. Wink</div><div class="otherReviewsInfo">Annual Review of Pharmacology and Toxicology 
                    Vol. 45:
                    335
                        -
                        355</div><div class="otherReviewSnipp"><ul><li ref-id="XR55"><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/full/10.1146/annurev.pharmtox.45.120403.095959#XR55"> ...<ref-snippet xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-id="XR55">This reaction (Reaction 4) is isoelectronic with the well-studied reaction of NO with O<sub>2</sub><sup>&minus;</sup> (Reaction 5), and both reactions occur at near diffusion-controlled rates (24, 35,</ref-snippet>... </a></li></ul></div></li><li class="otherReviewEntry"><div class="otherReviewsTitle"><h2><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/abs/10.1146/annurev.arplant.54.031902.134752" target="_top">NITRIC OXIDE: The Versatility of an Extensive Signal Molecule</a></h2></div><div class="otherReviewsAuthor">Lorenzo LamattinaCarlos Garc&iacute;a-MataMagdalena Graziano, Gabriela Pagnussat</div><div class="otherReviewsInfo">Annual Review of Plant Biology 
                    Vol. 54:
                    109
                        -
                        136</div><div class="otherReviewSnipp"><ul><li ref-id="XR75"><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/full/10.1146/annurev.arplant.54.031902.134752#XR75"> ...<ref-snippet xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-id="XR75">which can oxidize thiol residues to sulfenic and sulfonic acids (72).</ref-snippet>... </a></li></ul></div></li><li class="otherReviewEntry"><div class="otherReviewsTitle"><h2><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/abs/10.1146/annurev.bioeng.3.1.109" target="_top">CAN WE MODEL NITRIC OXIDE BIOTRANSPORT? A SURVEY OF MATHEMATICAL MODELS FOR A SIMPLE DIATOMIC MOLECULE WITH SURPRISINGLY COMPLEX BIOLOGICAL ACTIVITIES</a></h2></div><div class="otherReviewsAuthor">Donald G. Buerk</div><div class="otherReviewsInfo">Annual Review of Biomedical Engineering 
                    Vol. 3:
                    109
                        -
                        143</div><div class="otherReviewSnipp"><ul></ul></div></li><li class="otherReviewEntry"><div class="otherReviewsTitle"><h2><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/abs/10.1146/annurev.pharmtox.41.1.203" target="_top">NOVEL EFFECTS OF NITRIC OXIDE</a></h2></div><div class="otherReviewsAuthor">Karen L DavisEmil MartinIllarion V Turko, Ferid Murad</div><div class="otherReviewsInfo">Annual Review of Pharmacology and Toxicology 
                    Vol. 41:
                    203
                        -
                        236</div><div class="otherReviewSnipp"><ul><li ref-id="XR43"><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/full/10.1146/annurev.pharmtox.41.1.203#XR43"> ...<ref-snippet xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-id="XR43">NO also reacts with O2<sup>&bull;&minus;</sup> to produce the powerful oxidant, peroxynitrite (ONOO<sup>&minus;</sup>) (21).</ref-snippet>... </a></li></ul></div></li><li class="otherReviewEntry"></li></ul></div></li><li class="fulltext b15" refid="b15" id="b15ref"><span class="toggleImg orangeToggleImg"></span><span class="position">15.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Koppenol WH, Moreno JJ, Pryor WA, et al. 1992. Peroxynitrite, a cloaked oxidant formed by nitric oxide and superoxide. <i>Chem. Res. Toxicol.</i> 5:834&ndash;42 <script type="text/javascript">

				genRefLink(16, 'b15', '10.1021%2Ftx00030a017');
			</script> <script type="text/javascript">

				genRefLink(8, 'b15', '1336991');
			</script> <script type="text/javascript">

				genRefLink(128, 'b15', 'A1992KB00900018');
			</script> <script type="text/javascript">

            genSfxLinks('b15', '%26aulast%3DKoppenol%26aufirst%3DWH%26date%3D1992%26atitle%3DPeroxynitrite%252C%2Ba%2Bcloaked%2Boxidant%2Bformed%2Bby%2Bnitric%2Boxide%2Band%2Bsuperoxide.%26stitle%3DChem.%2BRes.%2BToxicol.%26volume%3D5%26spage%3D834%26id%3Ddoi%3A10.1021%252Ftx00030a017');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR19"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...which can disrupt lipid bilayers and oxidize protein methionine residues and thiols (15)....</span></li></ul><div class="otherReviews" style="display: none;"><p class="otherReviewsHeader">

                    Other reviews that cite this reference:
                </p><ul class="otherReviewsList"><li class="otherReviewEntry"><div class="otherReviewsTitle"><h2><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/abs/10.1146/annurev.pharmtox.44.101802.121851" target="_top">THE ROLE OF OXIDATIVE STRESS IN CARCINOGENESIS</a></h2></div><div class="otherReviewsAuthor">James E. Klaunig, Lisa M. Kamendulis</div><div class="otherReviewsInfo">Annual Review of Pharmacology and Toxicology 
                    Vol. 44:
                    239
                        -
                        267</div><div class="otherReviewSnipp"><ul><li ref-id="XR82"><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/full/10.1146/annurev.pharmtox.44.101802.121851#XR82"> ...<ref-snippet xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-id="XR82">is formed from the coupling of nitric oxide and superoxide (60, 61).</ref-snippet>... </a></li></ul></div></li><li class="otherReviewEntry"><div class="otherReviewsTitle"><h2><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/abs/10.1146/annurev.med.47.1.219" target="_top">NITRIC OXIDE SYNTHASE: Role as a Transmitter/Mediator in the Brain and Endocrine System</a></h2></div><div class="otherReviewsAuthor">Ted M. Dawson, M.D., Ph.D, Valina L. Dawson, Ph.D</div><div class="otherReviewsInfo">Annual Review of Medicine 
                    Vol. 47:
                    219
                        -
                        227</div><div class="otherReviewSnipp"><ul><li ref-id="XR54"><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/full/10.1146/annurev.med.47.1.219#XR54"> ...<ref-snippet xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-id="XR54">35) (Figure 2) Peroxynitrite may be toxic through a variety of mechanisms.</ref-snippet>... </a></li></ul></div></li><li class="otherReviewEntry"></li></ul></div></li><li class="fulltext b16" refid="b16" id="b16ref"><span class="toggleImg orangeToggleImg"></span><span class="position">16.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Beckman JS, Ischiropoulos H, Zhu L, et al. 1992. Kinetics of superoxide dismutase- and iron-catalyzed nitration of phenolics by peroxynitrite. <i>Arch. Biochem. Biophys.</i> 298:438&ndash;45 <script type="text/javascript">

				genRefLink(16, 'b16', '10.1016%2F0003-9861%2892%2990432-V');
			</script> <script type="text/javascript">

				genRefLink(8, 'b16', '1416975');
			</script> <script type="text/javascript">

				genRefLink(128, 'b16', 'A1992JU07000017');
			</script> <script type="text/javascript">

            genSfxLinks('b16', '%26aulast%3DBeckman%26aufirst%3DJS%26date%3D1992%26atitle%3DKinetics%2Bof%2Bsuperoxide%2Bdismutase-%2Band%2Biron-catalyzed%2Bnitration%2Bof%2Bphenolics%2Bby%2Bperoxynitrite.%26stitle%3DArch.%2BBiochem.%2BBiophys.%26volume%3D298%26spage%3D438%26id%3Ddoi%3A10.1016%252F0003-9861%252892%252990432-V');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR20"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...Peroxynitrites also react with SOD to form nitronium-like molecules, which modify tyrosine residues (16)....</span></li></ul><div class="otherReviews" style="display: none;"><p class="otherReviewsHeader">

                    Other reviews that cite this reference:
                </p><ul class="otherReviewsList"><li class="otherReviewEntry"><div class="otherReviewsTitle"><h2><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/abs/10.1146/annurev.pharmtox.41.1.203" target="_top">NOVEL EFFECTS OF NITRIC OXIDE</a></h2></div><div class="otherReviewsAuthor">Karen L DavisEmil MartinIllarion V Turko, Ferid Murad</div><div class="otherReviewsInfo">Annual Review of Pharmacology and Toxicology 
                    Vol. 41:
                    203
                        -
                        236</div><div class="otherReviewSnipp"><ul><li ref-id="XR162"><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/full/10.1146/annurev.pharmtox.41.1.203#XR162"> ...<ref-snippet xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-id="XR162">There are a number of in vitro chemical studies showing that peroxynitrite can nitrate tyrosine residues (53,</ref-snippet>... </a></li></ul></div></li><li class="otherReviewEntry"></li></ul></div></li><li class="fulltext b17" refid="b17" id="b17ref"><span class="toggleImg orangeToggleImg"></span><span class="position">17.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Beckman JS, Beckman TW, Chen J. 1989. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. <i>Proc. Natl. Acad. Sci. USA</i> 87:1620&ndash;24 <script type="text/javascript">

				genRefLink(16, 'b17', '10.1073%2Fpnas.87.4.1620');
			</script> <script type="text/javascript">

				genRefLink(8, 'b17', '2154753');
			</script> <script type="text/javascript">

				genRefLink(128, 'b17', 'A1990CP23800075');
			</script> <script type="text/javascript">

            genSfxLinks('b17', '%26aulast%3DBeckman%26aufirst%3DJS%26date%3D1989%26atitle%3DApparent%2Bhydroxyl%2Bradical%2Bproduction%2Bby%2Bperoxynitrite%253A%2Bimplications%2Bfor%2Bendothelial%2Binjury%2Bfrom%2Bnitric%2Boxide%2Band%2Bsuperoxide.%26stitle%3DProc.%2BNatl.%2BAcad.%2BSci.%2BUSA%26volume%3D87%26spage%3D1620%26id%3Ddoi%3A10.1073%252Fpnas.87.4.1620');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR21"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...Peroxynitrites are also protonated to form nitrosyl radicals, which decompose to OH&bull; (17)....</span></li></ul><div class="otherReviews" style="display: none;"><p class="otherReviewsHeader">

                    Other reviews that cite this reference:
                </p><ul class="otherReviewsList"><li class="otherReviewEntry"><div class="otherReviewsTitle"><h2><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/abs/10.1146/annurev.pharmtox.47.120505.105110" target="_top">Targeting Antioxidants to Mitochondria by Conjugation to Lipophilic Cations</a></h2></div><div class="otherReviewsAuthor">Michael P. Murphy, Robin A.J. Smith</div><div class="otherReviewsInfo">Annual Review of Pharmacology and Toxicology 
                    Vol. 47:
                    629
                        -
                        656</div><div class="otherReviewSnipp"><ul><li ref-id="XR36"><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/full/10.1146/annurev.pharmtox.47.120505.105110#XR36"> ...<ref-snippet xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-id="XR36">and also with nitric oxide to form the reactive and damaging oxidant peroxynitrite (32).</ref-snippet>... </a></li></ul></div></li><li class="otherReviewEntry"><div class="otherReviewsTitle"><h2><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/abs/10.1146/annurev.pharmtox.44.101802.121851" target="_top">THE ROLE OF OXIDATIVE STRESS IN CARCINOGENESIS</a></h2></div><div class="otherReviewsAuthor">James E. Klaunig, Lisa M. Kamendulis</div><div class="otherReviewsInfo">Annual Review of Pharmacology and Toxicology 
                    Vol. 44:
                    239
                        -
                        267</div><div class="otherReviewSnipp"><ul><li ref-id="XR81"><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/full/10.1146/annurev.pharmtox.44.101802.121851#XR81"> ...<ref-snippet xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-id="XR81">is formed from the coupling of nitric oxide and superoxide (60,</ref-snippet>... </a></li></ul></div></li><li class="otherReviewEntry"><div class="otherReviewsTitle"><h2><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/abs/10.1146/annurev.pharmtox.43.100901.135740" target="_top">NOVEL PHARMACOLOGICAL APPROACHES TO MANAGE INTERSTITIAL LUNG FIBROSIS IN THE TWENTY-FIRST CENTURY</a></h2></div><div class="otherReviewsAuthor">Shri N. Giri</div><div class="otherReviewsInfo">Annual Review of Pharmacology and Toxicology 
                    Vol. 43:
                    73
                        -
                        95</div><div class="otherReviewSnipp"><ul><li ref-id="XR95"><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/full/10.1146/annurev.pharmtox.43.100901.135740#XR95"> ...<ref-snippet xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-id="XR95">The latter is a potent oxidant that is produced rapidly in a reaction of NO with superoxide radicals (125).</ref-snippet>... </a></li></ul></div></li><li class="otherReviewEntry"><div class="otherReviewsTitle"><h2><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/abs/10.1146/annurev.bioeng.3.1.109" target="_top">CAN WE MODEL NITRIC OXIDE BIOTRANSPORT? A SURVEY OF MATHEMATICAL MODELS FOR A SIMPLE DIATOMIC MOLECULE WITH SURPRISINGLY COMPLEX BIOLOGICAL ACTIVITIES</a></h2></div><div class="otherReviewsAuthor">Donald G. Buerk</div><div class="otherReviewsInfo">Annual Review of Biomedical Engineering 
                    Vol. 3:
                    109
                        -
                        143</div><div class="otherReviewSnipp"><ul><li ref-id="XR104"><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/full/10.1146/annurev.bioeng.3.1.109#XR104"> ...<ref-snippet xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-id="XR104">sink 2) to form peroxynitrite (ONOO<sup>&minus;</sup>),   2   was first reported by Beckman et al (32).</ref-snippet>... </a></li></ul></div></li><li class="otherReviewEntry"><div class="otherReviewsTitle"><h2><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/abs/10.1146/annurev.pharmtox.39.1.191" target="_top">INHIBITION OF NITRIC OXIDE SYNTHASE AS A POTENTIAL THERAPEUTIC TARGET</a></h2></div><div class="otherReviewsAuthor">Adrian J. HobbsAnnie Higgs, Salvador Moncada</div><div class="otherReviewsInfo">Annual Review of Pharmacology and Toxicology 
                    Vol. 39:
                    191
                        -
                        220</div><div class="otherReviewSnipp"><ul><li ref-id="XR40"><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/full/10.1146/annurev.pharmtox.39.1.191#XR40"> ...<ref-snippet xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-id="XR40">Indeed the interaction between NO and O<sup>&minus;</sup><sub>2</sub> leads to the generation of peroxynitrite (ONOO<sup>&minus;</sup>), which is a powerful oxidant (36,</ref-snippet>... </a></li></ul></div></li><li class="otherReviewEntry"><div class="otherReviewsTitle"><h2><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/abs/10.1146/annurev.physiol.61.1.627" target="_top">SODIUM CHANNELS IN ALVEOLAR EPITHELIAL CELLS: Molecular Characterization, Biophysical Properties, and Physiological Significance</a></h2></div><div class="otherReviewsAuthor">Sadis Matalon, Hugh O'Brodovich</div><div class="otherReviewsInfo">Annual Review of Physiology 
                    Vol. 61:
                    627
                        -
                        661</div><div class="otherReviewSnipp"><ul><li ref-id="XR353"><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/full/10.1146/annurev.physiol.61.1.627#XR353"> ...<ref-snippet xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-id="XR353">&bull; NO with O<sub>2</sub><sup>&bull; &minus;</sup> react at a near-diffusion rate to form peroxynitrite (ONOO<sup>&minus;</sup>) (16),</ref-snippet>... </a></li><li ref-id="XR364"><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/full/10.1146/annurev.physiol.61.1.627#XR364"> ...<ref-snippet xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-id="XR364">ONOO<sup>&minus;</sup> decomposes spontaneously with a half-time of about 1 s (16).</ref-snippet>... </a></li></ul></div></li><li class="otherReviewEntry"><div class="otherReviewsTitle"><h2><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/abs/10.1146/annurev.neuro.22.1.123" target="_top">ETIOLOGY AND PATHOGENESIS OF PARKINSON'S DISEASE</a></h2></div><div class="otherReviewsAuthor">C. W. Olanow, W. G. Tatton</div><div class="otherReviewsInfo">Annual Review of Neuroscience 
                    Vol. 22:
                    123
                        -
                        144</div><div class="otherReviewSnipp"><ul><li ref-id="XR45"><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/full/10.1146/annurev.neuro.22.1.123#XR45"> ...<ref-snippet xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-id="XR45">NO reacts with superoxide radical to form peroxynitrite and hydroxyl radical, both powerful oxidizing agents (Beckman et al 1990).</ref-snippet>... </a></li></ul></div></li><li class="otherReviewEntry"><div class="otherReviewsTitle"><h2><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/abs/10.1146/annurev.pharmtox.38.1.159" target="_top">NEURONAL INJURY ASSOCIATED WITH HIV-1: Approaches to Treatment</a></h2></div><div class="otherReviewsAuthor">Stuart A. Lipton</div><div class="otherReviewsInfo">Annual Review of Pharmacology and Toxicology 
                    Vol. 38:
                    159
                        -
                        177</div><div class="otherReviewSnipp"><ul><li ref-id="XR195"><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/full/10.1146/annurev.pharmtox.38.1.159#XR195"> ...<ref-snippet xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-id="XR195">and one of these pathways to neurotoxicity involves the reaction of NO<sup>&bull;</sup> with O<sub>2</sub><sup>&bull; &minus;</sup> to form peroxynitrite (ONOO<sup>&minus;</sup>) (67, 112,</ref-snippet>... </a></li></ul></div></li><li class="otherReviewEntry"><div class="otherReviewsTitle"><h2><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/abs/10.1146/annurev.pharmtox.37.1.517" target="_top">THE HEME OXYGENASE SYSTEM:A Regulator of Second Messenger Gases</a></h2></div><div class="otherReviewsAuthor">Mahin D. Maines</div><div class="otherReviewsInfo">Annual Review of Pharmacology and Toxicology 
                    Vol. 37:
                    517
                        -
                        554</div><div class="otherReviewSnipp"><ul><li ref-id="XR60"><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/full/10.1146/annurev.pharmtox.37.1.517#XR60"> ...<ref-snippet xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-id="XR60">which is a free radical (&bull;NO) and can react with oxygen-derived radicals to further generate toxic-free radicals (104, 105),</ref-snippet>... </a></li><li ref-id="XR123"><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/full/10.1146/annurev.pharmtox.37.1.517#XR123"> ...<ref-snippet xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-id="XR123">such as iron in the heme molecule; and iron-sulfur clusters (99, 104, 105,</ref-snippet>... </a></li></ul></div></li><li class="otherReviewEntry"><div class="otherReviewsTitle"><h2><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/abs/10.1146/annurev.immunol.15.1.323" target="_top">NITRIC OXIDE AND MACROPHAGE FUNCTION</a></h2></div><div class="otherReviewsAuthor">John MacMickingQiao-wen Xie, Carl Nathan</div><div class="otherReviewsInfo">Annual Review of Immunology 
                    Vol. 15:
                    323
                        -
                        350</div><div class="otherReviewSnipp"><ul><li ref-id="XR277"><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/full/10.1146/annurev.immunol.15.1.323#XR277"> ...<ref-snippet xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-id="XR277">reminiscent of and perhaps attributable to the radicals &middot; OH and &middot; NO<sub>2</sub> (156).</ref-snippet>... </a></li></ul></div></li><li class="otherReviewEntry"><div class="otherReviewsTitle"><h2><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/abs/10.1146/annurev.pharmtox.37.1.327" target="_top">REPERFUSION INJURY AFTER LIVER PRESERVATION FOR TRANSPLANTATION</a></h2></div><div class="otherReviewsAuthor">John J. Lemasters and, Ronald G. Thurman</div><div class="otherReviewsInfo">Annual Review of Pharmacology and Toxicology 
                    Vol. 37:
                    327
                        -
                        338</div><div class="otherReviewSnipp"><ul><li ref-id="XR52"><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/full/10.1146/annurev.pharmtox.37.1.327#XR52"> ...<ref-snippet xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-id="XR52">an even more toxic and reactive radical, which may also contribute to reperfusion injury (44).</ref-snippet>... </a></li></ul></div></li><li class="otherReviewEntry"></li></ul></div></li><li class="fulltext b18" refid="b18" id="b18ref"><span class="toggleImg orangeToggleImg"></span><span class="position">18.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Rothstein J, Bristol LA, Hosler B, et al. 1994. Chronic inhibition of superoxide dismutase produces apoptotic death of spinal neurons. <i>Proc. Natl. Acad. Sci. USA</i> 91:4155&ndash;59 <script type="text/javascript">

				genRefLink(16, 'b18', '10.1073%2Fpnas.91.10.4155');
			</script> <script type="text/javascript">

				genRefLink(8, 'b18', '7910402');
			</script> <script type="text/javascript">

				genRefLink(128, 'b18', 'A1994NL60800012');
			</script> <script type="text/javascript">

            genSfxLinks('b18', '%26aulast%3DRothstein%26aufirst%3DJ%26date%3D1994%26atitle%3DChronic%2Binhibition%2Bof%2Bsuperoxide%2Bdismutase%2Bproduces%2Bapoptotic%2Bdeath%2Bof%2Bspinal%2Bneurons.%26stitle%3DProc.%2BNatl.%2BAcad.%2BSci.%2BUSA%26volume%3D91%26spage%3D4155%26id%3Ddoi%3A10.1073%252Fpnas.91.10.4155');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR22"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...Inhibition of Cu2+/Zn2+ SOD in cultured rat spinal cord slices with SOD1 antisense oligodeoxynucleotides leads to apoptotic degeneration of most spinal neurons (including motoneurons) within several weeks (18)....</span></li><li ref-id="XR52"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...apoptotic death of cultured rat spinal neurons induced by SOD inhibition could be greatly potentiated by concomitant block of glutamate transport and reduced by addition of AMPA receptor antagonists (18)....</span></li></ul><div class="otherReviews" style="display: none;"><p class="otherReviewsHeader">

                    Other reviews that cite this reference:
                </p><ul class="otherReviewsList"><li class="otherReviewEntry"><div class="otherReviewsTitle"><h2><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/abs/10.1146/annurev.neuro.22.1.123" target="_top">ETIOLOGY AND PATHOGENESIS OF PARKINSON'S DISEASE</a></h2></div><div class="otherReviewsAuthor">C. W. Olanow, W. G. Tatton</div><div class="otherReviewsInfo">Annual Review of Neuroscience 
                    Vol. 22:
                    123
                        -
                        144</div><div class="otherReviewSnipp"><ul><li ref-id="XR37"><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/full/10.1146/annurev.neuro.22.1.123#XR37"> ...<ref-snippet xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-id="XR37">and demonstrate a pattern of burst firing in response to exogenously administered glutamate (Rothstein et al 1994,</ref-snippet>... </a></li><li ref-id="XR83"><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/full/10.1146/annurev.neuro.22.1.123#XR83"> ...<ref-snippet xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-id="XR83">whereas apoptosis is increased when SOD-1 is underexpressed (Rothstein et al 1994,</ref-snippet>... </a></li></ul></div></li><li class="otherReviewEntry"></li></ul></div></li><li class="fulltext b19" refid="b19" id="b19ref"><span class="toggleImg orangeToggleImg"></span><span class="position">19.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">McCord JM, Fridovich I. 1969. Superoxide dismutase: an enzymic function for erythrocuprein (hemocuprein). <i>J. Biol. Chem.</i> 244:6049&ndash;55 <script type="text/javascript">

				genRefLink(8, 'b19', '5389100');
			</script> <script type="text/javascript">

				genRefLink(128, 'b19', 'A1969E736300001');
			</script> <script type="text/javascript">

            genSfxLinks('b19', '%26aulast%3DMcCord%26aufirst%3DJM%26date%3D1969%26atitle%3DSuperoxide%2Bdismutase%253A%2Ban%2Benzymic%2Bfunction%2Bfor%2Berythrocuprein%2B%2528hemocuprein%2529.%26stitle%3DJ.%2BBiol.%2BChem.%26volume%3D244%26spage%3D6049');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR23"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...However, SOD may be essential to aerobic life (19), and significant enzyme inhibition may likewise be injurious to all cells....</span></li></ul><div class="otherReviews" style="display: none;"><p class="otherReviewsHeader">

                    Other reviews that cite this reference:
                </p><ul class="otherReviewsList"><li class="otherReviewEntry"><div class="otherReviewsTitle"><h2><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/abs/10.1146/annurev.physiol.68.040104.110001" target="_top">OXIDATIVE STRESS IN MARINE ENVIRONMENTS: Biochemistry and Physiological Ecology</a></h2></div><div class="otherReviewsAuthor">Michael P. Lesser</div><div class="otherReviewsInfo">Annual Review of Physiology 
                    Vol. 68:
                    253
                        -
                        278</div><div class="otherReviewSnipp"><ul><li ref-id="XR251"><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/full/10.1146/annurev.physiol.68.040104.110001#XR251"> ...<ref-snippet xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-id="XR251">SUPEROXIDE DISMUTASE<img src="2003.gif" alt="" class="entityA" align="bottom">Superoxide dismutase (SOD) (EC 1.15.1.1), originally discovered by McCord & Fridovitch (55),</ref-snippet>... </a></li></ul></div></li><li class="otherReviewEntry"><div class="otherReviewsTitle"><h2><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/abs/10.1146/annurev.biochem.72.121801.161647" target="_top">COPPER-ZINC SUPEROXIDE DISMUTASE AND AMYOTROPHIC LATERAL SCLEROSIS</a></h2></div><div class="otherReviewsAuthor">Joan Selverstone Valentine, Peter A. Doucette, Soshanna Zittin Potter</div><div class="otherReviewsInfo">Annual Review of Biochemistry 
                    Vol. 74:
                    563
                        -
                        593</div><div class="otherReviewSnipp"><ul><li ref-id="XR139"><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/full/10.1146/annurev.biochem.72.121801.161647#XR139"> ...<ref-snippet xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-id="XR139">SOD1 can be purified from erythrocytes of fALS patients (87) using the well-established method of chloroform/ethanol extraction (88).</ref-snippet>... </a></li><li ref-id="XR155"><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/full/10.1146/annurev.biochem.72.121801.161647#XR155"> ...<ref-snippet xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-id="XR155">the conditions routinely used in its isolation are designed to take advantage of its high stability in the fully metallated state (88).</ref-snippet>... </a></li></ul></div></li><li class="otherReviewEntry"><div class="otherReviewsTitle"><h2><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/abs/10.1146/annurev.immunol.23.021704.115653" target="_top">HOW NEUTROPHILS KILL MICROBES</a></h2></div><div class="otherReviewsAuthor">Anthony W. Segal</div><div class="otherReviewsInfo">Annual Review of Immunology 
                    Vol. 23:
                    197
                        -
                        223</div><div class="otherReviewSnipp"><ul><li ref-id="XR64"><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/full/10.1146/annurev.immunol.23.021704.115653#XR64"> ...<ref-snippet xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-id="XR64">which accelerates the dismutation of 2O<sup>&minus;</sup><sub>2</sub> &rarr; O<sub>2</sub> + O<sub>2</sub><sup>2&minus;</sup> (21).</ref-snippet>... </a></li></ul></div></li><li class="otherReviewEntry"><div class="otherReviewsTitle"><h2><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/abs/10.1146/annurev.micro.57.030502.090938" target="_top">PATHWAYS OF OXIDATIVE DAMAGE</a></h2></div><div class="otherReviewsAuthor">James A. Imlay</div><div class="otherReviewsInfo">Annual Review of Microbiology 
                    Vol. 57:
                    395
                        -
                        418</div><div class="otherReviewSnipp"><ul><li ref-id="XR1"><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/full/10.1146/annurev.micro.57.030502.090938#XR1"> ...<ref-snippet xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-id="XR1">In 1969 McCord & Fridovich (64) reported the fortuitous isolation from bovine erythrocytes of an enzyme that dismuted superoxide (O<sub>2</sub><sup>&minus;</sup>).</ref-snippet>... </a></li><li ref-id="XR18"><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/full/10.1146/annurev.micro.57.030502.090938#XR18"> ...<ref-snippet xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-id="XR18">recently it has become evident that many other microbes utilize superoxide reductase rather than SOD to scavenge O<sub>2</sub><sup>&minus;</sup>, and peroxidases rather than catalases to scavenge H<sub>2</sub>O<sub>2</sub> (55, 63, 64).</ref-snippet>... </a></li></ul></div></li><li class="otherReviewEntry"><div class="otherReviewsTitle"><h2><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/abs/10.1146/annurev.biochem.72.081902.140918" target="_top">With the Help of Giants</a></h2></div><div class="otherReviewsAuthor">Irwin Fridovich</div><div class="otherReviewsInfo">Annual Review of Biochemistry 
                    Vol. 72:
                    1
                        -
                        18</div><div class="otherReviewSnipp"><ul><li ref-id="XR8"><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/full/10.1146/annurev.biochem.72.081902.140918#XR8"> ...<ref-snippet xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-id="XR8">McCord was there at the end and contributed mightily to the denouement (7, 8).</ref-snippet>... </a></li></ul></div></li><li class="otherReviewEntry"></li></ul></div></li><li class="fulltext b20" refid="b20" id="b20ref"><span class="toggleImg whiteToggleImg"></span><span class="position">20.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Elroy-Stein O, Bernstein Y, Groner Y. 1986. Overproduction of human Cu/Zn-superoxide dismutase in transfected cells: extenuation of paraquat-mediated cytotoxicity and enhancement of lipid peroxidation. <i>EMBO J.</i> 5:615&ndash;22 <script type="text/javascript">

				genRefLink(8, 'b20', '3011416');
			</script> <script type="text/javascript">

            genSfxLinks('b20', '%26aulast%3DElroy-Stein%26aufirst%3DO%26date%3D1986%26atitle%3DOverproduction%2Bof%2Bhuman%2BCu%252FZn-superoxide%2Bdismutase%2Bin%2Btransfected%2Bcells%253A%2Bextenuation%2Bof%2Bparaquat-mediated%2Bcytotoxicity%2Band%2Benhancement%2Bof%2Blipid%2Bperoxidation.%26stitle%3DEMBO%2BJ.%26volume%3D5%26spage%3D615');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR24"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...Overexpression of normal SOD1 resulted in increased lipid peroxidation (20) and distal tongue and hindlimb motor deficits (21)...</span></li></ul><div class="otherReviews" style="display: none;"></div></li><li class="fulltext b21" refid="b21" id="b21ref"><span class="toggleImg whiteToggleImg"></span><span class="position">21.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Avraham KB, Sugarman H, Rotshenker S, et al. 1992. Down's syndrome: morphological remodeling and increased complexity in the neuromuscular junction of transgenic CuZn superoxide dismutase mice. <i>J. Neurocytol.</i> 20:208&ndash;15 <script type="text/javascript">

				genRefLink(16, 'b21', '10.1007%2FBF01186993');
			</script> <script type="text/javascript">

				genRefLink(8, 'b21', '1828079');
			</script> <script type="text/javascript">

				genRefLink(128, 'b21', 'A1991FD31400005');
			</script> <script type="text/javascript">

            genSfxLinks('b21', '%26aulast%3DAvraham%26aufirst%3DKB%26date%3D1992%26atitle%3DDown%2527s%2Bsyndrome%253A%2Bmorphological%2Bremodeling%2Band%2Bincreased%2Bcomplexity%2Bin%2Bthe%2Bneuromuscular%2Bjunction%2Bof%2Btransgenic%2BCuZn%2Bsuperoxide%2Bdismutase%2Bmice.%26stitle%3DJ.%2BNeurocytol.%26volume%3D20%26spage%3D208%26id%3Ddoi%3A10.1007%252FBF01186993');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR25"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...and distal tongue and hindlimb motor deficits (21) in such mice,...</span></li></ul><div class="otherReviews" style="display: none;"></div></li><li class="fulltext b22" refid="b22" id="b22ref"><span class="toggleImg orangeToggleImg"></span><span class="position">22.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Gurney ME, Pu H-F, Chiu AY, et al. 1994. Motor neuron degeneration in mice expressing a human Cu,Zn superoxide dismutase mutation. <i>Science</i> 264:1772&ndash;75 <script type="text/javascript">

				genRefLink(16, 'b22', '10.1126%2Fscience.8209258');
			</script> <script type="text/javascript">

				genRefLink(8, 'b22', '8209258');
			</script> <script type="text/javascript">

				genRefLink(128, 'b22', 'A1994NR60000046');
			</script> <script type="text/javascript">

            genSfxLinks('b22', '%26aulast%3DGurney%26aufirst%3DME%26date%3D1994%26atitle%3DMotor%2Bneuron%2Bdegeneration%2Bin%2Bmice%2Bexpressing%2Ba%2Bhuman%2BCu%252CZn%2Bsuperoxide%2Bdismutase%2Bmutation.%26stitle%3DScience%26volume%3D264%26spage%3D1772%26id%3Ddoi%3A10.1126%252Fscience.8209258');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR26"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...who developed asymmetric weakness by three to four months of age and died within six months (22)....</span></li></ul><div class="otherReviews" style="display: none;"><p class="otherReviewsHeader">

                    Other reviews that cite this reference:
                </p><ul class="otherReviewsList"><li class="otherReviewEntry"><div class="otherReviewsTitle"><h2><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/abs/10.1146/annurev.biochem.72.121801.161647" target="_top">COPPER-ZINC SUPEROXIDE DISMUTASE AND AMYOTROPHIC LATERAL SCLEROSIS</a></h2></div><div class="otherReviewsAuthor">Joan Selverstone Valentine, Peter A. Doucette, Soshanna Zittin Potter</div><div class="otherReviewsInfo">Annual Review of Biochemistry 
                    Vol. 74:
                    563
                        -
                        593</div><div class="otherReviewSnipp"><ul><li ref-id="XR7"><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/full/10.1146/annurev.biochem.72.121801.161647#XR7"> ...<ref-snippet xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-id="XR7">and the pioneering fALS transgenic mouse studies provided strong support for this hypothesis (3).</ref-snippet>... </a></li><li ref-id="XR8"><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/full/10.1146/annurev.biochem.72.121801.161647#XR8"> ...<ref-snippet xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-id="XR8">Mice overexpressing either the human fALS mutant G93A SOD1 or human wild-type SOD1 both showed elevated levels of SOD activity relative to nontransgenic mice, but only the G93A fALS mutant mouse developed ALS (3).</ref-snippet>... </a></li></ul></div></li><li class="otherReviewEntry"></li></ul></div></li><li class="fulltext b23" refid="b23" id="b23ref"><span class="toggleImg whiteToggleImg"></span><span class="position">23.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Jones CT, Brock DJH, Chancellor AM, et al. 1993. Cu/Zn superoxide dismutase (SOD1) mutations and sporadic amyotrophic lateral sclerosis. <i>Lancet</i> 342:1050&ndash;51 <script type="text/javascript">

				genRefLink(16, 'b23', '10.1016%2F0140-6736%2893%2992905-9');
			</script> <script type="text/javascript">

				genRefLink(8, 'b23', '8105280');
			</script> <script type="text/javascript">

				genRefLink(128, 'b23', 'A1993MD06600035');
			</script> <script type="text/javascript">

            genSfxLinks('b23', '%26aulast%3DJones%26aufirst%3DCT%26date%3D1993%26atitle%3DCu%252FZn%2Bsuperoxide%2Bdismutase%2B%2528SOD1%2529%2Bmutations%2Band%2Bsporadic%2Bamyotrophic%2Blateral%2Bsclerosis.%26stitle%3DLancet%26volume%3D342%26spage%3D1050%26id%3Ddoi%3A10.1016%252F0140-6736%252893%252992905-9');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR27"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...although reduced Cu2+/Zn2+ SOD activity was observed in fALS patients with mutant SOD1, no SOD activity changes occurred in other ALS patients (23,...</span></li></ul><div class="otherReviews" style="display: none;"></div></li><li class="fulltext b24" refid="b24" id="b24ref"><span class="toggleImg whiteToggleImg"></span><span class="position">24.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Mitchell JD, Gart JA, Phillips TM, et al. 1993. Cu/Zn superoxide, free radicals, and motoneuron disease. <i>Lancet</i> 342:1051&ndash;52 <script type="text/javascript">

				genRefLink(16, 'b24', '10.1016%2F0140-6736%2893%2992906-A');
			</script> <script type="text/javascript">

				genRefLink(8, 'b24', '8105281');
			</script> <script type="text/javascript">

				genRefLink(128, 'b24', 'A1993MD06600036');
			</script> <script type="text/javascript">

            genSfxLinks('b24', '%26aulast%3DMitchell%26aufirst%3DJD%26date%3D1993%26atitle%3DCu%252FZn%2Bsuperoxide%252C%2Bfree%2Bradicals%252C%2Band%2Bmotoneuron%2Bdisease.%26stitle%3DLancet%26volume%3D342%26spage%3D1051%26id%3Ddoi%3A10.1016%252F0140-6736%252893%252992906-A');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR28"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...although reduced Cu2+/Zn2+ SOD activity was observed in fALS patients with mutant SOD1, no SOD activity changes occurred in other ALS patients (23, 24,...</span></li><li ref-id="XR31"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...Subtle forms of oxidative damage have nevertheless been observed in postmortem tissues from sALS patients (24,...</span></li></ul><div class="otherReviews" style="display: none;"></div></li><li class="fulltext b25" refid="b25" id="b25ref"><span class="toggleImg whiteToggleImg"></span><span class="position">25.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Robberecht W, Sapp P, Viaene MK, et al. 1994. Cu/Zn superoxide dismutase activity in familial and sporadic amyotrophic lateral sclerosis. <i>J. Neurochem.</i> 62:384&ndash;87 <script type="text/javascript">

				genRefLink(16, 'b25', '10.1046%2Fj.1471-4159.1994.62010384.x');
			</script> <script type="text/javascript">

				genRefLink(8, 'b25', '8263541');
			</script> <script type="text/javascript">

				genRefLink(128, 'b25', 'A1994MM53600049');
			</script> <script type="text/javascript">

            genSfxLinks('b25', '%26aulast%3DRobberecht%26aufirst%3DW%26date%3D1994%26atitle%3DCu%252FZn%2Bsuperoxide%2Bdismutase%2Bactivity%2Bin%2Bfamilial%2Band%2Bsporadic%2Bamyotrophic%2Blateral%2Bsclerosis.%26stitle%3DJ.%2BNeurochem.%26volume%3D62%26spage%3D384%26id%3Ddoi%3A10.1046%252Fj.1471-4159.1994.62010384.x');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR29"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...although reduced Cu2+/Zn2+ SOD activity was observed in fALS patients with mutant SOD1, no SOD activity changes occurred in other ALS patients (23, 24, 25,...</span></li><li ref-id="XR32"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...Subtle forms of oxidative damage have nevertheless been observed in postmortem tissues from sALS patients (24, 25,...</span></li></ul><div class="otherReviews" style="display: none;"></div></li><li class="fulltext b26" refid="b26" id="b26ref"><span class="toggleImg whiteToggleImg"></span><span class="position">26.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Bowling AC, Schulz JB, Brown RHJr, et al . 1993. Superoxide dismutase activity, oxidative damage, and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis. <i>J. Neurochem.</i> 61:2322&ndash;25 <script type="text/javascript">

				genRefLink(16, 'b26', '10.1111%2Fj.1471-4159.1993.tb07478.x');
			</script> <script type="text/javascript">

				genRefLink(8, 'b26', '8245985');
			</script> <script type="text/javascript">

				genRefLink(128, 'b26', 'A1993MH02200045');
			</script> <script type="text/javascript">

            genSfxLinks('b26', '%26aulast%3DBowling%26aufirst%3DAC%26date%3D1993%26atitle%3DSuperoxide%2Bdismutase%2Bactivity%252C%2Boxidative%2Bdamage%252C%2Band%2Bmitochondrial%2Benergy%2Bmetabolism%2Bin%2Bfamilial%2Band%2Bsporadic%2Bamyotrophic%2Blateral%2Bsclerosis.%26stitle%3DJ.%2BNeurochem.%26volume%3D61%26spage%3D2322%26id%3Ddoi%3A10.1111%252Fj.1471-4159.1993.tb07478.x');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR30"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...although reduced Cu2+/Zn2+ SOD activity was observed in fALS patients with mutant SOD1, no SOD activity changes occurred in other ALS patients (23, 24, 25, 26)....</span></li></ul><div class="otherReviews" style="display: none;"></div></li><li class="fulltext b27" refid="b27" id="b27ref"><span class="toggleImg whiteToggleImg"></span><span class="position">27.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Mitchell JD, Jackson MJ. 1992. <i>Free radicals, amyotrophic lateral sclerosis and neurodegenerative disease.</i> In <i>Handbook of Amyotrophic Lateral Sclerosis</i>, ed. RA Smith, pp. 553&ndash;41. New York: Dekker <script type="text/javascript">

            genSfxLinks('b27', '%26aulast%3DMitchell%26aufirst%3DJD%26date%3D1992%26spage%3D553');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR33"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...Subtle forms of oxidative damage have nevertheless been observed in postmortem tissues from sALS patients (24, 25, 27,...</span></li></ul><div class="otherReviews" style="display: none;"></div></li><li class="fulltext b28" refid="b28" id="b28ref"><span class="toggleImg whiteToggleImg"></span><span class="position">28.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Nakano Y, Hirayama K, Terao K. 1987. Hepatic ultrastructural changes in liver dysfunction in amyotrophic lateral sclerosis. <i>Ann. Neurol.</i> 44:103&ndash;6 <script type="text/javascript">

            genSfxLinks('b28', '%26aulast%3DNakano%26aufirst%3DY%26date%3D1987%26atitle%3DHepatic%2Bultrastructural%2Bchanges%2Bin%2Bliver%2Bdysfunction%2Bin%2Bamyotrophic%2Blateral%2Bsclerosis.%26stitle%3DAnn.%2BNeurol.%26volume%3D44%26spage%3D103');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR34"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...Subtle forms of oxidative damage have nevertheless been observed in postmortem tissues from sALS patients (24, 25, 27, 28)....</span></li></ul><div class="otherReviews" style="display: none;"></div></li><li class="fulltext b29" refid="b29" id="b29ref"><span class="toggleImg whiteToggleImg"></span><span class="position">29.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Kurland LT, Radhakrishnan K. 1993. <i>An update of the epidemiology of western pacific amyotrophic lateral sclerosis.</i> In <i>Neuroepidemiology: Theory and Practice</i>, ed. CA Molgaard, pp 73&ndash;87. New York: Academic <script type="text/javascript">

            genSfxLinks('b29', '%26aulast%3DKurland%26aufirst%3DLT%26date%3D1993%26spage%3D73');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR35"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...epidemiologic studies of Western Pacific ALS (ALS-Parkinsonism-dementia complex) implicated a toxin possibly derived from cycad seed flour (29)....</span></li></ul><div class="otherReviews" style="display: none;"></div></li><li class="fulltext b30" refid="b30" id="b30ref"><span class="toggleImg whiteToggleImg"></span><span class="position">30.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Spencer PS, Schaumburg HH. 1983. Lathyrism: a neurotoxic disease. <i>Neurobehav. Toxicol. Teratol.</i> 5:625&ndash;29 <script type="text/javascript">

				genRefLink(8, 'b30', '6422318');
			</script> <script type="text/javascript">

            genSfxLinks('b30', '%26aulast%3DSpencer%26aufirst%3DPS%26date%3D1983%26atitle%3DLathyrism%253A%2Ba%2Bneurotoxic%2Bdisease.%26stitle%3DNeurobehav.%2BToxicol.%2BTeratol.%26volume%3D5%26spage%3D625');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR36"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...has a structure similar to that of glutamate (30) and has neurotoxic effects similar to those of &beta;-oxalylamino-l-alanine (BOAA,...</span></li></ul><div class="otherReviews" style="display: none;"></div></li><li class="fulltext b31" refid="b31" id="b31ref"><span class="toggleImg whiteToggleImg"></span><span class="position">31.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Nunn PB, Seelig M, Zagoren JC, et al. 1987. Stereospecific acute neuronotoxicity of &ldquo;uncommon&rdquo; plant amino acids linked to human motor-system diseases. <i>Brain Res.</i> 410:375&ndash;79 <script type="text/javascript">

				genRefLink(16, 'b31', '10.1016%2F0006-8993%2887%2990342-8');
			</script> <script type="text/javascript">

				genRefLink(8, 'b31', '3109690');
			</script> <script type="text/javascript">

				genRefLink(128, 'b31', 'A1987H378400026');
			</script> <script type="text/javascript">

            genSfxLinks('b31', '%26aulast%3DNunn%26aufirst%3DPB%26date%3D1987%26atitle%3DStereospecific%2Bacute%2Bneuronotoxicity%2Bof%2B%25E2%2580%259Cuncommon%25E2%2580%259D%2Bplant%2Bamino%2Bacids%2Blinked%2Bto%2Bhuman%2Bmotor-system%2Bdiseases.%26stitle%3DBrain%2BRes.%26volume%3D410%26spage%3D375%26id%3Ddoi%3A10.1016%252F0006-8993%252887%252990342-8');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR37"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...the cause of lathyrism) when added to CNS explant cultures (31,...</span></li></ul><div class="otherReviews" style="display: none;"></div></li><li class="fulltext b32" refid="b32" id="b32ref"><span class="toggleImg whiteToggleImg"></span><span class="position">32.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Weiss JH, Koh J-Y, Choi D. 1989. Neurotoxicity of BMAA and BOAA on cultured cortical neurons. <i>Brain Res.</i> 497:64&ndash;71 <script type="text/javascript">

				genRefLink(16, 'b32', '10.1016%2F0006-8993%2889%2990970-0');
			</script> <script type="text/javascript">

				genRefLink(8, 'b32', '2551452');
			</script> <script type="text/javascript">

				genRefLink(128, 'b32', 'A1989AP85200008');
			</script> <script type="text/javascript">

            genSfxLinks('b32', '%26aulast%3DWeiss%26aufirst%3DJH%26date%3D1989%26atitle%3DNeurotoxicity%2Bof%2BBMAA%2Band%2BBOAA%2Bon%2Bcultured%2Bcortical%2Bneurons.%26stitle%3DBrain%2BRes.%26volume%3D497%26spage%3D64%26id%3Ddoi%3A10.1016%252F0006-8993%252889%252990970-0');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR38"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...the cause of lathyrism) when added to CNS explant cultures (31, 32)....</span></li></ul><div class="otherReviews" style="display: none;"></div></li><li class="fulltext b33" refid="b33" id="b33ref"><span class="toggleImg whiteToggleImg"></span><span class="position">33.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Spencer PS, Nunn PB, Hugon J, et al. 1986. Motor neuron disease on Guam: possible role of a food neurotoxin. <i>Lancet</i> 1:965 <script type="text/javascript">

				genRefLink(16, 'b33', '10.1016%2FS0140-6736%2886%2991059-7');
			</script> <script type="text/javascript">

				genRefLink(8, 'b33', '2871252');
			</script> <script type="text/javascript">

				genRefLink(128, 'b33', 'A1986C020000016');
			</script> <script type="text/javascript">

            genSfxLinks('b33', '%26aulast%3DSpencer%26aufirst%3DPS%26date%3D1986%26atitle%3DMotor%2Bneuron%2Bdisease%2Bon%2BGuam%253A%2Bpossible%2Brole%2Bof%2Ba%2Bfood%2Bneurotoxin.%26stitle%3DLancet%26volume%3D1%26spage%3D965%26id%3Ddoi%3A10.1016%252FS0140-6736%252886%252991059-7');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR39"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...However, reports that l-BMAA induced an ALS-like illness in monkeys (33)...</span></li></ul><div class="otherReviews" style="display: none;"></div></li><li class="fulltext b34" refid="b34" id="b34ref"><span class="toggleImg whiteToggleImg"></span><span class="position">34.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Kisby GE, Ellison M, Spencer PS. 1992. Content of the neurotoxins cycasin (methylazoxymethanol &beta;-D-glucoside) and BMAA (&beta;-2<i>N</i>-methylamino-L-alanine) in cycad flour prepared by Guam Chamorros. <i>Neurology</i> 42:1336&ndash;40 <script type="text/javascript">

				genRefLink(8, 'b34', '1620343');
			</script> <script type="text/javascript">

				genRefLink(128, 'b34', 'A1992JC95500017');
			</script> <script type="text/javascript">

            genSfxLinks('b34', '%26aulast%3DKisby%26aufirst%3DGE%26date%3D1992%26atitle%3DContent%2Bof%2Bthe%2Bneurotoxins%2Bcycasin%2B%2528methylazoxymethanol%2B%25CE%25B2-D-glucoside%2529%2Band%2BBMAA%2B%2528%25CE%25B2-2N-methylamino-L-alanine%2529%2Bin%2Bcycad%2Bflour%2Bprepared%2Bby%2BGuam%2BChamorros.%26stitle%3DNeurology%26volume%3D42%26spage%3D1336');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR40"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...reports that l-BMAA induced an ALS-like illness in monkeys (33) remain unconfirmed (34),...</span></li></ul><div class="otherReviews" style="display: none;"></div></li><li class="fulltext b35" refid="b35" id="b35ref"><span class="toggleImg whiteToggleImg"></span><span class="position">35.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Garruto RM, Yanagihara R, Gajdusek DC. 1988. Cycads and amyotrophic lateral sclerosis/Parkinsonism dementia. <i>Lancet</i> 2:1079 <script type="text/javascript">

				genRefLink(16, 'b35', '10.1016%2FS0140-6736%2888%2990099-2');
			</script> <script type="text/javascript">

				genRefLink(8, 'b35', '2903306');
			</script> <script type="text/javascript">

				genRefLink(128, 'b35', 'A1988Q742800034');
			</script> <script type="text/javascript">

            genSfxLinks('b35', '%26aulast%3DGarruto%26aufirst%3DRM%26date%3D1988%26atitle%3DCycads%2Band%2Bamyotrophic%2Blateral%2Bsclerosis%252FParkinsonism%2Bdementia.%26stitle%3DLancet%26volume%3D2%26spage%3D1079%26id%3Ddoi%3A10.1016%252FS0140-6736%252888%252990099-2');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR41"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...and l-BMAA levels present in washed cycad flour ingested by Chamorro Indians appear to be much lower (35)...</span></li></ul><div class="otherReviews" style="display: none;"></div></li><li class="fulltext b36" refid="b36" id="b36ref"><span class="toggleImg whiteToggleImg"></span><span class="position">36.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Seawright AA, Brown AW, Nolan CC, et al. 1990. Selective degeneration of cerebellar cortical neurons caused by cycad neurotoxin L-&beta;-methylaminoalanine (<span class="smallcaps">L</span>-BMAA) in rats. <i>Neuropathol. Appl. Neurobiol.</i> 16:153&ndash;69 <script type="text/javascript">

				genRefLink(16, 'b36', '10.1111%2Fj.1365-2990.1990.tb00944.x');
			</script> <script type="text/javascript">

				genRefLink(8, 'b36', '2345599');
			</script> <script type="text/javascript">

				genRefLink(128, 'b36', 'A1990CZ00100006');
			</script> <script type="text/javascript">

            genSfxLinks('b36', '%26aulast%3DSeawright%26aufirst%3DAA%26date%3D1990%26atitle%3DSelective%2Bdegeneration%2Bof%2Bcerebellar%2Bcortical%2Bneurons%2Bcaused%2Bby%2Bcycad%2Bneurotoxin%2BL-%25CE%25B2-methylaminoalanine%2B%2528L-BMAA%2529%2Bin%2Brats.%26stitle%3DNeuropathol.%2BAppl.%2BNeurobiol.%26volume%3D16%26spage%3D153%26id%3Ddoi%3A10.1111%252Fj.1365-2990.1990.tb00944.x');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR42"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...than those needed to produce other toxic effects in animal models (36) or in vitro....</span></li></ul><div class="otherReviews" style="display: none;"></div></li><li class="fulltext b37" refid="b37" id="b37ref"><span class="toggleImg whiteToggleImg"></span><span class="position">37.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Meldrum B. 1993. Amino acids as dietary excitotoxins: a contribution to understanding neurodegenerative disorders. <i>Brain Res. Rev.</i> 18:293&ndash;314 <script type="text/javascript">

				genRefLink(16, 'b37', '10.1016%2F0165-0173%2893%2990014-Q');
			</script> <script type="text/javascript">

				genRefLink(8, 'b37', '8401596');
			</script> <script type="text/javascript">

				genRefLink(128, 'b37', 'A1993LR29100002');
			</script> <script type="text/javascript">

            genSfxLinks('b37', '%26aulast%3DMeldrum%26aufirst%3DB%26date%3D1993%26atitle%3DAmino%2Bacids%2Bas%2Bdietary%2Bexcitotoxins%253A%2Ba%2Bcontribution%2Bto%2Bunderstanding%2Bneurodegenerative%2Bdisorders.%26stitle%3DBrain%2BRes.%2BRev.%26volume%3D18%26spage%3D293%26id%3Ddoi%3A10.1016%252F0165-0173%252893%252990014-Q');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR43"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...the incubation period of Western Pacific ALS is not consistent with the known effects of l-BMAA (37)....</span></li><li ref-id="XR47"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...Because glutamate and glutamate receptor agonists induce neuronal death in vitro and in vivo (37,...</span></li></ul><div class="otherReviews" style="display: none;"></div></li><li class="fulltext b38" refid="b38" id="b38ref"><span class="toggleImg whiteToggleImg"></span><span class="position">38.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Perry TL, Hansen S, Jones K. 1987. Brain glutamate deficiency in amyotrophic lateral sclerosis. <i>Neurology</i> 37:1845&ndash;48 <script type="text/javascript">

				genRefLink(8, 'b38', '2891083');
			</script> <script type="text/javascript">

				genRefLink(128, 'b38', 'A1987L054800004');
			</script> <script type="text/javascript">

            genSfxLinks('b38', '%26aulast%3DPerry%26aufirst%3DTL%26date%3D1987%26atitle%3DBrain%2Bglutamate%2Bdeficiency%2Bin%2Bamyotrophic%2Blateral%2Bsclerosis.%26stitle%3DNeurology%26volume%3D37%26spage%3D1845');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR44"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...Second, tissue glutamate levels (38, 39) and glutamate transport activity (40) are reduced in spinal cords in patients with sALS....</span></li></ul><div class="otherReviews" style="display: none;"></div></li><li class="fulltext b39" refid="b39" id="b39ref"><span class="toggleImg whiteToggleImg"></span><span class="position">39.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Plaitakis A, Constantakakis E, Smith J. 1988. The neuroexcitotoxic amino acids glutamate and aspartate are altered in the spinal cord and brain in amyotrophic lateral sclerosis. <i>Ann. Neurol.</i> 24:446&ndash;49 <script type="text/javascript">

				genRefLink(16, 'b39', '10.1002%2Fana.410240314');
			</script> <script type="text/javascript">

				genRefLink(8, 'b39', '2906529');
			</script> <script type="text/javascript">

				genRefLink(128, 'b39', 'A1988Q003100013');
			</script> <script type="text/javascript">

            genSfxLinks('b39', '%26aulast%3DPlaitakis%26aufirst%3DA%26date%3D1988%26atitle%3DThe%2Bneuroexcitotoxic%2Bamino%2Bacids%2Bglutamate%2Band%2Baspartate%2Bare%2Baltered%2Bin%2Bthe%2Bspinal%2Bcord%2Band%2Bbrain%2Bin%2Bamyotrophic%2Blateral%2Bsclerosis.%26stitle%3DAnn.%2BNeurol.%26volume%3D24%26spage%3D446%26id%3Ddoi%3A10.1002%252Fana.410240314');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR45"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...Second, tissue glutamate levels (38, 39) and glutamate transport activity (40) are reduced in spinal cords in patients with sALS....</span></li></ul><div class="otherReviews" style="display: none;"></div></li><li class="fulltext b40" refid="b40" id="b40ref"><span class="toggleImg orangeToggleImg"></span><span class="position">40.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Rothstein JD, Martin LJ, Kuncl RW. 1992. Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. <i>New Engl. J. Med.</i> 326:1464&ndash;68 <script type="text/javascript">

				genRefLink(16, 'b40', '10.1056%2FNEJM199205283262204');
			</script> <script type="text/javascript">

				genRefLink(8, 'b40', '1349424');
			</script> <script type="text/javascript">

				genRefLink(128, 'b40', 'A1992HV46900004');
			</script> <script type="text/javascript">

            genSfxLinks('b40', '%26aulast%3DRothstein%26aufirst%3DJD%26date%3D1992%26atitle%3DDecreased%2Bglutamate%2Btransport%2Bby%2Bthe%2Bbrain%2Band%2Bspinal%2Bcord%2Bin%2Bamyotrophic%2Blateral%2Bsclerosis.%26stitle%3DNew%2BEngl.%2BJ.%2BMed.%26volume%3D326%26spage%3D1464%26id%3Ddoi%3A10.1056%252FNEJM199205283262204');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR46"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...and glutamate transport activity (40) are reduced in spinal cords in patients with sALS....</span></li></ul><div class="otherReviews" style="display: none;"><p class="otherReviewsHeader">

                    Other reviews that cite this reference:
                </p><ul class="otherReviewsList"><li class="otherReviewEntry"><div class="otherReviewsTitle"><h2><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/abs/10.1146/annurev.pharmtox.39.1.431" target="_top">EXCITATORY AMINO ACID TRANSPORTERS: A Family in Flux</a></h2></div><div class="otherReviewsAuthor">R. P. Seal, S. G. Amara</div><div class="otherReviewsInfo">Annual Review of Pharmacology and Toxicology 
                    Vol. 39:
                    431
                        -
                        456</div><div class="otherReviewSnipp"><ul><li ref-id="XR267"><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/full/10.1146/annurev.pharmtox.39.1.431#XR267"> ...<ref-snippet xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-id="XR267">as well as in chronic neurodegenerative diseases such as Alzheimer's disease (156, 157) and amyotrophic lateral sclerosis (ALS) (158,</ref-snippet>... </a></li><li ref-id="XR271"><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/full/10.1146/annurev.pharmtox.39.1.431#XR271"> ...<ref-snippet xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-id="XR271">It has been proposed that the chronic suppression of <span class="smallcaps">l</span>-glutamate transport in ALS may be a significant factor in the pathophysiology of this disease (158).</ref-snippet>... </a></li></ul></div></li><li class="otherReviewEntry"><div class="otherReviewsTitle"><h2><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/abs/10.1146/annurev.neuro.20.1.245" target="_top">BCL-2 GENE FAMILY IN THE NERVOUS SYSTEM</a></h2></div><div class="otherReviewsAuthor">D. E. Merry, S. J. Korsmeyer</div><div class="otherReviewsInfo">Annual Review of Neuroscience 
                    Vol. 20:
                    245
                        -
                        267</div><div class="otherReviewSnipp"><ul><li ref-id="XR189"><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/full/10.1146/annurev.neuro.20.1.245#XR189"> ...<ref-snippet xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-id="XR189">. Rothstein et al (1992) proposed that it may also be a mechanism of cell death in ALS.</ref-snippet>... </a></li></ul></div></li><li class="otherReviewEntry"></li></ul></div></li><li class="fulltext b41" refid="b41" id="b41ref"><span class="toggleImg orangeToggleImg"></span><span class="position">41.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Choi DW. 1988. Glutamate neurotoxicity and diseases of the nervous system. <i>Neuron</i> 1:623&ndash;34 <script type="text/javascript">

				genRefLink(16, 'b41', '10.1016%2F0896-6273%2888%2990162-6');
			</script> <script type="text/javascript">

				genRefLink(8, 'b41', '2908446');
			</script> <script type="text/javascript">

				genRefLink(128, 'b41', 'A1988Q727600001');
			</script> <script type="text/javascript">

            genSfxLinks('b41', '%26aulast%3DChoi%26aufirst%3DDW%26date%3D1988%26atitle%3DGlutamate%2Bneurotoxicity%2Band%2Bdiseases%2Bof%2Bthe%2Bnervous%2Bsystem.%26stitle%3DNeuron%26volume%3D1%26spage%3D623%26id%3Ddoi%3A10.1016%252F0896-6273%252888%252990162-6');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR48"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...Because glutamate and glutamate receptor agonists induce neuronal death in vitro and in vivo (37, 41),...</span></li></ul><div class="otherReviews" style="display: none;"><p class="otherReviewsHeader">

                    Other reviews that cite this reference:
                </p><ul class="otherReviewsList"><li class="otherReviewEntry"><div class="otherReviewsTitle"><h2><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/abs/10.1146/annurev.pathol.1.110304.100218" target="_top">CALCIUM IN CELL INJURY AND DEATH*</a></h2></div><div class="otherReviewsAuthor">Zheng Dong, Pothana Saikumar, Joel M. Weinberg, Manjeri A. Venkatachalam</div><div class="otherReviewsInfo">Annual Review of Pathology: Mechanisms of Disease 
                    Vol. 1:
                    405
                        -
                        434</div><div class="otherReviewSnipp"><ul><li ref-id="XR10"><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/full/10.1146/annurev.pathol.1.110304.100218#XR10"> ...<ref-snippet xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-id="XR10">and epilepsy and may also be responsible for chronic neurodegeneration in Alzheimer's disease, Huntington's disease, amyotrophic lateral sclerosis, and HIV encephalopathies (<b>Figure 3</b>) (83</ref-snippet>... </a></li><li ref-id="XR14"><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/full/10.1146/annurev.pathol.1.110304.100218#XR14"> ...<ref-snippet xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-id="XR14">activation of glutamate receptors, and influx of Na<sup>+</sup> and Ca<sup>2+</sup> (83,</ref-snippet>... </a></li></ul></div></li><li class="otherReviewEntry"><div class="otherReviewsTitle"><h2><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/abs/10.1146/annurev.neuro.26.041002.131047" target="_top">NOVEL NEURAL MODULATORS</a></h2></div><div class="otherReviewsAuthor">Darren Boehning, Solomon H. Snyder</div><div class="otherReviewsInfo">Annual Review of Neuroscience 
                    Vol. 26:
                    105
                        -
                        131</div><div class="otherReviewSnipp"><ul><li ref-id="XR27"><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/full/10.1146/annurev.neuro.26.041002.131047#XR27"> ...<ref-snippet xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-id="XR27">as NMDA antagonists substantially reduce stroke damage in many animal models of stroke (Choi 1988,</ref-snippet>... </a></li></ul></div></li><li class="otherReviewEntry"><div class="otherReviewsTitle"><h2><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/abs/10.1146/annurev.pharmtox.38.1.159" target="_top">NEURONAL INJURY ASSOCIATED WITH HIV-1: Approaches to Treatment</a></h2></div><div class="otherReviewsAuthor">Stuart A. Lipton</div><div class="otherReviewsInfo">Annual Review of Pharmacology and Toxicology 
                    Vol. 38:
                    159
                        -
                        177</div><div class="otherReviewSnipp"><ul><li ref-id="XR46"><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/full/10.1146/annurev.pharmtox.38.1.159#XR46"> ...<ref-snippet xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-id="XR46">are thought to trigger pathways to neuronal cell death involving NMDA receptors that are similar to those just described (for reviews, see 42,</ref-snippet>... </a></li></ul></div></li><li class="otherReviewEntry"><div class="otherReviewsTitle"><h2><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/abs/10.1146/annurev.neuro.21.1.279" target="_top">SIGNAL TRANSDUCTION IN THE CAENORHABDITIS ELEGANS NERVOUS SYSTEM</a></h2></div><div class="otherReviewsAuthor">Cornelia I. Bargmann, Joshua M. Kaplan</div><div class="otherReviewsInfo">Annual Review of Neuroscience 
                    Vol. 21:
                    279
                        -
                        308</div><div class="otherReviewSnipp"><ul><li ref-id="XR165"><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/full/10.1146/annurev.neuro.21.1.279#XR165"> ...<ref-snippet xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-id="XR165">This pattern of neurotoxicity shares several features with glutamate-induced neurotoxicity, which has been termed excitotoxicity (Choi 1988).</ref-snippet>... </a></li></ul></div></li><li class="otherReviewEntry"><div class="otherReviewsTitle"><h2><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/abs/10.1146/annurev.neuro.21.1.347" target="_top">ZINC AND BRAIN INJURY</a></h2></div><div class="otherReviewsAuthor">Dennis W. Choi, Jae Y. Koh</div><div class="otherReviewsInfo">Annual Review of Neuroscience 
                    Vol. 21:
                    347
                        -
                        375</div><div class="otherReviewSnipp"><ul><li ref-id="XR3"><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/full/10.1146/annurev.neuro.21.1.347#XR3"> ...<ref-snippet xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-id="XR3">and has more speculatively been linked to the pathogenesis of certain neurodegenerative diseases (Meldrum 1985;, Rothman & Olney 1986;, Choi 1988,</ref-snippet>... </a></li></ul></div></li><li class="otherReviewEntry"><div class="otherReviewsTitle"><h2><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/abs/10.1146/annurev.neuro.20.1.125" target="_top">THE ROLE OF VESICULAR TRANSPORT PROTEINS IN SYNAPTIC TRANSMISSION AND NEURAL DEGENERATION</a></h2></div><div class="otherReviewsAuthor">Yongjian Liu and, Robert H. Edwards</div><div class="otherReviewsInfo">Annual Review of Neuroscience 
                    Vol. 20:
                    125
                        -
                        156</div><div class="otherReviewSnipp"><ul><li ref-id="XR159"><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/full/10.1146/annurev.neuro.20.1.125#XR159"> ...<ref-snippet xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-id="XR159">Unlike glutamate toxicity (Choi 1988), dopamine toxicity does not require specific receptors.</ref-snippet>... </a></li></ul></div></li><li class="otherReviewEntry"><div class="otherReviewsTitle"><h2><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/abs/10.1146/annurev.med.47.1.401" target="_top">THE ROLE OF ANTI-INFLAMMATORY DRUGS IN THE PREVENTION AND TREATMENT OF ALZHEIMER'S DISEASE</a></h2></div><div class="otherReviewsAuthor">John C. S. Breitner, M.D., M.P.H</div><div class="otherReviewsInfo">Annual Review of Medicine 
                    Vol. 47:
                    401
                        -
                        411</div><div class="otherReviewSnipp"><ul><li ref-id="XR91"><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/full/10.1146/annurev.med.47.1.401#XR91"> ...<ref-snippet xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-id="XR91">to induce long-term potentiation (74) or, with excessive stimulation, excitotoxic cell death (75,</ref-snippet>... </a></li></ul></div></li><li class="otherReviewEntry"></li></ul></div></li><li class="fulltext b42" refid="b42" id="b42ref"><span class="toggleImg whiteToggleImg"></span><span class="position">42.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Appel SH. 1993. Excitotoxic neuronal cell death in amyotrophic lateral sclerosis. <i>Trends Neurosci.</i> 16:3&ndash;4 <script type="text/javascript">

				genRefLink(16, 'b42', '10.1016%2F0166-2236%2893%2990039-O');
			</script> <script type="text/javascript">

				genRefLink(8, 'b42', '7679235');
			</script> <script type="text/javascript">

				genRefLink(128, 'b42', 'A1993KE47800002');
			</script> <script type="text/javascript">

            genSfxLinks('b42', '%26aulast%3DAppel%26aufirst%3DSH%26date%3D1993%26atitle%3DExcitotoxic%2Bneuronal%2Bcell%2Bdeath%2Bin%2Bamyotrophic%2Blateral%2Bsclerosis.%26stitle%3DTrends%2BNeurosci.%26volume%3D16%26spage%3D3%26id%3Ddoi%3A10.1016%252F0166-2236%252893%252990039-O');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR49"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...Others have countered that these data simply reflect glutamatergic cell loss mediated by other mechanisms (42),...</span></li></ul><div class="otherReviews" style="display: none;"></div></li><li class="fulltext b43" refid="b43" id="b43ref"><span class="toggleImg whiteToggleImg"></span><span class="position">43.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Rothstein JD, Jin L, Dykes-Hoberg M, et al. 1993. Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity. <i>Proc. Natl. Acad. Sci. USA</i> 90:6591&ndash;95 <script type="text/javascript">

				genRefLink(16, 'b43', '10.1073%2Fpnas.90.14.6591');
			</script> <script type="text/javascript">

				genRefLink(8, 'b43', '8393571');
			</script> <script type="text/javascript">

				genRefLink(128, 'b43', 'A1993LM68100045');
			</script> <script type="text/javascript">

            genSfxLinks('b43', '%26aulast%3DRothstein%26aufirst%3DJD%26date%3D1993%26atitle%3DChronic%2Binhibition%2Bof%2Bglutamate%2Buptake%2Bproduces%2Ba%2Bmodel%2Bof%2Bslow%2Bneurotoxicity.%26stitle%3DProc.%2BNatl.%2BAcad.%2BSci.%2BUSA%26volume%3D90%26spage%3D6591%26id%3Ddoi%3A10.1073%252Fpnas.90.14.6591');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR50"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...which was mediated by activation of &alpha;-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA)-sensitive glutamate receptors (43)....</span></li></ul><div class="otherReviews" style="display: none;"></div></li><li class="fulltext b44" refid="b44" id="b44ref"><span class="toggleImg orangeToggleImg"></span><span class="position">44.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Lafon-Cazal M, Pietri S, Culcasi M, et al. 1993. NMDA-dependent superoxide production and neurotoxicity. <i>Nature</i> 364:535&ndash;37 <script type="text/javascript">

				genRefLink(16, 'b44', '10.1038%2F364535a0');
			</script> <script type="text/javascript">

				genRefLink(8, 'b44', '7687749');
			</script> <script type="text/javascript">

            genSfxLinks('b44', '%26aulast%3DLafon-Cazal%26aufirst%3DM%26date%3D1993%26atitle%3DNMDA-dependent%2Bsuperoxide%2Bproduction%2Band%2Bneurotoxicity.%26stitle%3DNature%26volume%3D364%26spage%3D535%26id%3Ddoi%3A10.1038%252F364535a0');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR51"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...O2&bull;&minus;-activated death was dependent on calcium (Ca2+) and release of arachidonate and was reduced by trapping O2&bull;&minus; (44)....</span></li></ul><div class="otherReviews" style="display: none;"><p class="otherReviewsHeader">

                    Other reviews that cite this reference:
                </p><ul class="otherReviewsList"><li class="otherReviewEntry"><div class="otherReviewsTitle"><h2><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/abs/10.1146/annurev.neuro.20.1.245" target="_top">BCL-2 GENE FAMILY IN THE NERVOUS SYSTEM</a></h2></div><div class="otherReviewsAuthor">D. E. Merry, S. J. Korsmeyer</div><div class="otherReviewsInfo">Annual Review of Neuroscience 
                    Vol. 20:
                    245
                        -
                        267</div><div class="otherReviewSnipp"><ul><li ref-id="XR192"><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/full/10.1146/annurev.neuro.20.1.245#XR192"> ...<ref-snippet xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-id="XR192">A role for reactive oxygen species in excitotoxic death in vitro (Lafon-Cazal et al 1993)</ref-snippet>... </a></li></ul></div></li><li class="otherReviewEntry"></li></ul></div></li><li class="fulltext b45" refid="b45" id="b45ref"><span class="toggleImg whiteToggleImg"></span><span class="position">45.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Shy ME, Rowland LP, Smith T, et al. 1986. Motor neuron disease and plasma cell dyscrasia. <i>Neurology</i> 36:1429&ndash;36 <script type="text/javascript">

				genRefLink(8, 'b45', '3762961');
			</script> <script type="text/javascript">

				genRefLink(128, 'b45', 'A1986E703500004');
			</script> <script type="text/javascript">

            genSfxLinks('b45', '%26aulast%3DShy%26aufirst%3DME%26date%3D1986%26atitle%3DMotor%2Bneuron%2Bdisease%2Band%2Bplasma%2Bcell%2Bdyscrasia.%26stitle%3DNeurology%26volume%3D36%26spage%3D1429');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR54"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...evidence for an autoimmune etiology of sALS was largely clinical. sALS patients have an increased incidence of autoimmune disease (2), paraproteinemias (45,...</span></li></ul><div class="otherReviews" style="display: none;"></div></li><li class="fulltext b46" refid="b46" id="b46ref"><span class="toggleImg whiteToggleImg"></span><span class="position">46.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Latov N, Hays AP, Donofrio PD, et al. 1988. Monoclonal IgM with unique specificity to gangliosides GM1 and GD1b and to lacto-tetraose associated with human motor neuron disease. <i>Neurology</i> 38:763&ndash;68 <script type="text/javascript">

				genRefLink(8, 'b46', '2452383');
			</script> <script type="text/javascript">

				genRefLink(128, 'b46', 'A1988N193100023');
			</script> <script type="text/javascript">

            genSfxLinks('b46', '%26aulast%3DLatov%26aufirst%3DN%26date%3D1988%26atitle%3DMonoclonal%2BIgM%2Bwith%2Bunique%2Bspecificity%2Bto%2Bgangliosides%2BGM1%2Band%2BGD1b%2Band%2Bto%2Blacto-tetraose%2Bassociated%2Bwith%2Bhuman%2Bmotor%2Bneuron%2Bdisease.%26stitle%3DNeurology%26volume%3D38%26spage%3D763');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR55"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...evidence for an autoimmune etiology of sALS was largely clinical. sALS patients have an increased incidence of autoimmune disease (2), paraproteinemias (45, 46,...</span></li></ul><div class="otherReviews" style="display: none;"></div></li><li class="fulltext b47" refid="b47" id="b47ref"><span class="toggleImg whiteToggleImg"></span><span class="position">47.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Younger DS, Rowland LP, Latov N, et al. 1990. Motor neuron disease and amyotrophic lateral sclerosis: relation of high CSF protein content to paraproteinemia and clinical syndromes. <i>Neurology</i> 40:595&ndash;99 <script type="text/javascript">

				genRefLink(8, 'b47', '2320231');
			</script> <script type="text/javascript">

				genRefLink(128, 'b47', 'A1990CX89300006');
			</script> <script type="text/javascript">

            genSfxLinks('b47', '%26aulast%3DYounger%26aufirst%3DDS%26date%3D1990%26atitle%3DMotor%2Bneuron%2Bdisease%2Band%2Bamyotrophic%2Blateral%2Bsclerosis%253A%2Brelation%2Bof%2Bhigh%2BCSF%2Bprotein%2Bcontent%2Bto%2Bparaproteinemia%2Band%2Bclinical%2Bsyndromes.%26stitle%3DNeurology%26volume%3D40%26spage%3D595');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR56"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...evidence for an autoimmune etiology of sALS was largely clinical. sALS patients have an increased incidence of autoimmune disease (2), paraproteinemias (45, 46, 47),...</span></li></ul><div class="otherReviews" style="display: none;"></div></li><li class="fulltext b48" refid="b48" id="b48ref"><span class="toggleImg whiteToggleImg"></span><span class="position">48.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Meininger V, Duarte F, Binet S, et al. 1990. Serum monoclonal immunoglobulin in amyotrophic lateral sclerosis: a quantitative analysis using a new Western blot technique. <i>Neurology</i> 40(Suppl. 1):183(Abstr.)  <script type="text/javascript">

            genSfxLinks('b48', '%26aulast%3DMeininger%26aufirst%3DV%26date%3D1990%26atitle%3DSerum%2Bmonoclonal%2Bimmunoglobulin%2Bin%2Bamyotrophic%2Blateral%2Bsclerosis%253A%2Ba%2Bquantitative%2Banalysis%2Busing%2Ba%2Bnew%2BWestern%2Bblot%2Btechnique.%26stitle%3DNeurology%26volume%3D40%28Suppl.+1%29%26spage%3D183');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR57"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...evidence for an autoimmune etiology of sALS was largely clinical. sALS patients have an increased incidence of autoimmune disease (2), paraproteinemias (45, 46, 47), and serum monoclonal immunoglobulins (48),...</span></li></ul><div class="otherReviews" style="display: none;"></div></li><li class="fulltext b49" refid="b49" id="b49ref"><span class="toggleImg whiteToggleImg"></span><span class="position">49.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Bartfield H, Pollack MS, Cunningham-Rundles S, et al. 1982. HLA frequencies in amyotrophic lateral sclerosis. <i>Arch. Neurol.</i> 39:270&ndash;71 <script type="text/javascript">

				genRefLink(8, 'b49', '7073543');
			</script> <script type="text/javascript">

            genSfxLinks('b49', '%26aulast%3DBartfield%26aufirst%3DH%26date%3D1982%26atitle%3DHLA%2Bfrequencies%2Bin%2Bamyotrophic%2Blateral%2Bsclerosis.%26stitle%3DArch.%2BNeurol.%26volume%3D39%26spage%3D270');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR58"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...Likewise, increased cellular immunity to poliovirus (49, 50), myelin basic protein (50), and other CNS protein species (50...</span></li><li ref-id="XR64"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...the presence of circulating immune complexes and immune complex deposition in kidneys (49,...</span></li></ul><div class="otherReviews" style="display: none;"></div></li><li class="fulltext b50" refid="b50" id="b50ref"><span class="toggleImg whiteToggleImg"></span><span class="position">50.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Kott E, Livni E, Zamir R, et al. 1976. Amyotrophic lateral sclerosis: cell-mediated immunity to poliovirus and myelin basic protein in patients with high frequency of HLA-BW35. <i>Neurology</i> 26:376&ndash;77 <script type="text/javascript">

				genRefLink(128, 'b50', 'A1976BM46900139');
			</script> <script type="text/javascript">

            genSfxLinks('b50', '%26aulast%3DKott%26aufirst%3DE%26date%3D1976%26atitle%3DAmyotrophic%2Blateral%2Bsclerosis%253A%2Bcell-mediated%2Bimmunity%2Bto%2Bpoliovirus%2Band%2Bmyelin%2Bbasic%2Bprotein%2Bin%2Bpatients%2Bwith%2Bhigh%2Bfrequency%2Bof%2BHLA-BW35.%26stitle%3DNeurology%26volume%3D26%26spage%3D376');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR59"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...Likewise, increased cellular immunity to poliovirus (49, 50), myelin basic protein (50), and other CNS protein species (50...</span></li><li ref-id="XR60"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...Likewise, increased cellular immunity to poliovirus (49, 50), myelin basic protein (50), and other CNS protein species (50...</span></li><li ref-id="XR61"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...increased cellular immunity to poliovirus (49, 50), myelin basic protein (50), and other CNS protein species (50,...</span></li></ul><div class="otherReviews" style="display: none;"></div></li><li class="fulltext b51" refid="b51" id="b51ref"><span class="toggleImg whiteToggleImg"></span><span class="position">51.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Aspin J, Harrison R, Jehanli A, et al. 1986. Stimulation by mitogens and neuronal membranes from patients with motor neuron disease. <i>J. Neuroimmunol.</i> 11:31&ndash;40 <script type="text/javascript">

				genRefLink(16, 'b51', '10.1016%2F0165-5728%2886%2990072-X');
			</script> <script type="text/javascript">

				genRefLink(8, 'b51', '3944249');
			</script> <script type="text/javascript">

				genRefLink(128, 'b51', 'A1986A360500003');
			</script> <script type="text/javascript">

            genSfxLinks('b51', '%26aulast%3DAspin%26aufirst%3DJ%26date%3D1986%26atitle%3DStimulation%2Bby%2Bmitogens%2Band%2Bneuronal%2Bmembranes%2Bfrom%2Bpatients%2Bwith%2Bmotor%2Bneuron%2Bdisease.%26stitle%3DJ.%2BNeuroimmunol.%26volume%3D11%26spage%3D31%26id%3Ddoi%3A10.1016%252F0165-5728%252886%252990072-X');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR62"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...increased cellular immunity to poliovirus (49, 50), myelin basic protein (50), and other CNS protein species (50, 51)...</span></li></ul><div class="otherReviews" style="display: none;"></div></li><li class="fulltext b52" refid="b52" id="b52ref"><span class="toggleImg whiteToggleImg"></span><span class="position">52.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Cashman NR, Gurney ME, Antel JP. 1985. Immunology of amyotrophic lateral sclerosis. <i>Springer Semin. Immunopathol.</i> 8:141&ndash;52 <script type="text/javascript">

				genRefLink(16, 'b52', '10.1007%2FBF00197252');
			</script> <script type="text/javascript">

				genRefLink(8, 'b52', '2408348');
			</script> <script type="text/javascript">

				genRefLink(128, 'b52', 'A1985AFP9800010');
			</script> <script type="text/javascript">

            genSfxLinks('b52', '%26aulast%3DCashman%26aufirst%3DNR%26date%3D1985%26atitle%3DImmunology%2Bof%2Bamyotrophic%2Blateral%2Bsclerosis.%26stitle%3DSpringer%2BSemin.%2BImmunopathol.%26volume%3D8%26spage%3D141%26id%3Ddoi%3A10.1007%252FBF00197252');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR63"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...and other CNS protein species (50, 51) may be a secondary phenomenon (52)....</span></li></ul><div class="otherReviews" style="display: none;"></div></li><li class="fulltext b53" refid="b53" id="b53ref"><span class="toggleImg whiteToggleImg"></span><span class="position">53.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Oldstone MBA, Wilson CB, Perrin LH, et al. 1976. Evidence for immune complex formation in patients with amyotrophic lateral sclerosis. <i>Lancet</i> 2:977&ndash;99 <script type="text/javascript">

            genSfxLinks('b53', '%26aulast%3DOldstone%26aufirst%3DMBA%26date%3D1976%26atitle%3DEvidence%2Bfor%2Bimmune%2Bcomplex%2Bformation%2Bin%2Bpatients%2Bwith%2Bamyotrophic%2Blateral%2Bsclerosis.%26stitle%3DLancet%26volume%3D2%26spage%3D977');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR65"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...the presence of circulating immune complexes and immune complex deposition in kidneys (49, 53,...</span></li></ul><div class="otherReviews" style="display: none;"></div></li><li class="fulltext b54" refid="b54" id="b54ref"><span class="toggleImg whiteToggleImg"></span><span class="position">54.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Palo J, Rissanan A, Jolinen E, et al. 1978. Kidney and skin biopsy in amyotrophic lateral sclerosis. <i>Lancet</i> 1:1270 <script type="text/javascript">

				genRefLink(16, 'b54', '10.1016%2FS0140-6736%2878%2992518-7');
			</script> <script type="text/javascript">

				genRefLink(8, 'b54', '78043');
			</script> <script type="text/javascript">

				genRefLink(128, 'b54', 'A1978FB97200058');
			</script> <script type="text/javascript">

            genSfxLinks('b54', '%26aulast%3DPalo%26aufirst%3DJ%26date%3D1978%26atitle%3DKidney%2Band%2Bskin%2Bbiopsy%2Bin%2Bamyotrophic%2Blateral%2Bsclerosis.%26stitle%3DLancet%26volume%3D1%26spage%3D1270%26id%3Ddoi%3A10.1016%252FS0140-6736%252878%252992518-7');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR66"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...the presence of circulating immune complexes and immune complex deposition in kidneys (49, 53, 54,...</span></li></ul><div class="otherReviews" style="display: none;"></div></li><li class="fulltext b55" refid="b55" id="b55ref"><span class="toggleImg whiteToggleImg"></span><span class="position">55.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Smith RG, Engelhardt JI, Tajti J, Appel SH. 1993. Experimental immune-mediated motor neuron diseases: models for human ALS. <i>Brain Res. Bull.</i> 30:373&ndash;80 <script type="text/javascript">

				genRefLink(16, 'b55', '10.1016%2F0361-9230%2893%2990268-G');
			</script> <script type="text/javascript">

				genRefLink(8, 'b55', '8457886');
			</script> <script type="text/javascript">

				genRefLink(128, 'b55', 'A1993KM75200026');
			</script> <script type="text/javascript">

            genSfxLinks('b55', '%26aulast%3DSmith%26aufirst%3DRG%26date%3D1993%26atitle%3DExperimental%2Bimmune-mediated%2Bmotor%2Bneuron%2Bdiseases%253A%2Bmodels%2Bfor%2Bhuman%2BALS.%26stitle%3DBrain%2BRes.%2BBull.%26volume%3D30%26spage%3D373%26id%3Ddoi%3A10.1016%252F0361-9230%252893%252990268-G');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR67"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...55) of sALS patients; the postmortem identification of extracellular immunoglobulin and complement deposition at the neuromuscular junction,...</span></li></ul><div class="otherReviews" style="display: none;"></div></li><li class="fulltext b56" refid="b56" id="b56ref"><span class="toggleImg whiteToggleImg"></span><span class="position">56.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Donnenfeld H, Kascsak RJ, Bartfeld H. 1984. Deposits of IgG and C<sup>3</sup> in the spinal cord and motor cortex of ALS patients. <i>J. Neuroimmunol.</i> 6:51&ndash;57 <script type="text/javascript">

				genRefLink(16, 'b56', '10.1016%2F0165-5728%2884%2990042-0');
			</script> <script type="text/javascript">

				genRefLink(8, 'b56', '6368581');
			</script> <script type="text/javascript">

				genRefLink(128, 'b56', 'A1984SN82200006');
			</script> <script type="text/javascript">

            genSfxLinks('b56', '%26aulast%3DDonnenfeld%26aufirst%3DH%26date%3D1984%26atitle%3DDeposits%2Bof%2BIgG%2Band%2BC3%2Bin%2Bthe%2Bspinal%2Bcord%2Band%2Bmotor%2Bcortex%2Bof%2BALS%2Bpatients.%26stitle%3DJ.%2BNeuroimmunol.%26volume%3D6%26spage%3D51%26id%3Ddoi%3A10.1016%252F0165-5728%252884%252990042-0');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR68"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...of sALS patients; the postmortem identification of extracellular immunoglobulin and complement deposition at the neuromuscular junction, motor cortex, and spinal cord (56)...</span></li></ul><div class="otherReviews" style="display: none;"></div></li><li class="fulltext b57" refid="b57" id="b57ref"><span class="toggleImg whiteToggleImg"></span><span class="position">57.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Engelhardt JI, Appel SH. 1990. IgG reactivity in the spinal cord and motor cortex in amyotrophic lateral sclerosis. <i>Arch. Neurol.</i> 47:210&ndash;11 <script type="text/javascript">

				genRefLink(8, 'b57', '2122877');
			</script> <script type="text/javascript">

            genSfxLinks('b57', '%26aulast%3DEngelhardt%26aufirst%3DJI%26date%3D1990%26atitle%3DIgG%2Breactivity%2Bin%2Bthe%2Bspinal%2Bcord%2Band%2Bmotor%2Bcortex%2Bin%2Bamyotrophic%2Blateral%2Bsclerosis.%26stitle%3DArch.%2BNeurol.%26volume%3D47%26spage%3D210');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR69"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...; and IgG internalization within motoneurons (57) of sALS patients all suggest alterations observed in autoimmune disease....</span></li><li ref-id="XR74"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...High serum antibody titers to motoneurons, IgG precipitates at neuromuscular junctions and in motoneurons (57),...</span></li></ul><div class="otherReviews" style="display: none;"></div></li><li class="fulltext b58" refid="b58" id="b58ref"><span class="toggleImg whiteToggleImg"></span><span class="position">58.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Engelhardt JI, Appel SH, Killian JM. 1989. Experimental autoimmune motoneuron disease. <i>Ann. Neurol.</i> 26:368&ndash;76 <script type="text/javascript">

				genRefLink(16, 'b58', '10.1002%2Fana.410260310');
			</script> <script type="text/javascript">

				genRefLink(8, 'b58', '2802536');
			</script> <script type="text/javascript">

				genRefLink(128, 'b58', 'A1989AP76800009');
			</script> <script type="text/javascript">

            genSfxLinks('b58', '%26aulast%3DEngelhardt%26aufirst%3DJI%26date%3D1989%26atitle%3DExperimental%2Bautoimmune%2Bmotoneuron%2Bdisease.%26stitle%3DAnn.%2BNeurol.%26volume%3D26%26spage%3D368%26id%3Ddoi%3A10.1002%252Fana.410260310');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR71"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...Lower motoneuron disease in guinea pigs was induced by inoculation of purified bovine spinal cord motor neurons (58),...</span></li></ul><div class="otherReviews" style="display: none;"></div></li><li class="fulltext b59" refid="b59" id="b59ref"><span class="toggleImg whiteToggleImg"></span><span class="position">59.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Engelhardt JI, Appel SH, Killian JM. 1990. Motor neuron destruction in guinea pigs immunized with bovine spinal cord ventral horn homogenate: experimental autoimmune gray matter disease. <i>J. Neuroimmunol.</i> 27:21&ndash;31 <script type="text/javascript">

				genRefLink(16, 'b59', '10.1016%2F0165-5728%2890%2990132-7');
			</script> <script type="text/javascript">

				genRefLink(8, 'b59', '1690752');
			</script> <script type="text/javascript">

				genRefLink(128, 'b59', 'A1990CW04100003');
			</script> <script type="text/javascript">

            genSfxLinks('b59', '%26aulast%3DEngelhardt%26aufirst%3DJI%26date%3D1990%26atitle%3DMotor%2Bneuron%2Bdestruction%2Bin%2Bguinea%2Bpigs%2Bimmunized%2Bwith%2Bbovine%2Bspinal%2Bcord%2Bventral%2Bhorn%2Bhomogenate%253A%2Bexperimental%2Bautoimmune%2Bgray%2Bmatter%2Bdisease.%26stitle%3DJ.%2BNeuroimmunol.%26volume%3D27%26spage%3D21%26id%3Ddoi%3A10.1016%252F0165-5728%252890%252990132-7');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR72"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...while both upper and lower motoneuron degeneration was caused by inoculation of bovine spinal cord ventral horn homogenates (59)....</span></li></ul><div class="otherReviews" style="display: none;"></div></li><li class="fulltext b60" refid="b60" id="b60ref"><span class="toggleImg whiteToggleImg"></span><span class="position">60.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Cashman NR, Durham HD, Blusztajn JK, et al. 1992. Neuroblastoma x spinal cord (NSC) hybrid cell lines resemble developing motor neurons. <i>Dev. Dyn.</i> 194:209&ndash;21 <script type="text/javascript">

				genRefLink(8, 'b60', '1467557');
			</script> <script type="text/javascript">

				genRefLink(128, 'b60', 'A1992KA05800005');
			</script> <script type="text/javascript">

            genSfxLinks('b60', '%26aulast%3DCashman%26aufirst%3DNR%26date%3D1992%26atitle%3DNeuroblastoma%2Bx%2Bspinal%2Bcord%2B%2528NSC%2529%2Bhybrid%2Bcell%2Blines%2Bresemble%2Bdeveloping%2Bmotor%2Bneurons.%26stitle%3DDev.%2BDyn.%26volume%3D194%26spage%3D209');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR73"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...rabbit motoneuron loss was induced by injection of motoneuron hybrid cell homogenates (60)....</span></li><li ref-id="XR92"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...a motoneuron-neuroblastoma hybrid cell line (VSC 4.1) was produced using techniques that had formerly yielded a substantia nigra cell line (76) and other motoneuron lines (60,...</span></li></ul><div class="otherReviews" style="display: none;"></div></li><li class="fulltext b61" refid="b61" id="b61ref"><span class="toggleImg whiteToggleImg"></span><span class="position">61.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Engelhardt JI, Tajti J, Appel SH. 1993. Lymphocytic infiltrates in the spinal cord in amyotrophic lateral sclerosis. <i>Arch. Neurol.</i> 50:30&ndash;36 <script type="text/javascript">

				genRefLink(8, 'b61', '8093428');
			</script> <script type="text/javascript">

				genRefLink(128, 'b61', 'A1993KG09200008');
			</script> <script type="text/javascript">

            genSfxLinks('b61', '%26aulast%3DEngelhardt%26aufirst%3DJI%26date%3D1993%26atitle%3DLymphocytic%2Binfiltrates%2Bin%2Bthe%2Bspinal%2Bcord%2Bin%2Bamyotrophic%2Blateral%2Bsclerosis.%26stitle%3DArch.%2BNeurol.%26volume%3D50%26spage%3D30');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR75"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...and inflammatory cells within the spinal cord (61) were all documented in guinea pig models....</span></li></ul><div class="otherReviews" style="display: none;"></div></li><li class="fulltext b62" refid="b62" id="b62ref"><span class="toggleImg whiteToggleImg"></span><span class="position">62.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Appel SH, Engelhardt JI, Garcia J, et al. 1991. Immunoglobulins from animal models of motor neuron disease and human ALS passively transfer physiological abnormalities of the neuromuscular junction. <i>Proc. Natl. Acad. Sci. USA</i> 88:647&ndash;51 <script type="text/javascript">

				genRefLink(16, 'b62', '10.1073%2Fpnas.88.2.647');
			</script> <script type="text/javascript">

				genRefLink(8, 'b62', '1988960');
			</script> <script type="text/javascript">

				genRefLink(128, 'b62', 'A1991ET52100069');
			</script> <script type="text/javascript">

            genSfxLinks('b62', '%26aulast%3DAppel%26aufirst%3DSH%26date%3D1991%26atitle%3DImmunoglobulins%2Bfrom%2Banimal%2Bmodels%2Bof%2Bmotor%2Bneuron%2Bdisease%2Band%2Bhuman%2BALS%2Bpassively%2Btransfer%2Bphysiological%2Babnormalities%2Bof%2Bthe%2Bneuromuscular%2Bjunction.%26stitle%3DProc.%2BNatl.%2BAcad.%2BSci.%2BUSA%26volume%3D88%26spage%3D647%26id%3Ddoi%3A10.1073%252Fpnas.88.2.647');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR76"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...IgG from sALS patients and guinea pig models also passively transferred physiologic changes to mouse neuromuscular junctions (62)....</span></li><li ref-id="XR77"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...passively transferred IgG histochemically localized to motoneurons and neuromuscular junctions (62),...</span></li></ul><div class="otherReviews" style="display: none;"></div></li><li class="fulltext b63" refid="b63" id="b63ref"><span class="toggleImg whiteToggleImg"></span><span class="position">63.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Uchitel OD, Scornik F, Protti DA, et al. 1992. Long-term neuromuscular dysfunction produced by passive transfer of amyotrophic lateral sclerosis immunoglobulins. <i>Neurology</i> 42:2175&ndash;80 <script type="text/javascript">

				genRefLink(8, 'b63', '1436531');
			</script> <script type="text/javascript">

				genRefLink(128, 'b63', 'A1992JY62700020');
			</script> <script type="text/javascript">

            genSfxLinks('b63', '%26aulast%3DUchitel%26aufirst%3DOD%26date%3D1992%26atitle%3DLong-term%2Bneuromuscular%2Bdysfunction%2Bproduced%2Bby%2Bpassive%2Btransfer%2Bof%2Bamyotrophic%2Blateral%2Bsclerosis%2Bimmunoglobulins.%26stitle%3DNeurology%26volume%3D42%26spage%3D2175');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR78"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...passively transferred IgG histochemically localized to motoneurons and neuromuscular junctions (62), whereas chronic ALS IgG injections induced axonal degeneration (63)....</span></li></ul><div class="otherReviews" style="display: none;"></div></li><li class="fulltext b64" refid="b64" id="b64ref"><span class="toggleImg orangeToggleImg"></span><span class="position">64.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Robitaille R, Adler EM, Charlton MP. 1990. Strategic location of calcium channels at transmitter release sites of frog neuromuscular synapses. <i>Neuron</i> 5:773&ndash;79 <script type="text/javascript">

				genRefLink(16, 'b64', '10.1016%2F0896-6273%2890%2990336-E');
			</script> <script type="text/javascript">

				genRefLink(8, 'b64', '1980068');
			</script> <script type="text/javascript">

				genRefLink(128, 'b64', 'A1990EQ38100004');
			</script> <script type="text/javascript">

            genSfxLinks('b64', '%26aulast%3DRobitaille%26aufirst%3DR%26date%3D1990%26atitle%3DStrategic%2Blocation%2Bof%2Bcalcium%2Bchannels%2Bat%2Btransmitter%2Brelease%2Bsites%2Bof%2Bfrog%2Bneuromuscular%2Bsynapses.%26stitle%3DNeuron%26volume%3D5%26spage%3D773%26id%3Ddoi%3A10.1016%252F0896-6273%252890%252990336-E');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR79"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...Because ACh release at neuromuscular junctions is dependent upon voltage-gated calcium channel (VGCC) activation and increased intracellular Ca2+ concentrations (64,...</span></li></ul><div class="otherReviews" style="display: none;"><p class="otherReviewsHeader">

                    Other reviews that cite this reference:
                </p><ul class="otherReviewsList"><li class="otherReviewEntry"><div class="otherReviewsTitle"><h2><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/abs/10.1146/annurev.physiol.61.1.725" target="_top">ELECTROPHYSIOLOGY OF SYNAPTIC VESICLE CYCLING</a></h2></div><div class="otherReviewsAuthor">Henrique von Gersdorff, Gary Matthews</div><div class="otherReviewsInfo">Annual Review of Physiology 
                    Vol. 61:
                    725
                        -
                        752</div><div class="otherReviewSnipp"><ul><li ref-id="XR106"><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/full/10.1146/annurev.physiol.61.1.725#XR106"> ...<ref-snippet xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-id="XR106">the more synchronous activation of secretion throughout the terminal from voltage-clamp pulses and also the strategic colocalization of synaptic vesicles and Ca<sup>2+</sup> channels (93).</ref-snippet>... </a></li></ul></div></li><li class="otherReviewEntry"></li></ul></div></li><li class="fulltext b65" refid="b65" id="b65ref"><span class="toggleImg whiteToggleImg"></span><span class="position">65.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Uchitel OD, Protti DA, Sanchez V, et al. 1992. P-type voltage-dependent calcium influx and transmitter release in mammalian synapses. <i>Proc. Natl. Acad. Sci. USA</i> 89:3330&ndash;33 <script type="text/javascript">

				genRefLink(16, 'b65', '10.1073%2Fpnas.89.8.3330');
			</script> <script type="text/javascript">

				genRefLink(8, 'b65', '1348859');
			</script> <script type="text/javascript">

				genRefLink(128, 'b65', 'A1992HP04300035');
			</script> <script type="text/javascript">

            genSfxLinks('b65', '%26aulast%3DUchitel%26aufirst%3DOD%26date%3D1992%26atitle%3DP-type%2Bvoltage-dependent%2Bcalcium%2Binflux%2Band%2Btransmitter%2Brelease%2Bin%2Bmammalian%2Bsynapses.%26stitle%3DProc.%2BNatl.%2BAcad.%2BSci.%2BUSA%26volume%3D89%26spage%3D3330%26id%3Ddoi%3A10.1073%252Fpnas.89.8.3330');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR80"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...Because ACh release at neuromuscular junctions is dependent upon voltage-gated calcium channel (VGCC) activation and increased intracellular Ca2+ concentrations (64, 65),...</span></li></ul><div class="otherReviews" style="display: none;"></div></li><li class="fulltext b66" refid="b66" id="b66ref"><span class="toggleImg whiteToggleImg"></span><span class="position">66.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Engelhardt JI, Appel SH, Jakab K, et al. 1991. <i>Immune-mediated models of motor neuron destruction in the guinea pig.</i> In <i>Advances in Neurology: Amyotrophic Lateral Sclerosis and Other Motor Neuron Diseases</i>, ed. LP Rowland, 56:369&ndash;79. New York: Raven <script type="text/javascript">

            genSfxLinks('b66', '%26aulast%3DEngelhardt%26aufirst%3DJI%26date%3D1991%26volume%3D56%26spage%3D369');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR81"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...Early electrophysiologic studies tested this hypothesis on L-type VGCCs but demonstrated reduced L-type Ca2+ currents and charge movement following sALS IgG or Fab fragment addition to L-type VGCCs in myotubes (66,...</span></li></ul><div class="otherReviews" style="display: none;"></div></li><li class="fulltext b67" refid="b67" id="b67ref"><span class="toggleImg whiteToggleImg"></span><span class="position">67.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Delbono O, Garcia J, Appel SH, et al. 1991. Calcium current and charge movement of mammalian muscle: action of amyotrophic lateral sclerosis immunoglobulins. <i>J. Physiol.</i> 444:723&ndash;42 <script type="text/javascript">

				genRefLink(8, 'b67', '1668354');
			</script> <script type="text/javascript">

				genRefLink(128, 'b67', 'A1991GV30100041');
			</script> <script type="text/javascript">

            genSfxLinks('b67', '%26aulast%3DDelbono%26aufirst%3DO%26date%3D1991%26atitle%3DCalcium%2Bcurrent%2Band%2Bcharge%2Bmovement%2Bof%2Bmammalian%2Bmuscle%253A%2Baction%2Bof%2Bamyotrophic%2Blateral%2Bsclerosis%2Bimmunoglobulins.%26stitle%3DJ.%2BPhysiol.%26volume%3D444%26spage%3D723');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR82"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...Early electrophysiologic studies tested this hypothesis on L-type VGCCs but demonstrated reduced L-type Ca2+ currents and charge movement following sALS IgG or Fab fragment addition to L-type VGCCs in myotubes (66, 67,...</span></li></ul><div class="otherReviews" style="display: none;"></div></li><li class="fulltext b68" refid="b68" id="b68ref"><span class="toggleImg whiteToggleImg"></span><span class="position">68.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Delbono O, Garcia J, Appel SH, et al. 1991. IgG from amyotrophic lateral sclerosis affects tubular calcium channels of skeletal muscle. <i>Am. J. Physiol.</i> 260:C1347&ndash;C1351 <script type="text/javascript">

				genRefLink(8, 'b68', '1647668');
			</script> <script type="text/javascript">

				genRefLink(128, 'b68', 'A1991FU84100026');
			</script> <script type="text/javascript">

            genSfxLinks('b68', '%26aulast%3DDelbono%26aufirst%3DO%26date%3D1991%26atitle%3DIgG%2Bfrom%2Bamyotrophic%2Blateral%2Bsclerosis%2Baffects%2Btubular%2Bcalcium%2Bchannels%2Bof%2Bskeletal%2Bmuscle.%26stitle%3DAm.%2BJ.%2BPhysiol.%26volume%3D260%26spage%3DC1347');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR83"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...Early electrophysiologic studies tested this hypothesis on L-type VGCCs but demonstrated reduced L-type Ca2+ currents and charge movement following sALS IgG or Fab fragment addition to L-type VGCCs in myotubes (66, 67, 68,...</span></li></ul><div class="otherReviews" style="display: none;"></div></li><li class="fulltext b69" refid="b69" id="b69ref"><span class="toggleImg whiteToggleImg"></span><span class="position">69.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Delbono O, Magnelli V, Sawada T, et al. 1993. F<sub>ab</sub> fragments from amyotrophic lateral sclerosis IgG affect calcium channels of skeletal muscle. <i>Am. J. Physiol.</i> 264:C537&ndash;C543 <script type="text/javascript">

				genRefLink(8, 'b69', '8384783');
			</script> <script type="text/javascript">

				genRefLink(128, 'b69', 'A1993KV27000004');
			</script> <script type="text/javascript">

            genSfxLinks('b69', '%26aulast%3DDelbono%26aufirst%3DO%26date%3D1993%26atitle%3DFab%2Bfragments%2Bfrom%2Bamyotrophic%2Blateral%2Bsclerosis%2BIgG%2Baffect%2Bcalcium%2Bchannels%2Bof%2Bskeletal%2Bmuscle.%26stitle%3DAm.%2BJ.%2BPhysiol.%26volume%3D264%26spage%3DC537');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR84"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...Early electrophysiologic studies tested this hypothesis on L-type VGCCs but demonstrated reduced L-type Ca2+ currents and charge movement following sALS IgG or Fab fragment addition to L-type VGCCs in myotubes (66, 67, 68, 69)...</span></li></ul><div class="otherReviews" style="display: none;"></div></li><li class="fulltext b70" refid="b70" id="b70ref"><span class="toggleImg whiteToggleImg"></span><span class="position">70.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Magnelli V, Sawada T, Delbono O, et al. 1993. Amyotrophic lateral sclerosis immunoglobulins action on single skeletal muscle Ca<sup>2+</sup> channels. <i>J. Physiol.</i> 461:103&ndash;18 <script type="text/javascript">

				genRefLink(8, 'b70', '8394422');
			</script> <script type="text/javascript">

				genRefLink(128, 'b70', 'A1993KN98000007');
			</script> <script type="text/javascript">

            genSfxLinks('b70', '%26aulast%3DMagnelli%26aufirst%3DV%26date%3D1993%26atitle%3DAmyotrophic%2Blateral%2Bsclerosis%2Bimmunoglobulins%2Baction%2Bon%2Bsingle%2Bskeletal%2Bmuscle%2BCa2%252B%2Bchannels.%26stitle%3DJ.%2BPhysiol.%26volume%3D461%26spage%3D103');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR85"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...Early electrophysiologic studies tested this hypothesis on L-type VGCCs but demonstrated reduced L-type Ca2+ currents and charge movement following sALS IgG or Fab fragment addition to L-type VGCCs in myotubes (66, 67, 68, 69) and VGCCs inserted in lipid bilayers (70)....</span></li></ul><div class="otherReviews" style="display: none;"></div></li><li class="fulltext b71" refid="b71" id="b71ref"><span class="toggleImg whiteToggleImg"></span><span class="position">71.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Llinas R, Sugimori M, Cherksey BD, et al. 1993. IgG from amyotrophic lateral sclerosis patients increase current through P-type calcium channels in mammalian cerebellar Purkinje cells and in isolated channel protein in lipid bilayers. <i>Proc. Natl. Acad. Sci. USA</i> 90:11743&ndash;47 <script type="text/javascript">

				genRefLink(16, 'b71', '10.1073%2Fpnas.90.24.11743');
			</script> <script type="text/javascript">

				genRefLink(8, 'b71', '8265620');
			</script> <script type="text/javascript">

				genRefLink(128, 'b71', 'A1993MM51500063');
			</script> <script type="text/javascript">

            genSfxLinks('b71', '%26aulast%3DLlinas%26aufirst%3DR%26date%3D1993%26atitle%3DIgG%2Bfrom%2Bamyotrophic%2Blateral%2Bsclerosis%2Bpatients%2Bincrease%2Bcurrent%2Bthrough%2BP-type%2Bcalcium%2Bchannels%2Bin%2Bmammalian%2Bcerebellar%2BPurkinje%2Bcells%2Band%2Bin%2Bisolated%2Bchannel%2Bprotein%2Bin%2Blipid%2Bbilayers.%26stitle%3DProc.%2BNatl.%2BAcad.%2BSci.%2BUSA%26volume%3D90%26spage%3D11743%26id%3Ddoi%3A10.1073%252Fpnas.90.24.11743');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR86"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...sALS IgG was shown to increase P-type Ca2+ currents in cerebellar Purkinje cells (71)...</span></li></ul><div class="otherReviews" style="display: none;"></div></li><li class="fulltext b72" refid="b72" id="b72ref"><span class="toggleImg whiteToggleImg"></span><span class="position">72.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">O'Shaughnessy MP, Viglioni H, Kim YI. 1993. Effect of ALS plasma on calcium currents in bovine adrenal cells. <i>Soc. Neurosci. Abstr.</i> 19:234(Abstr.)  <script type="text/javascript">

            genSfxLinks('b72', '%26aulast%3DO%2527Shaughnessy%26aufirst%3DMP%26date%3D1993%26atitle%3DEffect%2Bof%2BALS%2Bplasma%2Bon%2Bcalcium%2Bcurrents%2Bin%2Bbovine%2Badrenal%2Bcells.%26stitle%3DSoc.%2BNeurosci.%2BAbstr.%26volume%3D19%26spage%3D234');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR87"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...sALS IgG was shown to increase P-type Ca2+ currents in cerebellar Purkinje cells (71) and adrenal cells (72)...</span></li></ul><div class="otherReviews" style="display: none;"></div></li><li class="fulltext b73" refid="b73" id="b73ref"><span class="toggleImg whiteToggleImg"></span><span class="position">73.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Mosier DR, Delbono O, Olcese R, et al. 1994. Amyotrophic lateral sclerosis IgG enhances brain calcium currents expressed in <i>Xenopus oocytes</i>. <i>Soc. Neurosci. Abstr.</i> 20:620(Abstr.)  <script type="text/javascript">

            genSfxLinks('b73', '%26aulast%3DMosier%26aufirst%3DDR%26date%3D1994%26atitle%3DAmyotrophic%2Blateral%2Bsclerosis%2BIgG%2Benhances%2Bbrain%2Bcalcium%2Bcurrents%2Bexpressed%2Bin%2BXenopus%2Boocytes.%26stitle%3DSoc.%2BNeurosci.%2BAbstr.%26volume%3D20%26spage%3D620');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR88"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...and adrenal cells (72) and to increase N-type Ca2+ currents expressed in oocytes (73)....</span></li></ul><div class="otherReviews" style="display: none;"></div></li><li class="fulltext b74" refid="b74" id="b74ref"><span class="toggleImg whiteToggleImg"></span><span class="position">74.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Smith RG, Hamilton S, Hoffman F, et al. 1992. Serum antibodies to skeletal muscle-derived L-type calcium channels in patients with amyotrophic lateral sclerosis. <i>New Engl. J. Med.</i> 327:1721&ndash;28 <script type="text/javascript">

				genRefLink(16, 'b74', '10.1056%2FNEJM199212103272405');
			</script> <script type="text/javascript">

				genRefLink(8, 'b74', '1331790');
			</script> <script type="text/javascript">

				genRefLink(128, 'b74', 'A1992KA89700005');
			</script> <script type="text/javascript">

            genSfxLinks('b74', '%26aulast%3DSmith%26aufirst%3DRG%26date%3D1992%26atitle%3DSerum%2Bantibodies%2Bto%2Bskeletal%2Bmuscle-derived%2BL-type%2Bcalcium%2Bchannels%2Bin%2Bpatients%2Bwith%2Bamyotrophic%2Blateral%2Bsclerosis.%26stitle%3DNew%2BEngl.%2BJ.%2BMed.%26volume%3D327%26spage%3D1721%26id%3Ddoi%3A10.1056%252FNEJM199212103272405');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR89"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...Antibody titers appeared to correlate with ALS progression rate (74)....</span></li></ul><div class="otherReviews" style="display: none;"></div></li><li class="fulltext b75" refid="b75" id="b75ref"><span class="toggleImg whiteToggleImg"></span><span class="position">75.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Kimura F, Smith RG, Delbono O, et al. 1994. Immunoglobulins from patients with amyotrophic lateral sclerosis recognize L-type voltage-gated calcium channel alpha<sub>i</sub> subunit. <i>Ann. Neurol.</i> 35:164&ndash;71 <script type="text/javascript">

				genRefLink(16, 'b75', '10.1002%2Fana.410350207');
			</script> <script type="text/javascript">

				genRefLink(8, 'b75', '8109897');
			</script> <script type="text/javascript">

				genRefLink(128, 'b75', 'A1994MW50600006');
			</script> <script type="text/javascript">

            genSfxLinks('b75', '%26aulast%3DKimura%26aufirst%3DF%26date%3D1994%26atitle%3DImmunoglobulins%2Bfrom%2Bpatients%2Bwith%2Bamyotrophic%2Blateral%2Bsclerosis%2Brecognize%2BL-type%2Bvoltage-gated%2Bcalcium%2Bchannel%2Balphai%2Bsubunit.%26stitle%3DAnn.%2BNeurol.%26volume%3D35%26spage%3D164%26id%3Ddoi%3A10.1002%252Fana.410350207');
        </script></div><ul class="refSnip" style="display: none;"></ul><div class="otherReviews" style="display: none;"></div></li><li class="fulltext b76" refid="b76" id="b76ref"><span class="toggleImg orangeToggleImg"></span><span class="position">76.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Crawford GD, Le W-D, Smith RG et al. 1992. A novel N18TG2 x mesencephalon hybrid expresses properties that suggest a dopaminergic cell line of substantia nigra origin. <i>J. Neurosci.</i> 12:3392&ndash;98 <script type="text/javascript">

				genRefLink(8, 'b76', '1356145');
			</script> <script type="text/javascript">

				genRefLink(128, 'b76', 'A1992JN80700008');
			</script> <script type="text/javascript">

            genSfxLinks('b76', '%26aulast%3DCrawford%26aufirst%3DGD%26date%3D1992%26atitle%3DA%2Bnovel%2BN18TG2%2Bx%2Bmesencephalon%2Bhybrid%2Bexpresses%2Bproperties%2Bthat%2Bsuggest%2Ba%2Bdopaminergic%2Bcell%2Bline%2Bof%2Bsubstantia%2Bnigra%2Borigin.%26stitle%3DJ.%2BNeurosci.%26volume%3D12%26spage%3D3392');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR90"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...sALS IgG reacted only with the ionophore-containing &alpha;1-subunit of the VGCC (76)....</span></li><li ref-id="XR91"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...a motoneuron-neuroblastoma hybrid cell line (VSC 4.1) was produced using techniques that had formerly yielded a substantia nigra cell line (76)...</span></li></ul><div class="otherReviews" style="display: none;"><p class="otherReviewsHeader">

                    Other reviews that cite this reference:
                </p><ul class="otherReviewsList"><li class="otherReviewEntry"><div class="otherReviewsTitle"><h2><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/abs/10.1146/annurev.neuro.22.1.123" target="_top">ETIOLOGY AND PATHOGENESIS OF PARKINSON'S DISEASE</a></h2></div><div class="otherReviewsAuthor">C. W. Olanow, W. G. Tatton</div><div class="otherReviewsInfo">Annual Review of Neuroscience 
                    Vol. 22:
                    123
                        -
                        144</div><div class="otherReviewSnipp"><ul><li ref-id="XR71"><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/full/10.1146/annurev.neuro.22.1.123#XR71"> ...<ref-snippet xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-id="XR71">An immune model of PD has been created through the use of antibodies generated against a hybrid line of dopaminergic neurons (Crawford et al 1992).</ref-snippet>... </a></li></ul></div></li><li class="otherReviewEntry"></li></ul></div></li><li class="fulltext b77" refid="b77" id="b77ref"><span class="toggleImg whiteToggleImg"></span><span class="position">77.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Salazar-Gruezo EF, Kim S, Kim H. 1991. Embryonic mouse spinal cord motor neuron hybrid cells. <i>NeuroReport</i> 2:505&ndash;8 <script type="text/javascript">

				genRefLink(16, 'b77', '10.1097%2F00001756-199109000-00002');
			</script> <script type="text/javascript">

				genRefLink(8, 'b77', '1751804');
			</script> <script type="text/javascript">

            genSfxLinks('b77', '%26aulast%3DSalazar-Gruezo%26aufirst%3DEF%26date%3D1991%26atitle%3DEmbryonic%2Bmouse%2Bspinal%2Bcord%2Bmotor%2Bneuron%2Bhybrid%2Bcells.%26stitle%3DNeuroReport%26volume%3D2%26spage%3D505%26id%3Ddoi%3A10.1097%252F00001756-199109000-00002');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR93"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...a motoneuron-neuroblastoma hybrid cell line (VSC 4.1) was produced using techniques that had formerly yielded a substantia nigra cell line (76) and other motoneuron lines (60, 77)....</span></li></ul><div class="otherReviews" style="display: none;"></div></li><li class="fulltext b78" refid="b78" id="b78ref"><span class="toggleImg whiteToggleImg"></span><span class="position">78.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Mosier DR, Baldelli P, Delbono O, et al. 1994. Amyotrophic lateral sclerosis immunoglobulins increase Ca<sup>2+</sup> currents in a motoneuron cell line. <i>Ann. Neurol.</i> In press <script type="text/javascript">

            genSfxLinks('b78', '%26aulast%3DMosier%26aufirst%3DDR%26date%3D1994%26atitle%3DAmyotrophic%2Blateral%2Bsclerosis%2Bimmunoglobulins%2Bincrease%2BCa2%252B%2Bcurrents%2Bin%2Ba%2Bmotoneuron%2Bcell%2Bline.%26stitle%3DAnn.%2BNeurol.');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR94"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...In physiological experiments using whole cell patch-clamp of cyclic adenosine monophosphate (cAMP)-differentiated VSC 4.1 cells, sALS IgG significantly increased high-threshold VGCC currents (78)....</span></li></ul><div class="otherReviews" style="display: none;"></div></li><li class="fulltext b79" refid="b79" id="b79ref"><span class="toggleImg whiteToggleImg"></span><span class="position">79.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Colom LV, Alexianu ME, Smith RG, et al. 1994. Amyotrophic lateral sclerosis immunoglobulins increase intracellular calcium in a motoneuron cell line. <i>Soc. Neurosci. Abstr.</i> In press <script type="text/javascript">

            genSfxLinks('b79', '%26aulast%3DColom%26aufirst%3DLV%26date%3D1994%26atitle%3DAmyotrophic%2Blateral%2Bsclerosis%2Bimmunoglobulins%2Bincrease%2Bintracellular%2Bcalcium%2Bin%2Ba%2Bmotoneuron%2Bcell%2Bline.%26stitle%3DSoc.%2BNeurosci.%2BAbstr.');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR95"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...sALS IgG-mediated Ca2+ entry into VSC 4.1 cells was found to follow two patterns (79)....</span></li><li ref-id="XR105"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...This cytotoxicity may be triggered by transient rather than sustained Ca2+ entry (79,...</span></li></ul><div class="otherReviews" style="display: none;"></div></li><li class="fulltext b80" refid="b80" id="b80ref"><span class="toggleImg whiteToggleImg"></span><span class="position">80.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Smith RG, Alexianu M, Crawford G, et al. 1994. Cytotoxicity of immunoglobulins from amyotrophic lateral sclerosis. <i>Proc. Natl. Acad. Sci. USA</i> 91:3393&ndash;97 <script type="text/javascript">

				genRefLink(16, 'b80', '10.1073%2Fpnas.91.8.3393');
			</script> <script type="text/javascript">

				genRefLink(8, 'b80', '8159758');
			</script> <script type="text/javascript">

				genRefLink(128, 'b80', 'A1994NF96800110');
			</script> <script type="text/javascript">

            genSfxLinks('b80', '%26aulast%3DSmith%26aufirst%3DRG%26date%3D1994%26atitle%3DCytotoxicity%2Bof%2Bimmunoglobulins%2Bfrom%2Bamyotrophic%2Blateral%2Bsclerosis.%26stitle%3DProc.%2BNatl.%2BAcad.%2BSci.%2BUSA%26volume%3D91%26spage%3D3393%26id%3Ddoi%3A10.1073%252Fpnas.91.8.3393');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR96"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...significant cell loss was observed after two to three days (80)....</span></li></ul><div class="otherReviews" style="display: none;"></div></li><li class="fulltext b81" refid="b81" id="b81ref"><span class="toggleImg whiteToggleImg"></span><span class="position">81.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Alexiann ME, Mohamed AH, Smith RG, et al. 1994. Apoptotic cell death of a hybrid motoneuron cell line induced by immunoglobulins from patients with amyotrophic lateral sclerosis. <i>J. Neurochem.</i> In press <script type="text/javascript">

            genSfxLinks('b81', '%26aulast%3DAlexiann%26aufirst%3DME%26date%3D1994%26atitle%3DApoptotic%2Bcell%2Bdeath%2Bof%2Ba%2Bhybrid%2Bmotoneuron%2Bcell%2Bline%2Binduced%2Bby%2Bimmunoglobulins%2Bfrom%2Bpatients%2Bwith%2Bamyotrophic%2Blateral%2Bsclerosis.%26stitle%3DJ.%2BNeurochem.');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR97"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...Cell blebbing and fragmentation began shortly thereafter (81). sALS IgG-induced apoptosis can be prevented by previous incubation with the endonuclease inhibitor aurintricarboxylate or with the protein synthesis inhibitor cycloheximide,...</span></li></ul><div class="otherReviews" style="display: none;"></div></li><li class="fulltext b82" refid="b82" id="b82ref"><span class="toggleImg whiteToggleImg"></span><span class="position">82.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Graham LTJr ,  Shank RP, Werman R, et al. 1967. Distribution of some synaptic transmitter suspects in cat spinal cord: glutamic acid, aspartic acid, gamma-aminobutyric acid, glycine, and glutamine. <i>J. Neurochem.</i> 14:465&ndash;72 <script type="text/javascript">

				genRefLink(16, 'b82', '10.1111%2Fj.1471-4159.1967.tb09545.x');
			</script> <script type="text/javascript">

				genRefLink(8, 'b82', '6022905');
			</script> <script type="text/javascript">

				genRefLink(128, 'b82', 'A19679129900011');
			</script> <script type="text/javascript">

            genSfxLinks('b82', '%26aulast%3DGraham%26aufirst%3DLT%26date%3D1967%26atitle%3DDistribution%2Bof%2Bsome%2Bsynaptic%2Btransmitter%2Bsuspects%2Bin%2Bcat%2Bspinal%2Bcord%253A%2Bglutamic%2Bacid%252C%2Baspartic%2Bacid%252C%2Bgamma-aminobutyric%2Bacid%252C%2Bglycine%252C%2Band%2Bglutamine.%26stitle%3DJ.%2BNeurochem.%26volume%3D14%26spage%3D465%26id%3Ddoi%3A10.1111%252Fj.1471-4159.1967.tb09545.x');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR98"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...Ca2+ entry into presynaptic terminals of glutamatergic neurons contacting motoneurons (82,...</span></li></ul><div class="otherReviews" style="display: none;"></div></li><li class="fulltext b83" refid="b83" id="b83ref"><span class="toggleImg whiteToggleImg"></span><span class="position">83.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Shaw PJ, Ince PG, Johnson M, et al. 1991. The quantitative autographic distribution of [<sup>3</sup>H]MK-801 binding sites in the normal human spinal cord. <i>Brain Res.</i> 539:164&ndash;68 <script type="text/javascript">

				genRefLink(16, 'b83', '10.1016%2F0006-8993%2891%2990701-V');
			</script> <script type="text/javascript">

				genRefLink(8, 'b83', '1826627');
			</script> <script type="text/javascript">

				genRefLink(128, 'b83', 'A1991EU30000023');
			</script> <script type="text/javascript">

            genSfxLinks('b83', '%26aulast%3DShaw%26aufirst%3DPJ%26date%3D1991%26atitle%3DThe%2Bquantitative%2Bautographic%2Bdistribution%2Bof%2B%255B3H%255DMK-801%2Bbinding%2Bsites%2Bin%2Bthe%2Bnormal%2Bhuman%2Bspinal%2Bcord.%26stitle%3DBrain%2BRes.%26volume%3D539%26spage%3D164%26id%3Ddoi%3A10.1016%252F0006-8993%252891%252990701-V');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR99"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...Ca2+ entry into presynaptic terminals of glutamatergic neurons contacting motoneurons (82, 83) might also be induced by sALS IgG....</span></li></ul><div class="otherReviews" style="display: none;"></div></li><li class="fulltext b84" refid="b84" id="b84ref"><span class="toggleImg whiteToggleImg"></span><span class="position">84.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Legendre P, Rosenmund C, Westbrook GL. 1993. Inactivation of NMDA channels in cultured hippocampal neurons by intracellular calcium. <i>J. Neurosci.</i> 13:674&ndash;84 <script type="text/javascript">

				genRefLink(8, 'b84', '7678859');
			</script> <script type="text/javascript">

				genRefLink(128, 'b84', 'A1993KL12300023');
			</script> <script type="text/javascript">

            genSfxLinks('b84', '%26aulast%3DLegendre%26aufirst%3DP%26date%3D1993%26atitle%3DInactivation%2Bof%2BNMDA%2Bchannels%2Bin%2Bcultured%2Bhippocampal%2Bneurons%2Bby%2Bintracellular%2Bcalcium.%26stitle%3DJ.%2BNeurosci.%26volume%3D13%26spage%3D674');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR100"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...VGCC activation has been implicated in the regulation of excitotoxic ligand-gated ion channel function (84),...</span></li></ul><div class="otherReviews" style="display: none;"></div></li><li class="fulltext b85" refid="b85" id="b85ref"><span class="toggleImg whiteToggleImg"></span><span class="position">85.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Valentino K, Newcomb R, Gadborg T, et al. 1993. A selective N-type calcium channel antagonist protects against neuronal loss after global cerebral ischemia. <i>Proc. Natl. Acad. Sci. USA</i> 90:7894&ndash;97 <script type="text/javascript">

				genRefLink(16, 'b85', '10.1073%2Fpnas.90.16.7894');
			</script> <script type="text/javascript">

				genRefLink(8, 'b85', '8102803');
			</script> <script type="text/javascript">

				genRefLink(128, 'b85', 'A1993LT43700098');
			</script> <script type="text/javascript">

            genSfxLinks('b85', '%26aulast%3DValentino%26aufirst%3DK%26date%3D1993%26atitle%3DA%2Bselective%2BN-type%2Bcalcium%2Bchannel%2Bantagonist%2Bprotects%2Bagainst%2Bneuronal%2Bloss%2Bafter%2Bglobal%2Bcerebral%2Bischemia.%26stitle%3DProc.%2BNatl.%2BAcad.%2BSci.%2BUSA%26volume%3D90%26spage%3D7894%26id%3Ddoi%3A10.1073%252Fpnas.90.16.7894');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR101"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...VGCC activation has been implicated in the regulation of excitotoxic ligand-gated ion channel function (84), in intracellular Ca2+ homeostasis, and in neuronal survival (85,...</span></li></ul><div class="otherReviews" style="display: none;"></div></li><li class="fulltext b86" refid="b86" id="b86ref"><span class="toggleImg whiteToggleImg"></span><span class="position">86.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Larmet Y, Dolphin AC, Davies AM. 1992. Intracellular calcium regulates the survival of early sensory neurons before they become dependent on neurotrophic factors. <i>Neuron</i> 9:563&ndash;74 <script type="text/javascript">

				genRefLink(16, 'b86', '10.1016%2F0896-6273%2892%2990193-H');
			</script> <script type="text/javascript">

				genRefLink(8, 'b86', '1524830');
			</script> <script type="text/javascript">

				genRefLink(128, 'b86', 'A1992JM57100017');
			</script> <script type="text/javascript">

            genSfxLinks('b86', '%26aulast%3DLarmet%26aufirst%3DY%26date%3D1992%26atitle%3DIntracellular%2Bcalcium%2Bregulates%2Bthe%2Bsurvival%2Bof%2Bearly%2Bsensory%2Bneurons%2Bbefore%2Bthey%2Bbecome%2Bdependent%2Bon%2Bneurotrophic%2Bfactors.%26stitle%3DNeuron%26volume%3D9%26spage%3D563%26id%3Ddoi%3A10.1016%252F0896-6273%252892%252990193-H');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR102"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...VGCC activation has been implicated in the regulation of excitotoxic ligand-gated ion channel function (84), in intracellular Ca2+ homeostasis, and in neuronal survival (85, 86,...</span></li></ul><div class="otherReviews" style="display: none;"></div></li><li class="fulltext b87" refid="b87" id="b87ref"><span class="toggleImg whiteToggleImg"></span><span class="position">87.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Koh J-Y, Cotman CW. 1992. Programmed cell death: its possible contribution to neurotoxicity mediated by calcium channel antagonists. <i>Brain Res.</i> 587:233&ndash;40 <script type="text/javascript">

				genRefLink(16, 'b87', '10.1016%2F0006-8993%2892%2991002-V');
			</script> <script type="text/javascript">

				genRefLink(8, 'b87', '1525659');
			</script> <script type="text/javascript">

				genRefLink(128, 'b87', 'A1992JK43500008');
			</script> <script type="text/javascript">

            genSfxLinks('b87', '%26aulast%3DKoh%26aufirst%3DJ-Y%26date%3D1992%26atitle%3DProgrammed%2Bcell%2Bdeath%253A%2Bits%2Bpossible%2Bcontribution%2Bto%2Bneurotoxicity%2Bmediated%2Bby%2Bcalcium%2Bchannel%2Bantagonists.%26stitle%3DBrain%2BRes.%26volume%3D587%26spage%3D233%26id%3Ddoi%3A10.1016%252F0006-8993%252892%252991002-V');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR103"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...VGCC activation has been implicated in the regulation of excitotoxic ligand-gated ion channel function (84), in intracellular Ca2+ homeostasis, and in neuronal survival (85, 86, 87,...</span></li></ul><div class="otherReviews" style="display: none;"></div></li><li class="fulltext b88" refid="b88" id="b88ref"><span class="toggleImg orangeToggleImg"></span><span class="position">88.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Franklin JL, Johnson EMJr . 1992. Suppression of programmed cell death by sustained elevation of cytoplasmic calcium. <i>Trends Neurosci.</i> 15:501&ndash;8 <script type="text/javascript">

				genRefLink(16, 'b88', '10.1016%2F0166-2236%2892%2990103-F');
			</script> <script type="text/javascript">

				genRefLink(8, 'b88', '1282751');
			</script> <script type="text/javascript">

				genRefLink(128, 'b88', 'A1992JZ37000013');
			</script> <script type="text/javascript">

            genSfxLinks('b88', '%26aulast%3DFranklin%26aufirst%3DJL%26date%3D1992%26atitle%3DSuppression%2Bof%2Bprogrammed%2Bcell%2Bdeath%2Bby%2Bsustained%2Belevation%2Bof%2Bcytoplasmic%2Bcalcium.%26stitle%3DTrends%2BNeurosci.%26volume%3D15%26spage%3D501%26id%3Ddoi%3A10.1016%252F0166-2236%252892%252990103-F');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR104"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...VGCC activation has been implicated in the regulation of excitotoxic ligand-gated ion channel function (84), in intracellular Ca2+ homeostasis, and in neuronal survival (85, 86, 87, 88)....</span></li></ul><div class="otherReviews" style="display: none;"><p class="otherReviewsHeader">

                    Other reviews that cite this reference:
                </p><ul class="otherReviewsList"><li class="otherReviewEntry"><div class="otherReviewsTitle"><h2><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/abs/10.1146/annurev.pharmtox.42.083101.143836" target="_top">CELLULAR MECHANISMS FOR THE REPRESSION OF APOPTOSIS*</a></h2></div><div class="otherReviewsAuthor">Carl D. Bortner, John A. Cidlowski</div><div class="otherReviewsInfo">Annual Review of Pharmacology and Toxicology 
                    Vol. 42:
                    259
                        -
                        281</div><div class="otherReviewSnipp"><ul><li ref-id="XR198"><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/full/10.1146/annurev.pharmtox.42.083101.143836#XR198"> ...<ref-snippet xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-id="XR198">Further support of a role for potassium in apoptotic regulation comes from studies that demonstrate that depolarizing concentrations of extracellular potassium in the culture medium promote the survival of primary neurons in vitro in the absence of specific neurotrophic factors (154).</ref-snippet>... </a></li></ul></div></li><li class="otherReviewEntry"><div class="otherReviewsTitle"><h2><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/abs/10.1146/annurev.biochem.68.1.821" target="_top">CREB: A Stimulus-Induced Transcription Factor Activated by A Diverse Array of Extracellular Signals</a></h2></div><div class="otherReviewsAuthor">Adam J. Shaywitz, Michael E. Greenberg</div><div class="otherReviewsInfo">Annual Review of Biochemistry 
                    Vol. 68:
                    821
                        -
                        861</div><div class="otherReviewSnipp"><ul><li ref-id="XR305"><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/full/10.1146/annurev.biochem.68.1.821#XR305"> ...<ref-snippet xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-id="XR305">raising the possibility that CREB is involved in this process (191, 199, 200).</ref-snippet>... </a></li></ul></div></li><li class="otherReviewEntry"></li></ul></div></li><li class="fulltext b89" refid="b89" id="b89ref"><span class="toggleImg whiteToggleImg"></span><span class="position">89.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Dubinsky JM. 1993. Intracellular calcium levels during the period of delayed excitotoxicity. <i>J. Neurosci.</i> 13:623&ndash;31 <script type="text/javascript">

				genRefLink(8, 'b89', '8093901');
			</script> <script type="text/javascript">

				genRefLink(128, 'b89', 'A1993KL12300019');
			</script> <script type="text/javascript">

            genSfxLinks('b89', '%26aulast%3DDubinsky%26aufirst%3DJM%26date%3D1993%26atitle%3DIntracellular%2Bcalcium%2Blevels%2Bduring%2Bthe%2Bperiod%2Bof%2Bdelayed%2Bexcitotoxicity.%26stitle%3DJ.%2BNeurosci.%26volume%3D13%26spage%3D623');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR106"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...This cytotoxicity may be triggered by transient rather than sustained Ca2+ entry (79, 89),...</span></li></ul><div class="otherReviews" style="display: none;"></div></li><li class="fulltext b90" refid="b90" id="b90ref"><span class="toggleImg whiteToggleImg"></span><span class="position">90.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Duchen MR. 1992. Ca<sup>2+</sup>-dependent changes in the mitochondrial energetics in single dissociated mouse sensory neurons. <i>Biochem. J.</i> 283:41&ndash;50 <script type="text/javascript">

				genRefLink(8, 'b90', '1373604');
			</script> <script type="text/javascript">

				genRefLink(128, 'b90', 'A1992HN03400008');
			</script> <script type="text/javascript">

            genSfxLinks('b90', '%26aulast%3DDuchen%26aufirst%3DMR%26date%3D1992%26atitle%3DCa2%252B-dependent%2Bchanges%2Bin%2Bthe%2Bmitochondrial%2Benergetics%2Bin%2Bsingle%2Bdissociated%2Bmouse%2Bsensory%2Bneurons.%26stitle%3DBiochem.%2BJ.%26volume%3D283%26spage%3D41');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR107"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...VGCC activation and increased intracellular Ca2+ have been shown to increase mitochondrial activity (90)...</span></li></ul><div class="otherReviews" style="display: none;"></div></li><li class="fulltext b91" refid="b91" id="b91ref"><span class="toggleImg whiteToggleImg"></span><span class="position">91.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Roveri A, Coassin M, Maiorino M, et al. 1992. Effect of hydrogen peroxide on calcium homeostasis in smooth muscle cells. <i>Arch. Biochem. Biophys.</i> 297:265&ndash;70 <script type="text/javascript">

				genRefLink(16, 'b91', '10.1016%2F0003-9861%2892%2990671-I');
			</script> <script type="text/javascript">

				genRefLink(8, 'b91', '1497346');
			</script> <script type="text/javascript">

				genRefLink(128, 'b91', 'A1992JH36600011');
			</script> <script type="text/javascript">

            genSfxLinks('b91', '%26aulast%3DRoveri%26aufirst%3DA%26date%3D1992%26atitle%3DEffect%2Bof%2Bhydrogen%2Bperoxide%2Bon%2Bcalcium%2Bhomeostasis%2Bin%2Bsmooth%2Bmuscle%2Bcells.%26stitle%3DArch.%2BBiochem.%2BBiophys.%26volume%3D297%26spage%3D265%26id%3Ddoi%3A10.1016%252F0003-9861%252892%252990671-I');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR108"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...VGCC activation and increased intracellular Ca2+ have been shown to increase mitochondrial activity (90) and oxidative injury (91,...</span></li></ul><div class="otherReviews" style="display: none;"></div></li><li class="fulltext b92" refid="b92" id="b92ref"><span class="toggleImg whiteToggleImg"></span><span class="position">92.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Nicotera P, Bellamo G, Orrenius S. 1990. The role of Ca<sup>2+</sup> in cell killing. <i>Chem. Res. Toxicol.</i> 3:484&ndash;94 <script type="text/javascript">

				genRefLink(16, 'b92', '10.1021%2Ftx00018a001');
			</script> <script type="text/javascript">

				genRefLink(8, 'b92', '2103319');
			</script> <script type="text/javascript">

				genRefLink(128, 'b92', 'A1990EK64000002');
			</script> <script type="text/javascript">

            genSfxLinks('b92', '%26aulast%3DNicotera%26aufirst%3DP%26date%3D1990%26atitle%3DThe%2Brole%2Bof%2BCa2%252B%2Bin%2Bcell%2Bkilling.%26stitle%3DChem.%2BRes.%2BToxicol.%26volume%3D3%26spage%3D484%26id%3Ddoi%3A10.1021%252Ftx00018a001');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR109"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...VGCC activation and increased intracellular Ca2+ have been shown to increase mitochondrial activity (90) and oxidative injury (91, 92),...</span></li></ul><div class="otherReviews" style="display: none;"></div></li><li class="fulltext b93" refid="b93" id="b93ref"><span class="toggleImg whiteToggleImg"></span><span class="position">93.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Cantoni O, Sestili P, Cattabeni F, et al. 1989. Calcium chelator Quin-2 prevents hydrogen peroxide-induced DNA breakage and cytotoxicity. <i>Eur. J. Biochem.</i> 182:209&ndash;12 <script type="text/javascript">

				genRefLink(16, 'b93', '10.1111%2Fj.1432-1033.1989.tb14819.x');
			</script> <script type="text/javascript">

				genRefLink(8, 'b93', '2544421');
			</script> <script type="text/javascript">

				genRefLink(128, 'b93', 'A1989AD92100001');
			</script> <script type="text/javascript">

            genSfxLinks('b93', '%26aulast%3DCantoni%26aufirst%3DO%26date%3D1989%26atitle%3DCalcium%2Bchelator%2BQuin-2%2Bprevents%2Bhydrogen%2Bperoxide-induced%2BDNA%2Bbreakage%2Band%2Bcytotoxicity.%26stitle%3DEur.%2BJ.%2BBiochem.%26volume%3D182%26spage%3D209%26id%3Ddoi%3A10.1111%252Fj.1432-1033.1989.tb14819.x');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR110"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...and Ca2+ chelators can prevent H2O2&minus;-induced DNA breakdown and cytotoxicity (93)....</span></li></ul><div class="otherReviews" style="display: none;"></div></li><li class="fulltext b94" refid="b94" id="b94ref"><span class="toggleImg whiteToggleImg"></span><span class="position">94.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Ratan RR, Murphy TH, Baraban JM. 1994. Oxidative stress induces apoptosis in embryonic cortical neurons. <i>J. Neurochem.</i> 62:376&ndash;79 <script type="text/javascript">

				genRefLink(16, 'b94', '10.1046%2Fj.1471-4159.1994.62010376.x');
			</script> <script type="text/javascript">

				genRefLink(8, 'b94', '7903353');
			</script> <script type="text/javascript">

				genRefLink(128, 'b94', 'A1994MM53600047');
			</script> <script type="text/javascript">

            genSfxLinks('b94', '%26aulast%3DRatan%26aufirst%3DRR%26date%3D1994%26atitle%3DOxidative%2Bstress%2Binduces%2Bapoptosis%2Bin%2Bembryonic%2Bcortical%2Bneurons.%26stitle%3DJ.%2BNeurochem.%26volume%3D62%26spage%3D376%26id%3Ddoi%3A10.1046%252Fj.1471-4159.1994.62010376.x');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR111"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...Because oxidative stress may also increase release of Ca2+ from intracellular stores, activate endonucleases, and induce DNA fragmentation (94),...</span></li></ul><div class="otherReviews" style="display: none;"></div></li><li class="fulltext b95" refid="b95" id="b95ref"><span class="toggleImg orangeToggleImg"></span><span class="position">95.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Zhang J, Dawson VL, Dawson TM, et al. 1994. Nitric oxide activity of poly(ADP-Ribose) synthetase in neurotoxicity. <i>Science</i> 1263:687&ndash;89 <script type="text/javascript">

				genRefLink(16, 'b95', '10.1126%2Fscience.8080500');
			</script> <script type="text/javascript">

				genRefLink(8, 'b95', '8080500');
			</script> <script type="text/javascript">

            genSfxLinks('b95', '%26aulast%3DZhang%26aufirst%3DJ%26date%3D1994%26atitle%3DNitric%2Boxide%2Bactivity%2Bof%2Bpoly%2528ADP-Ribose%2529%2Bsynthetase%2Bin%2Bneurotoxicity.%26stitle%3DScience%26volume%3D1263%26spage%3D687%26id%3Ddoi%3A10.1126%252Fscience.8080500');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR112"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...endonuclease activation is not a final step in this process because stimulation of poly[adenosine diphosphate (ADP)-ribose] synthetase after radical- or endonuclease-induced DNA strand breakage can cause nuclear protein polyribosylation and cell death by depletion of &beta;-nicotinamide adenine dinucleotide and adenosine triphosphate (ATP) (95)....</span></li></ul><div class="otherReviews" style="display: none;"><p class="otherReviewsHeader">

                    Other reviews that cite this reference:
                </p><ul class="otherReviewsList"><li class="otherReviewEntry"><div class="otherReviewsTitle"><h2><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/abs/10.1146/annurev.pharmtox.47.120505.105311" target="_top">Cell Signaling and Neuronal Death</a></h2></div><div class="otherReviewsAuthor">Makoto R. Hara, Solomon H. Snyder</div><div class="otherReviewsInfo">Annual Review of Pharmacology and Toxicology 
                    Vol. 47:
                    117
                        -
                        141</div><div class="otherReviewSnipp"><ul><li ref-id="XR83"><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/full/10.1146/annurev.pharmtox.47.120505.105311#XR83"> ...<ref-snippet xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-id="XR83">Neurotoxicity in brain cultures is markedly diminished by treatment with PARP inhibitors (109),</ref-snippet>... </a></li></ul></div></li><li class="otherReviewEntry"><div class="otherReviewsTitle"><h2><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/abs/10.1146/annurev.med.47.1.219" target="_top">NITRIC OXIDE SYNTHASE: Role as a Transmitter/Mediator in the Brain and Endocrine System</a></h2></div><div class="otherReviewsAuthor">Ted M. Dawson, M.D., Ph.D, Valina L. Dawson, Ph.D</div><div class="otherReviewsInfo">Annual Review of Medicine 
                    Vol. 47:
                    219
                        -
                        227</div><div class="otherReviewSnipp"><ul><li ref-id="XR56"><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/full/10.1146/annurev.med.47.1.219#XR56"> ...<ref-snippet xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-id="XR56">recent studies indicate that neurotoxicity may occur through DNA damage and the subsequent activation of the nuclear enzyme PARS (36).</ref-snippet>... </a></li><li ref-id="XR58"><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/full/10.1146/annurev.med.47.1.219#XR58"> ...<ref-snippet xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-id="XR58">Consistent with this possibility is that cortical cultures are protected from glutamate and NO neurotoxicity by a series of PARS inhibitors (36).</ref-snippet>... </a></li></ul></div></li><li class="otherReviewEntry"></li></ul></div></li><li class="fulltext b96" refid="b96" id="b96ref"><span class="toggleImg orangeToggleImg"></span><span class="position">96.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Ince P, Stout N, Shaw P, et al. 1993. Parvalbumin and calbindin D-28k in the human motor system and in motor neuron disease. <i>Neuropathol. Appl. Neurobiol.</i> 19:291&ndash;99 <script type="text/javascript">

				genRefLink(16, 'b96', '10.1111%2Fj.1365-2990.1993.tb00443.x');
			</script> <script type="text/javascript">

				genRefLink(8, 'b96', '8232749');
			</script> <script type="text/javascript">

				genRefLink(128, 'b96', 'A1993LR11600001');
			</script> <script type="text/javascript">

            genSfxLinks('b96', '%26aulast%3DInce%26aufirst%3DP%26date%3D1993%26atitle%3DParvalbumin%2Band%2Bcalbindin%2BD-28k%2Bin%2Bthe%2Bhuman%2Bmotor%2Bsystem%2Band%2Bin%2Bmotor%2Bneuron%2Bdisease.%26stitle%3DNeuropathol.%2BAppl.%2BNeurobiol.%26volume%3D19%26spage%3D291%26id%3Ddoi%3A10.1111%252Fj.1365-2990.1993.tb00443.x');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR113"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...Onuf's nucleus motoneurons and oculomotor, trochlear, and abducens nerve neurons) (96,...</span></li></ul><div class="otherReviews" style="display: none;"><p class="otherReviewsHeader">

                    Other reviews that cite this reference:
                </p><ul class="otherReviewsList"><li class="otherReviewEntry"><div class="otherReviewsTitle"><h2><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/abs/10.1146/annurev.neuro.27.070203.144244" target="_top">UNRAVELING THE MECHANISMS INVOLVED IN MOTOR NEURON DEGENERATION IN ALS</a></h2></div><div class="otherReviewsAuthor">Lucie I. Bruijn, Timothy M. Miller, Don W. Cleveland</div><div class="otherReviewsInfo">Annual Review of Neuroscience 
                    Vol. 27:
                    723
                        -
                        749</div><div class="otherReviewSnipp"><ul><li ref-id="XR120"><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/full/10.1146/annurev.neuro.27.070203.144244#XR120"> ...<ref-snippet xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-id="XR120">the spinal motor neurons at risk are relatively reduced in intracellular calcium-binding components such as calbindin D28k and parvalbumin (Alexianu et al. 1994, Ince et al. 1993),</ref-snippet>... </a></li></ul></div></li><li class="otherReviewEntry"></li></ul></div></li><li class="fulltext b97" refid="b97" id="b97ref"><span class="toggleImg whiteToggleImg"></span><span class="position">97.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Alexianu ME, Smith RG, Appel SH. 1994. Calcium binding proteins and selective vulnerability in ALS. <i>Neurology</i> 44(Suppl. 2):A343(Abstr.)  <script type="text/javascript">

            genSfxLinks('b97', '%26aulast%3DAlexianu%26aufirst%3DME%26date%3D1994%26atitle%3DCalcium%2Bbinding%2Bproteins%2Band%2Bselective%2Bvulnerability%2Bin%2BALS.%26stitle%3DNeurology%26volume%3D44%28Suppl.+2%29%26spage%3DA343');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR114"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...Onuf's nucleus motoneurons and oculomotor, trochlear, and abducens nerve neurons) (96, 97)....</span></li><li ref-id="XR115"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...This finding is consistent with the presence of much higher immunoreactive calbindin and parvalbumin levels in undifferentiated VSC 4.1 cells (97)....</span></li></ul><div class="otherReviews" style="display: none;"></div></li><li class="fulltext b98" refid="b98" id="b98ref"><span class="toggleImg whiteToggleImg"></span><span class="position">98.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Juntti-Berggren L, Larsson O, Rorsman P, et al. 1993. Increased activity of L-type Ca<sup>2+</sup> channels exposed to serum from patients with type I diabetes. <i>Science</i> 261:86&ndash;90 <script type="text/javascript">

				genRefLink(16, 'b98', '10.1126%2Fscience.7686306');
			</script> <script type="text/javascript">

				genRefLink(8, 'b98', '7686306');
			</script> <script type="text/javascript">

            genSfxLinks('b98', '%26aulast%3DJuntti-Berggren%26aufirst%3DL%26date%3D1993%26atitle%3DIncreased%2Bactivity%2Bof%2BL-type%2BCa2%252B%2Bchannels%2Bexposed%2Bto%2Bserum%2Bfrom%2Bpatients%2Bwith%2Btype%2BI%2Bdiabetes.%26stitle%3DScience%26volume%3D261%26spage%3D86%26id%3Ddoi%3A10.1126%252Fscience.7686306');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR116"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...may result from pancreatic islet cell destruction initiated by antibody-mediated increased Ca2+ entry through L-type VGCCs (98)....</span></li></ul><div class="otherReviews" style="display: none;"></div></li><li class="fulltext b99" refid="b99" id="b99ref"><span class="toggleImg whiteToggleImg"></span><span class="position">99.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Bensimon G, Lacomblez L, Meininger V, et al. 1994. A controlled trial of riluzole in amyotrophic lateral sclerosis. <i>New Engl. J. Med.</i> 330:585&ndash;91 <script type="text/javascript">

				genRefLink(16, 'b99', '10.1056%2FNEJM199403033300901');
			</script> <script type="text/javascript">

				genRefLink(8, 'b99', '8302340');
			</script> <script type="text/javascript">

				genRefLink(128, 'b99', 'A1994MY57300001');
			</script> <script type="text/javascript">

            genSfxLinks('b99', '%26aulast%3DBensimon%26aufirst%3DG%26date%3D1994%26atitle%3DA%2Bcontrolled%2Btrial%2Bof%2Briluzole%2Bin%2Bamyotrophic%2Blateral%2Bsclerosis.%26stitle%3DNew%2BEngl.%2BJ.%2BMed.%26volume%3D330%26spage%3D585%26id%3Ddoi%3A10.1056%252FNEJM199403033300901');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR117"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...therapies designed to reduce excitotoxic cell injury are often associated with significant side effects, although medicines such as riluzole (99) are currently being tested....</span></li></ul><div class="otherReviews" style="display: none;"></div></li><li class="fulltext b100" refid="b100" id="b100ref"><span class="toggleImg whiteToggleImg"></span><span class="position">100.<img src="2002.gif" alt="" class="entityA" align="bottom"></span><div class="citation">Appel SH, Appel LV. 1994. <i>Treatment of amyotrophic lateral sclerosis.</i> In <i>Neurodegenerative Diseases</i>, ed. DB Calne, pp. 523&ndash;42. New York: Saunders <script type="text/javascript">

            genSfxLinks('b100', '%26aulast%3DAppel%26aufirst%3DSH%26date%3D1994%26spage%3D523');
        </script></div><ul class="refSnip" style="display: none;"><li ref-id="XR118"><span class="arrowImage"><img src="round-gray-left.png"></span><span class="textSnippet">...until definitive remedies and gene therapies are available, helping ALS patients remains a considerable challenge for clinicians (100)....</span></li></ul><div class="otherReviews" style="display: none;"></div></li></ul></div><div id="reviewsTab"><div id="srcNode" class="yui3-accordion"><div id="item1" class="yui3-accordion-item" data-contentheight="stretch" data-expanded="true"><div class="yui3-widget-hd"><a class="yui3-accordion-item-label" href="javascript:void(0)">USERS ALSO READ</a></div><div id="bodyid1" class="yui3-widget-bd"><div id="pm1" style="position: relative; overflow: auto; height: 100%;"><div class="relatedEntry"><div class="art_title"><h2><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/abs/10.1146/annurev.neuro.27.070203.144244" target="_top">UNRAVELING THE MECHANISMS INVOLVED IN MOTOR NEURON DEGENERATION IN ALS</a></h2></div><span class="art_authors">Lucie I. Bruijn</span>, <span class="art_authors">Timothy M. Miller</span>, <span class="art_source"> and </span><span class="art_authors">Don W. Cleveland</span><div class="art_meta">Annual Review of Neuroscience <em>

                   Vol. 27</em> <strong>(2004)</strong>:
            723-749</div><a class="articleLink" href="http://www.annualreviews.org.proxy.library.emory.edu/doi/abs/10.1146/annurev.neuro.27.070203.144244">Abstract</a>
				| <a class="ref nowrap" href="http://www.annualreviews.org.proxy.library.emory.edu/doi/full/10.1146/annurev.neuro.27.070203.144244">Full Text</a>
			| <a class="articleLink" href="http://www.annualreviews.org.proxy.library.emory.edu/doi/pdf/10.1146/annurev.neuro.27.070203.144244" target="_top" onclick="newWindow(this.href);return false" title="PDF, opens new window">PDF (1955 KB)</a>
				| <a class="ref nowrap" href="http://www.annualreviews.org.proxy.library.emory.edu/doi/suppl/10.1146/annurev.neuro.27.070203.144244">Supplemental Materials</a>&nbsp;</div><div class="relatedEntry"><div class="art_title"><h2><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/abs/10.1146/annurev.med.46.1.381" target="_top">CLASSIFICATION OF EPSTEIN-BARR VIRUS-ASSOCIATED POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASES: Implications for Understanding their Pathogenesis and Developing Rational Treatment Strategies</a></h2></div><span class="art_authors">Douglas W. Hanto, M.D., Ph.D.</span><div class="art_meta">Annual Review of Medicine <em>

                   Vol. 46</em> <strong>(1995)</strong>:
            381-394</div><a class="articleLink" href="http://www.annualreviews.org.proxy.library.emory.edu/doi/abs/10.1146/annurev.med.46.1.381">Abstract</a>
				| <a class="ref nowrap" href="http://www.annualreviews.org.proxy.library.emory.edu/doi/full/10.1146/annurev.med.46.1.381">Full Text</a>
			| <a class="articleLink" href="http://www.annualreviews.org.proxy.library.emory.edu/doi/pdf/10.1146/annurev.med.46.1.381" target="_top" onclick="newWindow(this.href);return false" title="PDF, opens new window">PDF (117 KB)</a>&nbsp;</div><div class="relatedEntry"><div class="art_title"><h2><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/abs/10.1146/annurev.med.46.1.361" target="_top">THE CURRENT MANAGEMENT OF CARCINOMA OF THE HEAD OF THE PANCREAS</a></h2></div><span class="art_authors">John L. Cameron</span><div class="art_meta">Annual Review of Medicine <em>

                   Vol. 46</em> <strong>(1995)</strong>:
            361-370</div><a class="articleLink" href="http://www.annualreviews.org.proxy.library.emory.edu/doi/abs/10.1146/annurev.med.46.1.361">Abstract</a>
				| <a class="ref nowrap" href="http://www.annualreviews.org.proxy.library.emory.edu/doi/full/10.1146/annurev.med.46.1.361">Full Text</a>
			| <a class="articleLink" href="http://www.annualreviews.org.proxy.library.emory.edu/doi/pdf/10.1146/annurev.med.46.1.361" target="_top" onclick="newWindow(this.href);return false" title="PDF, opens new window">PDF (66 KB)</a>&nbsp;</div><div class="relatedEntry"><div class="art_title"><h2><a href="http://www.annualreviews.org.proxy.library.emory.edu/doi/abs/10.1146/annurev.med.46.1.123" target="_top">ALCOHOL IN THE ELDERLY</a></h2></div><span class="art_authors">Mary Dufour, M.D., M.P.H. and </span><span class="art_authors">Richard K. Fuller, M.D., M.S.</span><div class="art_meta">Annual Review of Medicine <em>

                   Vol. 46</em> <strong>(1995)</strong>:
            123-132</div><a class="articleLink" href="http://www.annualreviews.org.proxy.library.emory.edu/doi/abs/10.1146/annurev.med.46.1.123">Abstract</a>
				| <a class="ref nowrap" href="http://www.annualreviews.org.proxy.library.emory.edu/doi/full/10.1146/annurev.med.46.1.123">Full Text</a>
			| <a class="articleLink" href="http://www.annualreviews.org.proxy.library.emory.edu/doi/pdf/10.1146/annurev.med.46.1.123" target="_top" onclick="newWindow(this.href);return false" title="PDF, opens new window">PDF (68 KB)</a>&nbsp;</div><!-- recommendedArticlesContent --></div></div></div><div id="item3" class="yui3-accordion-item" data-contentheight="stretch"><div class="yui3-widget-hd"><a class="yui3-accordion-item-label" href="javascript:void(0)">THIS REVIEW IS CITED BY</a></div><div id="bodyid3" class="yui3-widget-bd"><div id="pm3" style="position: relative; overflow: auto; height: 100%;"><div class="articleLinks2"><i>Web of Science</i> &reg;:
                <script type="text/javascript">

             genSideRelated('128','/servlet/linkout?suffix=s0&dbid=128&doi=10.1146%2Fannurev.med.46.1.133&url=http%253A%252F%252Flinks.isiglobalnet2.com%252Fgateway%252FGateway.cgi%253F%2526GWVersion%253D2%2526SrcAuth%253DAnnualReviews%2526SrcApp%253DAnnualReviews%2526DestLinkType%253DRelatedRecords%2526KeyAID%253D10.1146%252Fannurev.med.46.1.133%2526DestApp%253DWOS_CPL','Related Records &#174;');
        </script>| <script type="text/javascript">

             genSideRelated('128','/servlet/linkout?suffix=s0&dbid=128&doi=10.1146%2Fannurev.med.46.1.133&url=http%253A%252F%252Flinks.isiglobalnet2.com%252Fgateway%252FGateway.cgi%253F%2526GWVersion%253D2%2526SrcAuth%253DAnnualReviews%2526SrcApp%253DAnnualReviews%2526DestLinkType%253DCitingArticles%2526KeyAID%253D10.1146%252Fannurev.med.46.1.133%2526DestApp%253DWOS_CPL','Times Cited: 28');
        </script></div><div class="citedBySection"><div class="citedByEntry"><h2>Copper/zinc superoxide dismutase overexpression promotes survival of cortical neurons exposed to neurotoxins in vitro</h2><div class="artAuthors">Jacques Borg, <span class="art_source"> and </span>Jacqueline London</div><div class="art_source"><span class="NLM_source">Journal of Neuroscience Research</span> Vol. 70(2): 180-189<div class="links"><a href="http://dx.doi.org.proxy.library.emory.edu/10.1002/jnr.10404" target="_top" class="ref">[CrossRef]</a></div></div></div><div class="citedByEntry"><h2>Familial amyotrophic lateral sclerosis</h2><div class="artAuthors">Collette K. Hand, <span class="art_source"> and </span>Guy A. Rouleau</div><div class="art_source"><span class="NLM_source">Muscle & Nerve</span> Vol. 25(2): 135-159<div class="links"><a href="http://dx.doi.org.proxy.library.emory.edu/10.1002/mus.10001" target="_top" class="ref">[CrossRef]</a></div></div></div><div class="citedByEntry"><h2>A Novel Locus for Familial Amyotrophic Lateral Sclerosis, on Chromosome 18q</h2><div class="artAuthors">C HAND</div><div class="art_source"><span class="NLM_source">The American Journal of Human Genetics</span> Vol. 70(1): 251-256<div class="links"><a href="http://dx.doi.org.proxy.library.emory.edu/10.1086/337945" target="_top" class="ref">[CrossRef]</a></div></div></div><div class="citedByEntry"><h2>Disturbances in the Peripheral T-Cell Repertoire of Patients with Motor Neuron Disease: High Levels of Activation and Indirect Evidence of Superantigen</h2><div class="artAuthors">K. Katchar, L. Osorio, S. Conradi, H. Wigzell, <span class="art_source"> and </span>D. Gigliotti</div><div class="art_source"><span class="NLM_source">Scandinavian Journal of Immunology</span> Vol. 54(1-2): 220-224<div class="links"><a href="http://dx.doi.org.proxy.library.emory.edu/10.1046/j.1365-3083.2001.00923.x" target="_top" class="ref">[CrossRef]</a></div></div></div><div class="citedByEntry"><h2>Reduced glutathione in amyotrophic lateral sclerosis: an open, crossover, randomized trial</h2><div class="artAuthors">A. Chili, A. Cucatto, A. A. Terreni, <span class="art_source"> and </span>D. Schiffer</div><div class="art_source"><span class="NLM_source">The Italian Journal of Neurological Sciences</span> Vol. 19(6): 363-366<div class="links"><a href="http://dx.doi.org.proxy.library.emory.edu/10.1007/BF02341783" target="_top" class="ref">[CrossRef]</a></div></div></div><br><a class="citedByLink" href="http://www.annualreviews.org.proxy.library.emory.edu/doi/citedby/10.1146/annurev.med.46.1.133">See more...</a></div></div></div></div></div></div><div id="kwdSearchTab"><div class="kwdSearch"><div class="kwdSearch-hd"><a class="kwdSearch-label" href="javascript:void(0)">QUICK SEARCH</a></div><div class="kwdSearch-bd"><p>Search for articles by the same authors or containing the same key words. Select below.</p><div class="quickSearch_content"><form method="post" action="http://www.annualreviews.org.proxy.library.emory.edu/doi/full/10.1146/annurev.med.46.1.133?select23=Choose" onsubmit="onAuthorSearchClick(this); return false;" name="frmQuickSearch" id="frmQuickSearch"><input name="type" value="simple" type="hidden"><input name="action" value="search" type="hidden"><input name="nh" value="10" type="hidden"><input name="displaySummary" value="false" type="hidden"><input name="pageSize" value="20" type="hidden"><input name="textFieldQueryFormat" value="true" type="hidden"><div class="pageTitle search">SEARCH IN:</div><div class="entry searchSelect"><span class="black9pt"><select name="dbname" size="1"><option value="ar" selected="selected">Annual Reviews</option><script type="text/javascript">

				genSideQuickSearch('8','medline','PubMed');
			</script>  </select></span></div><!--quicksearch authors--><div class="pageTitle">BY AUTHORS:</div><div class="entry"><span class="check"><input class="input_boxes" value="Smith, R. Glenn" name="sauthcbx" type="checkbox"></span><span class="data">R. Glenn Smith, M.D., Ph.D. and </span></div><div class="entry"><span class="check"><input class="input_boxes" value="Appel, Stanley H." name="sauthcbx" type="checkbox"></span><span class="data"><input name="checkboxNum" value="2" type="HIDDEN">Stanley H. Appel, M.D.</span></div><!--/quicksearch authors--><!--quicksearch keywords--><div class="pageTitle">KEYWORDS:</div><div class="entry"><span class="check"><input class="input_boxes" value="autoimmune motoneuron injury" name="keycbx" type="checkbox"></span><span class="data">autoimmune motoneuron injury</span></div><div class="entry"><span class="check"><input class="input_boxes" value="calcium channel" name="keycbx" type="checkbox"></span><span class="data">calcium channel</span></div><div class="entry"><span class="check"><input class="input_boxes" value="excitotoxicity" name="keycbx" type="checkbox"></span><span class="data">excitotoxicity</span></div><div class="entry"><span class="check"><input class="input_boxes" value="oxidative injury" name="keycbx" type="checkbox"></span><span class="data">oxidative injury</span></div><div class="entry"><span class="check"><input class="input_boxes" value="superoxide dismutase deficiency" name="keycbx" type="checkbox"></span><span class="data">superoxide dismutase deficiency</span></div><!--/quicksearch keywords--><div><input name="result" value="true" type="hidden"><input name="type" value="simple" type="hidden"><input src="search.png" alt="Search" id="qSearchButton" border="0" type="image"></div></form></div></div></div></div>








    <script type="text/javascript">

        var dict = {};

        // use these values of dict to change way we retrieve content over https
        // the base is used to load loader-min.js (over https we'll serve it locally)
        if (document.location.protocol == "http:") {
            dict['comboBase'] = '/action/yui/combo?';
            dict['combine'] = true;
            dict['timeout'] = 10000;
            dict['base'] = '/templates/jsp/js/';
        }

        function createTab(id, isActive) {
            YUI(dict).use('node', function(Y) {
                var tabContent = Y.one('#' + id); // get element with given id

                // create div with appropriate class and append to it content of div found with id
                var className = isActive ? '' : 'ui-tabs-bd-hidden';
                var outerDiv = Y.Node.create("<div class=\"" + className + "\"></div>");
                outerDiv.appendChild(tabContent);

                // append created div in body of tabs (content of tabs)
                var matchingDiv = Y.one('.ui-tabs-bd');
                matchingDiv.append(outerDiv);

                Y.all('.ui-tabs').each(function() {
                    // listen to onClick event for children of .ui-tabs, when click call toggleTabs
                    this.delegate('click', toggleTabs, '.ui-tabs-hd a');
                });

                function toggleTabs(e) {
                    var ui_tabs = e.container,
                        tabs = ui_tabs.all('.ui-tabs-hd li'),
                        contents = ui_tabs.all('.ui-tabs-bd > div'),
                        tab = e.currentTarget.get('parentNode');

                    // adds/removes classes from tab labels and according tab content
                    // matching tab content are found with item(...).indexOf(...) method
                    contents.addClass('ui-tabs-bd-hidden')
                            .item(tabs.removeClass('ui-tabs-hd-active').indexOf(tab.addClass('ui-tabs-hd-active')))
                            .removeClass('ui-tabs-bd-hidden');

                    e.preventDefault();
                }
            });
        }
    </script>
    <div class="ui-tabs ">
        
        <ul class="ui-tabs-hd ">
            
                <li>
                    <a href="javascript:void(0);">Figures </a>
                </li>
            
                <li>
                    <a href="javascript:void(0);">References </a>
                </li>
            
                <li>
                    <a href="javascript:void(0);">Related Reviews </a>
                </li>
            
                <li>
                    <a href="javascript:void(0);">Keyword Search </a>
                </li>
            
        </ul>
        
        <div id="mainTabsContent">
            <div class="ui-tabs-bd ">
                <script type="text/javascript">

                    YUI(dict).use('node', function(Y) {
                        Y.on("domready", function() {
                            var foundActive = false; // did we already found active tab?
                            
                            var hasContent = false; // does the current tab have content?

                            

                            // if call to template sets activeTabContentId attr then don't try to find active tab
                            // use the given one, otherwise get actual content of tab if they are not empty and we
                            // haven't  found yet the active tab then set foundActive and hasContent to true
                            var tabInnerHtml = Y.one("#figuresTab").get('innerHTML');
                            // include className "emptyText" in div holding a small text indicating that this tab
                            // doesn't include content, so tab has real content if its innerHTML is not empty
                            // and doesn't include this string
                            var isNotEmptyContent = tabInnerHtml != '' && tabInnerHtml.indexOf("emptyText") < 0;
                            if(!false &&  isNotEmptyContent && !foundActive) {
                                foundActive = true;
                                hasContent = true;
                            }
                            var isActive = false || hasContent;
                            // if this is the active tab then set active class name to tab's label element
                            if(isActive) {
                                Y.all('.ui-tabs-hd > li').item(0).addClass('ui-tabs-hd-active');
                            }
                            // call function to build content of tab
                            createTab("figuresTab", isActive);
                            
                            var hasContent = false; // does the current tab have content?

                            

                            // if call to template sets activeTabContentId attr then don't try to find active tab
                            // use the given one, otherwise get actual content of tab if they are not empty and we
                            // haven't  found yet the active tab then set foundActive and hasContent to true
                            var tabInnerHtml = Y.one("#referencesTab").get('innerHTML');
                            // include className "emptyText" in div holding a small text indicating that this tab
                            // doesn't include content, so tab has real content if its innerHTML is not empty
                            // and doesn't include this string
                            var isNotEmptyContent = tabInnerHtml != '' && tabInnerHtml.indexOf("emptyText") < 0;
                            if(!false &&  isNotEmptyContent && !foundActive) {
                                foundActive = true;
                                hasContent = true;
                            }
                            var isActive = false || hasContent;
                            // if this is the active tab then set active class name to tab's label element
                            if(isActive) {
                                Y.all('.ui-tabs-hd > li').item(1).addClass('ui-tabs-hd-active');
                            }
                            // call function to build content of tab
                            createTab("referencesTab", isActive);
                            
                            var hasContent = false; // does the current tab have content?

                            

                            // if call to template sets activeTabContentId attr then don't try to find active tab
                            // use the given one, otherwise get actual content of tab if they are not empty and we
                            // haven't  found yet the active tab then set foundActive and hasContent to true
                            var tabInnerHtml = Y.one("#reviewsTab").get('innerHTML');
                            // include className "emptyText" in div holding a small text indicating that this tab
                            // doesn't include content, so tab has real content if its innerHTML is not empty
                            // and doesn't include this string
                            var isNotEmptyContent = tabInnerHtml != '' && tabInnerHtml.indexOf("emptyText") < 0;
                            if(!false &&  isNotEmptyContent && !foundActive) {
                                foundActive = true;
                                hasContent = true;
                            }
                            var isActive = false || hasContent;
                            // if this is the active tab then set active class name to tab's label element
                            if(isActive) {
                                Y.all('.ui-tabs-hd > li').item(2).addClass('ui-tabs-hd-active');
                            }
                            // call function to build content of tab
                            createTab("reviewsTab", isActive);
                            
                            var hasContent = false; // does the current tab have content?

                            

                            // if call to template sets activeTabContentId attr then don't try to find active tab
                            // use the given one, otherwise get actual content of tab if they are not empty and we
                            // haven't  found yet the active tab then set foundActive and hasContent to true
                            var tabInnerHtml = Y.one("#kwdSearchTab").get('innerHTML');
                            // include className "emptyText" in div holding a small text indicating that this tab
                            // doesn't include content, so tab has real content if its innerHTML is not empty
                            // and doesn't include this string
                            var isNotEmptyContent = tabInnerHtml != '' && tabInnerHtml.indexOf("emptyText") < 0;
                            if(!false &&  isNotEmptyContent && !foundActive) {
                                foundActive = true;
                                hasContent = true;
                            }
                            var isActive = false || hasContent;
                            // if this is the active tab then set active class name to tab's label element
                            if(isActive) {
                                Y.all('.ui-tabs-hd > li').item(3).addClass('ui-tabs-hd-active');
                            }
                            // call function to build content of tab
                            createTab("kwdSearchTab", isActive);
                            

                            // add rounded corners
                            var uiTabsTopCorners = Y.all(".articleFullText .ui-tabs,.ui-tabs-hd > li");
                            uiTabsTopCorners.each(function(v) {

                                // dynamically create spans for rounded corners
                                var control = Y.Node.create(
                                        '<span class="rnd_corners">' +
                                        '<span class="rnd1"></span>' +
                                        '<span class="rnd2"></span>' +
                                        '<span class="rnd3"></span>' +
                                        '</span>'
                                    );

                                // prepend spans in desired node
                                var initTop = function() {
                                    v.prepend(control);
                                };

                                control.on("domready", initTop());
                            });

                            // now tabs content are ready remove JSLoading
                            // class name that was hiding them
                            Y.all('.JSLoading').removeClass('JSLoading');
                        });
                    });
                </script>
            </div>
        </div>
    </div>

 
                </div>
            </div>
        </div>

    


<!-- when referer is not from literatum (referer is null or not equals to the default host), display note on abstarct page -->



                        </div>
                      </div>
                </div>
                <div class="outerFooter">
                    <div id="footer">
                        
<span class="rnd_corners tp"><span class="rnd1"></span><span class="rnd2"></span><span class="rnd3"></span></span>
<div class="footerSnip">
    
<span class="fontSize2"><span style="font-family: Lucida Sans Unicode,Lucida Grande,sans-serif;">&nbsp;<a style="color: white; text-decoration: none;" href="http://www.annualreviews.org.proxy.library.emory.edu/page/about/trademark">COPYRIGHT 2010</a>&nbsp;&nbsp; |&nbsp;&nbsp; <a style="color: white; text-decoration: none;" title="Supplemental Materials" href="http://www.annualreviews.org.proxy.library.emory.edu/db/suppl">SUPPLEMENTAL MATERIALS</a>&nbsp;&nbsp; |&nbsp;&nbsp; <a style="color: white; text-decoration: none;" title="Personnel Directory" href="http://www.annualreviews.org.proxy.library.emory.edu/db/directory">ANNUAL REVIEWS DIRECTORY</a>&nbsp;&nbsp; |&nbsp;&nbsp; <a style="color: white; text-decoration: none;" href="http://www.annualreviews.org.proxy.library.emory.edu/page/about/privacy">PRIVACY POLICY</a></span></span><a style="color: white; text-decoration: none;" href="http://www.annualreviews.org.proxy.library.emory.edu/page/about/privacy"><span class="fontSize2"><span style="font-family: Lucida Sans Unicode,Lucida Grande,sans-serif;">&nbsp;&nbsp; |&nbsp;&nbsp;</span></span></a> <a title="Contact Annual Reviews" href="http://www.annualreviews.org.proxy.library.emory.edu/page/about/contact-us"><span style="color: white; text-decoration: none;"><span class="fontSize2"><span style="font-family: Lucida Sans Unicode,Lucida Grande,sans-serif;">CONTACT US</span></span><span class="fontSize2"><span style="font-family: Lucida Sans Unicode,Lucida Grande,sans-serif;"></span></span></span><span style="color: white; text-decoration: none;"><span class="fontSize2"><span style="font-family: Lucida Sans Unicode,Lucida Grande,sans-serif;"></span></span></span></a><a style="color: white; text-decoration: none;" href="http://www.annualreviews.org.proxy.library.emory.edu/doi/full/page/about/privacy"><span class="fontSize2"><span style="font-family: Lucida Sans Unicode,Lucida Grande,sans-serif;">&nbsp;</span></span></a><span style="color: white; text-decoration: none;"><span class="fontSize2"><span style="font-family: Lucida Sans Unicode,Lucida Grande,sans-serif;">&nbsp; |&nbsp;&nbsp;</span></span></span> <a title="Find Us On Facebook" href="http://www.facebook.com/AnnualReviews"><img alt="" style="vertical-align: text-bottom;" title="Find us on Facebook" src="facebook_badgesmall.png" height="21" width="21"></a>&nbsp;&nbsp;<a title="Follow Us On Twitter" href="http://www.twitter.com/AnnualReviews"><img alt="" style="vertical-align: text-bottom;" title="Follow Us on Twitter" src="twitter_badge_small.png" height="21" width="21"></a>&nbsp;&nbsp;<a title="Connect With Us On LinkedIn" href="http://www.linkedin.com/companies/annual-reviews"><img alt="" style="vertical-align: text-bottom;" title="Connect With Us on LinkedIn" src="linkedin_badge_small.png" height="21" width="21"></a>&nbsp;&nbsp;<a title="Follow Us on RSS" href="http://www.annualreviews.org.proxy.library.emory.edu/page/about/rssfeeds"><img alt="" style="vertical-align: text-bottom;" title="Follow Us on RSS" src="rss_image.png" height="21" width="21"></a> 
<br>

</div>



    

<script type="text/javascript" src="ga.js"></script>
<script type="text/javascript">try{var pageTracker=_gat._getTracker("UA-1828393-3");pageTracker._trackPageview()}catch(err){}</script>

    

<span class="rnd_corners btm"><span class="rnd3"></span><span class="rnd2"></span><span class="rnd1"></span></span>
                    </div>
                </div>
            </div>
        </div>
        <div class="bottomBorder"></div>
        <div class="bottomFooter">
            
<table style="margin: 10px;" class="mceItemTable" width="975">
<tbody style="text-align: left;">
<tr style="text-align: left;">
<td style="text-align: left;" valign="top"><span class="fontSize2"><span style="font-family: Lucida Sans Unicode,Lucida Grande,sans-serif;">Partner of:&nbsp; <a title="Agora" href="http://www.aginternetwork.org/en/"><img alt="" src="agora-sml.gif"></a>&nbsp;&nbsp;&nbsp; <a title="HINARI" href="http://www.who.int.proxy.library.emory.edu/hinari/en/"><img alt="" src="hinari-sml.gif"></a>
<br>
</span></span></td>
<td style="text-align: left;" valign="top">
<p><span class="fontSize2"><br>
</span></p>
<p><span class="fontSize2"><span style="font-family: Lucida Sans Unicode,Lucida Grande,sans-serif;">Technology Partner - <a title="Technology Partner - Atypon" href="http://www.atypon.com/">Atypon</a>
<br>
</span></span></p>
</td>
<td style="text-align: left;"><span class="fontSize2"><span style="font-family: Lucida Sans Unicode,Lucida Grande,sans-serif;">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;</span> <a title="Project Counter" href="http://www.projectcounter.org/members.html"><img alt="" src="counterlogo.jpg"></a> &nbsp;<a title="crossref membership" href="http://www.crossref.org/"><img alt="" src="crmemberlogo.gif"></a><span style="font-family: Lucida Sans Unicode,Lucida Grande,sans-serif;"></span></span><span style="font-family: Lucida Sans Unicode,Lucida Grande,sans-serif;"><span class="fontSize2"><br>
</span></span></td>
</tr>
</tbody>
</table>

        </div>
    </div>
</div>
                
</body>
</html>
